



Protein Discovery Platform Using Deer 





A thesis submitted for the degree of Doctor of Philosophy at the 
University of Otago, Dunedin, New Zealand 
 
 
Sir John Walsh Research Institute 






The ability to activate and regulate stem cells during wound healing and tissue 
regeneration is a promising field which could bring innovative approaches into 
regenerative medicine. The regenerative capacity of invertebrates has been well 
documented, however in mammals, stem cells that drive organ regeneration are rare. 
Deer antler is the only known mammalian structure that can annually regenerate to 
produce a complex tissue. The neural crest derived stem cells that drive this process result 
in antler growing at up to 2 cm/day. Deer antler appears to outweigh lower-order animal 
models when investigating the regulation of stem cell-based regeneration. Pleiotrophin 
(PTN) is a multifunctional heparin-binding growth factor; the PTN gene is found highly 
expressed within the active antler stem cell tissues. The studies presented in this thesis 
aimed to examine the location of stem cells during antler growth, the proteomic profiles 
of different pools of stem cells involved in antler generation and regeneration, and the 
role of the PTN growth factor family in stem cell regulation. 
 
The differentially expressed proteins between cells derived from stem cell niches involved 
in antlerogenesis (antlerogenic periosteum) and regeneration (potentiated and dormant 
pedicle periosteum), and cells derived from deer facial periosteum as a control (n = 3) 
were identified using 2D-DIGE-based quantitative proteomics. Label-free mass 
spectrometry was further used to detect the protein expression profiles of antler stem 
cell tissues under different stages of activation and included: dormant pedicle periosteum, 
growth centre, post-active stem cells from mid-beam periosteum, and control facial 
periosteum (n = 3). Mesenchymal stem cell markers CD73, CD90 and CD105, along with 
PTN/midkine (MDK) growth factors and their receptors (PTPRZ, ALK, NOTCH2, ITGAV and 
ITGB3), were examined in antler tissues using immunohistochemistry. In vitro effects of 
PTN on proliferation and osteogenic differentiation of antler stem cells were also 
investigated. 
 
Ninety-two differentially expressed proteins were identified by 2D-DIGE. Bioinformatic 
analysis indicated the epithelial-mesenchymal transition process may participate in the 
initiation of wound healing and subsequent antler regeneration; cell mobility was highly 
 III 
involved during antler regeneration; energy and nucleotide metabolism may however be 
less active in antler regeneration as compared to that in antler generation phase. 
Immunohistochemistry confirmed the central role of stem cells in the development of this 
mammalian structure by localising the mesenchymal stem cell markers within the antler 
growth centre. Label-free quantification distinguished unique markers of dormant (6), 
active (87) and post-active (3) antler stem cells showing that the greatest number of 
proteins was exclusively found in the active stem cell tissue. There were only 12 proteins 
detected with expression levels that significantly differed between tissue with dormant 
stem cells and the control tissues. Protein profiles of these two groups showed that antler 
stem cells may use similar mechanisms to maintain dormancy within a stem cell niche. 
One hundred fifty-three significantly regulated proteins were found between antler stem 
cell tissues under different activation stages; activation of antler stem cells was associated 
with up-regulation of a number of canonical pathways and molecular/cellular functions 
such as Hippo and canonical Wnt signalling. PTN was identified as the dominant growth 
factor in the PTN/MDK family with higher expression levels in the antler growth centre. 
High expression of PTPRZ and ALK co-localised with PTN suggested their potential 
interactions. The high levels of PTN and PTPRZ also reflected the antler stem cell activation 
status during the regenerative process. When antler stem cells were cultured in vitro 
under the normoxic condition, no PTN was expressed and exogenous PTN did not induce 
differentiation or proliferation but rather stem cell maintenance. 
 
In summary, this research project explores potential biomarkers for mammalian stem 
cells, as well as the key proteins, biological processes and pathways involved in stem cell 
maintenance, development and activation during antler generation and regeneration.  
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DPCs dermal papilla cells PRM/MRM parallel/multiple reaction 
monitoring 
DPP dormant pedicle periosteum PSEN1 presenilin 1 
DPP-IV dipeptidyl peptidase IV PSEN2 presenilin 2 
DPPCs dormant pedicle periosteum cells PTH1R parathyroid hormone 1 
receptor 
DRPs differentially regulated proteins PTHRP parathyroid hormone like 
hormone 
DTT dithiothreitol PTM  post-translational 
modification 
dUMP deoxyuridine monophosphate PTN pleiotrophin 
DUT  deoxyuridine triphosphatase PTPRZ receptor-type tyrosine-
protein phosphatase zeta 
dUTP deoxyuridine triphosphate PVDF polyvinylidene fluoride  
EDTA ethylenediamine tetraacetic acid qRT-PCR quantitative real-time 
polymerase chain reaction 
EFB1 elongation factor 1-beta R5P ribose 5-phosphate 
ELISA enzyme-linked immunosorbent assay  RAR and RXR 
families 
retinoic acid receptor and 
retinoid X receptor families 
EMT epithelial-mesenchymal transition RCN1  reticulocalbin 1 
EPAS1 endothelial PAS domain protein 1 REL REL proto-oncogene, NF-kB 
subunit 
 XXII 
ESC embryonic stem cell rhPTN recombinant human PTN 
EST expressed sequence tag RM  reserve mesenchyme layer  
FA formic acid  RNA-seq RNA sequencing 
FABP4 fatty acid binding protein 4 RUNX2 RUNX family transcription 
factor 2 
FAM207A family with sequence similarity 207 
member A 
S sonication 
FAM83A family with sequence similarity 83 
member A 
S100A10 S100 calcium binding protein 
A10 
FASP filter-aided sample preparation S100A4  S100 calcium binding protein 
A4 
FBS  fetal bovine serum S100A7 S100 calcium binding protein 
A7 
FKBP4 FKBP prolyl isomerase 4 SDS  sodium dodecyl sulphate 
FKBPL  FKBP prolyl isomerase like SDS-PAGE sodium dodecyl sulphate-
polyacrylamide gel 
electrophoresis 
FN1 fibronectin 1 sec second 
FOS fos proto-oncogene, AP-1 transcription 
factor subunit 
SFRP4  secreted frizzled related 
protein 4 
FOXO4 forkhead box protein O4 SHC1 SHC adaptor protein 1 
FP facial periosteum SILAC stable isotope labelling 
by/with amino acids in cell 
culture  
FPCs facial periosteum cells Slug  snail family transcriptional 
repressor 2 
Freeze freeze dried SOX2 SRY-box transcription factor 2 
g gram SOX9 SRY-box transcription factor 9 
GAPDH glyceraldehyde-3-phosphate 
dehydrogenase 
SPARC  secreted protein acidic and 
cysteine rich 
GC growth centre SRC  SRC proto-oncogene, non-
receptor tyrosine kinase 
GCCs growth centre cells SREBF1/2 sterol regulatory element 
binding transcription factor 
1/2 
GDF10  growth differentiation factor 10 SRF serum response factor 
GNB1 G protein subunit beta 1 SRPX sushi repeat containing 
protein X-linked 
 XXIII 
GNB2 G protein subunit beta 2 STMN1 stathmin 1 
GNG4 G protein subunit gamma 4 T testosterone 
GO Gene Ontology TALDO1 transaldolase 1 
GPCRs G protein-coupled receptors  TBST tris-buffered saline buffer and 
0.1% of Tween-20 
GTSE1  G2 and S-phase expressed 1 TEK TEK receptor tyrosine kinase 
h hour TFA trifluoroacetic acid 
HCA hierarchical cluster analysis TGFBR1 transforming growth factor 
beta receptor 1 
HIF1A hypoxia-inducible factor 1 alpha TIC total ion current 
HIF2A hypoxia-inducible factor 2 alpha TKT  transketolase 
HMGB1  high-mobility group box 1 TMSB10 thymosin beta 10 
HNRNPK heterogeneous nuclear 
ribonucleoprotein K 
TMT tandem mass tag 
HP haptoglobin TP53 tumour protein p53 
HRP  horseradish peroxidase TPM  tropomyosins 
HSD honestly significant difference TPM1 tropomyosin 1 
HSP90  heat shock protein 90  TPT1 tumour protein, 
translationally-controlled 1 
HSP90AA1  heat shock protein 90 alpha family 
class A member 1 
Trad traditional 
HSP90AB1 heat shock protein 90 alpha family 
class B member 1 
TTR  transthyretin 
HSP90B1 heat shock protein 90 beta family 
member 1 
TZ transition zone layer 
HSPA1A  heat shock protein family A (Hsp70) 
member 1A 
UHRF1 ubiquitin like with PHD and 
ring finger domains 1 








HSPA9  heat shock 70  UV ultraviolet 
HSPD1  heat shock 60 V volt 
HUVECs  human umbilical vein endothelial cells  v:v volume:volume 
IAA iodoacetamide v/v volume/volume 
IBSP integrin binding sialoprotein VEGF  vascular endothelial growth 
factor 
 XXIV 
IEF isoelectric focusing VEGFA vascular endothelial growth 
factor A 
IGF1 insulin like growth factor 1 Vh volt hour 
INSIG1 insulin-induced gene 1 protein VIM vimentin 
IPA Ingenuity Pathway Analysis W watts 
IPG immobilised pH gradient w/v weight/volume 
IPMK inositol polyphosphate multikinase WNT4 wnt family member 4 
iPSCs induced pluripotent stem cells YAP1 yes associated protein 1 
ISH in situ hybridisation YWHAB/Z 14-3-3 beta and zeta 
ITGAV integrin subunit alpha V μg microgram 
ITGB3 integrin subunit beta 3 μL microliter 
iTRAQ isobaric tags for relative and absolute 
quantitation 
μm  micrometre 
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1.1 Introduction  
Each chapter within this thesis, with the exception of the review of the literature, is 
written in the manuscript style derived from the published papers or to facilitate its 
submission for publication; but all have some modifications to fit the thesis format. 
Whenever necessary, the detailed experimental methods and supportive materials (i.e. 
raw data) can be found in the appendices. 
 
This chapter provides an introduction and brief literature review of stem cell-based 
regeneration. Deer antler, a neural crest stem cell-based mammalian regenerative 
structure, is used as our experimental model. The proteomics technical platforms used 
for investigating the molecular mechanisms underlying antler tissue regeneration are also 
introduced. 
 
1.2 Regenerative medicine 
Regenerative medicine as an emerging field in medicine that could provide promising 
alternative solutions in treating congenital defects, injuries and diseases in humans (Mao 
& Mooney, 2015). Long term, it could ultimately solve the significant issues associated 
with organ shortages in transplant patients experiencing organ failure and damaged 
(Dzobo et al., 2018; Heidary Rouchi & Mahdavi-Mazdeh, 2015). Regenerative medicine is 
an interdisciplinary field utilising engineering and life science principles to achieve 
organ/tissue regeneration in vitro (Dzobo et al., 2018; Mao & Mooney, 2015). Its clinical 
application, such as in craniofacial bone regeneration, mainly depends on the interactions 
between biomaterials, growth factors and stem cells (Ito, 2019; Murphy & Atala, 2013; 
Tollemar et al., 2016). Among them, biomaterials like hydrogels provide the scaffold for 
stem cell adhesion and functioning, and also regulate the release of growth factors within 
the microenvironment; stem cells then grow and differentiate into the desired tissue 
types determined by the growth factor microenvironment (Ito, 2019; Mitchell et al., 2016; 
Murphy & Atala, 2013). Understanding stem cell maintenance, regulation, and activation 
within a unique stem cell niche and then manipulating the stem cell-niche interactions 
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will therefore contribute to the development of regenerative medicine (de Lucas et al., 
2018; Lane et al., 2014). 
 
1.3 Mammalian stem cells 
In order to address the question of how to regulate stem cells, it is necessary to first define 
what constitutes a mammalian stem cell. Stem cells are known to play crucial roles in 
tissue and organ formation and regeneration in mammals (Terskikh et al., 2006). Based 
on a current definition, cells need to fulfil four criteria to be stem cells (Slack, 2018). Stem 
cells should: 
• have the ability of self-renewal. 
• maintain stemness and stem cell behaviour as regulated by the contacting 
microenvironment. 
• be progenitor cells and generate different types of differentiated cells. 
• last for long periods of time, meaning indefinite growth in vitro or lifelong presence in 
vivo. 
 
 Mammalian stem cell types 
Mammalian stem cells can be classified into two categories depending on their cellular 
properties. One type is induced pluripotent stem cells (iPSCs), which are primed stem cells 
induced by cell reprogramming factors; the other one is naïve stem cells (Nichols & Smith, 
2009). In mammals, the zygote has the greatest naïve stem pluripotency as it can form 
the whole body (Reichmann et al., 2018). Embryonic stem cells (ESCs) originate from the 
zygote and differentiate into four different germ layers including endoderm, mesoderm, 
ectoderm and neural crest (Chen et al., 2012; Liu & Cheung, 2016; Schmitteckert et al., 
2020; Wobus, 2001). A zygote is thus the only cell with the totipotent differentiation 
capacity (Figure 1.1) (Berdasco & Esteller, 2011; Menon et al., 2016). The iPSCs and ESCs 
are defined as pluripotent and can differentiate into most cell types. The four germ layers 
with multipotent capacity can produce differentiated cells for specific organs and tissues. 
The adult stem cells residing within organs/tissues derived from different germ layers are 
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therefore considered to possess the lowest differentiation capacity in the mammalian 
stem cell lineage. 
 
 
Figure 1.1 Mammalian stem cell types and potency. There are two types of mammalian 
stem cells; one is induced pluripotent stem cells (iPSCs), and the other one is embryonic 
stem cells (ESCs). 
 
 Adult stem cells 
Although adult stem cells have limited differentiation capacity as compared to embryonic 
stem cells, they play important roles in physiological cell turnover and mild injury repair 
in the adult, such as hepatocyte replication and bone fracture healing (Carpino et al., 2016; 
Iaquinta et al., 2019; Montagnani et al., 2016). The mammalian adult stem cell 
populations are also tissue-specific. They reside in various tissues and organs including 
skin, bone marrow, lung, kidney, and liver (Montagnani et al., 2016). It is however still 
difficult to accurately identify organ specific stem cells, and some even remain disputed, 
such as the existence of “cardiac stem cells” (Kretzschmar et al., 2018; Spangrude, 2003). 
Their ability to drive repair and regeneration is also not static, and in mammals it is 
attenuate with aging (Yun, 2015). This is especially evident in neurodegenerative 
disorders commonly found in elderly; where decreasing neural stem cells result in age-
related cognitive decline (Artegiani & Calegari, 2012). Investigation of how to distinguish, 
maintain and activate adult stem cells is therefore of great importance in clinical medicine. 
 
 Neural crest-derived stem cells 
Multiple adult stem cell pools, in various tissues and organs, are derived from the neural 
crest (Dupin et al., 2018), the fourth germ layer of embryogenesis (Figure 1.1). The neural 
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crest is a specific cell population unique to vertebrate embryos; together with the neural 
tube and the epidermis, they originate from the ectoderm (Selleck & Bronner-Fraser, 
1995). Neural crest stem cells undergo an epithelial-mesenchymal transition to 
delaminate from the neural tube and then become motile resulting in wide distribution 
throughout the embryo (Bronner & Simões-Costa, 2016). The neural crest stem cells form 
a large number of cell types, of which the descendants can be found not only in neurons 
of the peripheral nervous system and craniofacial structures like tooth, but also in skin, 
heart, and gut (Hall, 2008; Liu & Cheung, 2016). Among them, dental stem cells have been 
identified as having high potential therapeutic utility. The merits of dental stem cells, 
compared to other sources, include less invasive harvesting and low-risk autologous 
immune rejection (Achilleos & Trainor, 2012; Shyamala et al., 2015). The origin of the 
neural crest stem cells means they retain the capability to differentiate into other neural 
crest stem cell-derived tissues, such as the nervous system. The pool of stem cells 
responsible for deer antler regeneration is also a derivative of the craniofacial structures 
and are increasingly considered a good model to investigate regulation and differentiation 
of neural crest-derived stem cells (Kierdorf et al., 2009; Wang et al., 2019b). 
 
1.4 Deer antler - a neural crest stem cell-based mammalian regenerative 
model 
Deer antler is the cranial appendage of deer which regenerates annually from a pool of 
neural crest derived stem cells (De et al., 2014). Deer is an even-toed ungulate ruminant 
belonging to Cervidae (Theodor, 2001). One of the widely accepted classifications is to 
divide the antlered Cervidae into two subfamilies, namely Cervinae and Capreolinae. 
There are 47 species under these two subfamilies which are native to Europe, Asia, North 
Africa, and Americas (Hernandez Fernandez & Vrba, 2005). Horn is another type of cranial 
appendages found in the even-toed hoofed ruminant, like cattle and sheep. It is markedly 
different to antler as it has a bone core, covered by a permanent sheath of keratin. Antlers 
grow with soft tissues (dermis/epidermis) covering the bone and then before maturation 
shed the skin to leave the bone exposed, they can also regrow annually unlike a horn (De 
et al., 2014; Janis & Scott, 1987). Deer antler is normally considered a male deer 
characteristic (De et al., 2014). There are however two exceptions to this in nature. One 
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is reindeer which grow antlers in both the male and female, however the latter is much 
smaller in size (Hall, 2005). The other exception is the water deer, in which both sexes lack 
antlers (Randi et al., 1998). Apart from these two exceptions, all other deer species have 
male-specific antler generation and regeneration (Hall, 2005). 
 
 Antler generation 
When a deer is born, no obvious protrusion can be found on the head. The antler forms 
from two regions of periosteum overlying the lateral crests of the frontal bone (Figure 
1.2A), called antlerogenic periosteum. Antler generation starts from these thin layers of 
periosteum. After reaching puberty, antlerogenic periosteum induces the formation of 
the pedicle (Figure 1.2B), a permanent bone appendage attached to the deer frontal bone, 
and then the development of the first-years antler (Figure 1.2C) (Li & Suttie, 2001). The 
evidence for this is based on the following findings. 
• Antlerogenic periosteum deletion and transplantation, including the ectopic 
transplantation of antlerogenic periosteum on the nasal bone and foreleg, and its 
xenogeneic transplantation together with covering skin onto a nude mouse (Goss, 
1983; Li et al., 2009a; Li et al., 2001; Li & Suttie, 2001). The former experiment resulted 
in the formation of a pedicle and antler at the implanted sites rather than original 
regions; the latter experiment produced a pedicle-shaped protuberance with antler-
like bony tissue in the nude mouse. 
• All cell types constituting the intra-component (bone) of the pedicle and first-year 
antler were identified as descendant from antlerogenic periosteum cells by tracing a 
labelled LacZ gene before and after pedicle formation in vivo (Li & Suttie, 2001). 
• Antlerogenic periosteum cells express multiple mesenchymal and embryonic stem cell 
markers when cultured in vitro; they have high telomerase enzyme activity and high 
nucleostemin expression suggesting robust self-renewal and proliferation of the 
antlerogenic periosteum stem cells. They can also be induced to differentiate into 
numerous cell types including chondroblasts, adipocytes, osteoblasts and muscle 
precursor cells (Berg et al., 2007; Li et al., 2009b; Wang et al., 2019a). In addition, the 
mesenchymal/epithelial interactions between the antlerogenic periosteum and its 
overlying skin are indispensable for the initiation of antler generation. This has been 
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proven by in situ membrane insertion between the antlerogenic periosteum and 
enveloping skin, as well as their co-transplantation onto a nude mouse (Li et al., 2009a; 
Li et al., 2008). Covering skin may therefore provide a microenvironment required for 
the maintenance and regulation of antler stem cells. 
 
Collectively, the stem cells residing in antlerogenic periosteum interacting with the 
overlying antler skin result in antlerogenesis. 
 
 
Figure 1.2 Deer antler generation and regeneration. When a deer reaches puberty, 
antlerogenic periosteum (A; red), which is situated over the frontal bone, grows into a 
permanent bone protrusion, called pedicle (B; Blue), and the periosteum around the 
pedicle produces antlers annually (C; Brown). (C) Deer antler growth is driven from stem 
cells residing in the reserve mesenchyme layer (RM) within the growth centre, which is in 
the antler tip; other layers include dermis (D), blood vessel (BV), precartilage (PC), 
transition zone (TZ), and cartilage (C). Number 1 means pedicle formation from 
antlerogenic periosteum; number 2 means the antler growth and regrowth (after 
shedding of the last year antler; number 3) from the pedicle periosteum. 
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 Antler regeneration 
The annual regrowth of antler is derived from the periosteum around the pedicle (Figure 
1.2B). Pedicle is considered to be the main derivative structure formed from the 
antlerogenic periosteum, and both of them are of neural crest origin (Kierdorf & Kierdorf, 
2002). Pedicle growth consists of four ossification processes (Li & Suttie, 1994) and is 
initiated via intramembranous ossification to form the frontal lateral crest, which includes 
antlerogenic periosteum and underlying cancellous bone (under 5 mm of pedicle in 
height). In the transitional stage (5-20 mm of pedicle in height), the pedicle develops into 
three parts from distal to proximal containing periosteum/perichondrium, 
osseocartilaginous tissue, and osseous tissue, but with an extended proportion of 
osseocartilaginous tissue later in this stage. When the cartilaginous tissue appears, the 
pedicle formation enters into the third stage, namely pedicle endochondral ossification 
(25-40 mm of pedicle in height). The last stage is endochondral ossification (60 mm of 
pedicle in height) which only occurs with the appearance of antler velvet (skin). 
 
After shedding of the first-years antler, it is believed that the periosteum of the pedicle is 
responsible for inducing the subsequent years antler. Experiments have investigated the 
role of pedicle skin, bone, and periosteum in antler regeneration and found that total and 
partial pedicle periosteum deletion experiments result in ablation of antler growth (Li et 
al., 2007a). The pedicle periosteum is divided into dormant (proximal two-thirds) and 
potentiated (distal third) portions based on the degree of contact between periosteum 
and covering skin (Figure 1.2B), and the interaction between distal pedicle periosteum 
and covering skin provides the niche required to trigger antler regeneration (Li & Suttie, 
2003; Li et al., 2007c; Li et al., 2009b). Antler stem cells residing in the pedicle periosteum 
express both mesenchymal and embryonic stem cell markers in vitro and can be induced 
into multiple cell types, such as osteoblasts, chondrocytes, adipocytes, and neuronal-like 
cells (Li et al., 2009b; Rolf et al., 2008; Wang et al., 2019a). Recent studies have further 
confirmed pedicle periosteum cells as neural-crest-derived stem cells (Dong et al., 2019; 
Kierdorf et al., 2009; Wang et al., 2019b). Ectopic transplantation of pedicle periosteum 
however cannot induce antler formation (Li et al., 2007a) suggesting the multipotency of 
pedicle periosteum is similar but not as robust as antlerogenic periosteum. 
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When antler formation is initiated and enters into the annual regeneration cycle, antler 
growth is regulated by testosterone levels (Fennessy & Suttie, 1985; Price et al., 2005b). 
In early spring, and under relatively low testosterone levels, wound healing takes place 
over the cast plane of a pedicle stump following the shedding of the previous year’s hard 
antler (Li et al., 2005; Price et al., 2005b). Interestingly, instead of forming a scar to seal 
the defect, the distal pedicle skin rapidly heals the open wound (Li et al., 2005). Periosteal 
stem cells residing in the distal pedicle periosteum are activated and form active stem cell 
pools on the distal surface known as growth centres (Li, 2012; Li et al., 2005). When the 
testosterone level is barely detectable during summer, the active stem cells in the antler 
growth centre differentiate into multiple layers including dermis, blood vessel, reserve 
mesenchyme, precartilage, cartilage, and bone (Figure 1.2C), with an antler growth rate 
of up to 2 cm/day and as much as 30 kg within three months (Goss, 1983, 1990; Kierdorf 
et al., 2003; Li & Suttie, 1994; Li et al., 2005; Price et al., 2005a). In autumn, as the breeding 
season commences and with testosterone levels increasing to their peak, the antler velvet 
sheds to expose the bare bony antler surface (Fennessy & Suttie, 1985; Lincoln, 1971; 
Price et al., 2005b). Hard antler is retained and attached firmly to the pedicle under 
declining testosterone levels until the next year’s spring (Fennessy & Suttie, 1985; Price 
et al., 2005b). Castration of the deer during rapid antler growth also confirms antler 
regeneration is testosterone level-dependent. In red deer, castration may affect velvet 
shedding and antlers do not become mature and turn into bone; in castrated fallow and 
roe deer, antlers have even been shown to become tumour-like structures (Price et al., 
2005b). 
 
 Animal models of regeneration 
Deer antler is a unique mammalian model among the regenerative animal models, and is 
regarded as an ideal to investigate neural crest stem cell-based regeneration (Table 1.1). 
 
Four different classifications of regeneration listed in Table 1.1 are introduced first prior 
to discussing differences between deer antler and other animal models. Based on the 
regeneration capacity (Bely & Nyberg, 2010; Mehta & Singh, 2019), the highest level is 
called whole body regeneration, under which an animal can regenerate any part of the 
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body into the entire organism, for example, one planarian can be cut up to 279 tiny pieces 
and each piece regenerates completely (Morgan, 1898). Structure regeneration is the 
second level and includes regeneration of multi-cellular types but excluding regeneration 
of internal organs, such as deer antler regeneration. Organ regeneration refers to size and 
function restoration of internal organs coming from several lineages of cells, such as 
zebrafish heart and newt lens regeneration. Tissue regeneration is the repair of a defect 
within a structure or organ by a homogeneous cell population, such as epidermal 
regeneration. 
 
Within the animal models of regeneration, deer antler is referred to as representative of 
a physiologically regenerative structure. Physiological regeneration refers to the regular 
and repeated renewal of a particular structure or tissue; it is a natural process happening 
throughout the life of an organism. Reparative regeneration however is initiated only 
when some parts of the body are lost or damaged; they can be restored partially or 
completely depending on the species (Franco et al., 2013; Iismaa et al., 2018). 
Regeneration in the majority of animal models is triggered by signalling induced after 
injury. Deer antler is therefore a rare structure model of physiological regeneration (Table 
1.1). 
 
Deer antler is also the only known animal model of regeneration that does not form from 
a dedifferentiation-based blastema to achieve structural regeneration in vertebrates (Li & 
Chu, 2016; Li et al., 2005). This is unusual considering nearly all the other animal structures, 
such as salamander limb and lizard tail, are regenerated from a dedifferentiation-based 
blastema (Alibardi, 2017, 2018; McCusker & Gardiner, 2014). Both deer antler generation 
and regeneration are however stem cell-based (Wang et al., 2019a). Dedifferentiation is 
a process by which organisms produce new cells; these cells normally lose their 
differentiated characteristics and become progenitor cells. The blastema is one example 
of dedifferentiation. It consists of undifferentiated progenitor cells and appears at the 
amputation site to contribute to structure regeneration (Tanaka & Reddien, 2011). 
Invertebrates like Hydra and Planaria can regenerate their whole body using stem cells 
(Tanaka & Reddien, 2011); it is fascinating why deer, as a more phylogenetically evolved 
 11 
species than salamander and lizard, adopts stem cell rather than a blastema-based 
structure regeneration. Antler regeneration therefore has similarities to both stem cell-
based whole-body regeneration and blastema-based structure regeneration. This makes 
deer antler an ideal model to investigate both kinds of regeneration. 
 
Mammalian models of regeneration are important considering they are closer to Homo 
sapiens when compared to other animal models (Table 1.1). Within mammalian models, 
the regenerative capacity of deer antler appears to be more robust than in African spiny 
mice. Spiny mice, different from other rodents, can regenerate tissues including skin and 
muscle (The Developmental Cell Editorial Team, 2017). Tissue regeneration of spiny mice 
is both blastema-dependent as in the ear pinna (Simkin et al., 2017), and stem cell-
dependent in skin (Jiang et al., 2019). African spiny mice can thus utilise both regeneration 
processes to repair tissue after injury; deer antler uses only stem-cell-based regeneration 
but this results in a more complex structure containing skin, nerves, blood vessels, reserve 
mesenchyme, cartilage and bone (Table 1.1 and Figure 1.2). Deer antler therefore 
provides an opportunity to address how deer retain this strong regenerative capability 
compared to other mammals, and how antler stem cells are regulated during this 
exquisite process. 
 
Table 1.1 Comparison of representative animal models of regeneration. 
Species Taxa Class 
Regeneration 
classification 
(Bely & Nyberg, 




(Franco et al., 
2013; Iismaa 






(Braun & Keren, 2018; 
Buzgariu et al., 2018) 
Cnidaria Hydrozoa Whole body Reparative Stem cell 
Planaria  
(Gehrke & Srivastava, 
2016; Pellettieri et al., 
2010) 
Platyhelminthes Rhabditophora Whole body Reparative Stem cell 
Zebrafish  
(Brilli Skvarca et al., 2019; 






and stem cell 
Xenopus/Salamander  
(Jewhurst & McLaughlin, 






and stem cell 
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Species Taxa Class 
Regeneration 
classification 
(Bely & Nyberg, 




(Franco et al., 
2013; Iismaa 






(Alibardi, 2017, 2018; 
Londono et al., 2017; 






and stem cell 
African spiny mice  
(Jiang et al., 2019; Simkin 
et al., 2017; The 
Developmental Cell 
Editorial Team, 2017) 
Vertebrate Mammalia Tissue Reparative 
Dedifferentiation 
and stem cell 
Deer  
(Li, 2012; The 
Developmental Cell 
Editorial Team, 2017; 
Wang et al., 2019a) 
Vertebrate Mammalia Structure Physiological Stem cell 
 
Overall, the study of deer antler, as a physiological stem cell-based mammalian 
regeneration model, is of great value to regenerative medicine. A large variety of proteins 
are expressed in different stages of antler generation and regeneration, and it is these 
protein-protein interactions that play an important role in regulating the stem cells 
involved in antler growth and development (Dong et al., 2019; Dong et al., 2020). One of 
the mainstream approaches to discover these proteins and the underlying mechanisms is 
proteomics. 
 
1.5 Proteomics and regeneration 
 Introduction of proteomics  
Proteome refers to the entire set of proteins encoded by a genome in a given type of cell, 
tissue or organism at a given time under defined conditions (Yoithapprabhunath et al., 
2015). This word is coined from the total protein complement of a genome (Wasinger et 
al., 1995). The term proteomics is the study of the proteome similar to the word genomics, 
the study of the genome (Tyers & Mann, 2003). Proteomic studies generate large-scale 
protein datasets and analyse protein profiles to elucidate the different properties of 
proteins in samples directly or indirectly including: location, abundance, isoforms and 
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post-translational modifications, protein-protein interactions, and protein activity 
patterns (Chandramouli & Qian, 2009; Tyers & Mann, 2003). Proteomics is one of the 
fastest growing areas in life sciences, and is undergoing a knowledge explosion era with 
numerous new approaches (Aebersold & Mann, 2003). 
 
 Qualitative and quantitative proteomics 
Proteomics can be divided into qualitative and quantitative proteomics based on 
applications (Domon & Aebersold, 2006). Qualitative proteomics is used to characterise 
proteins in complex mixtures (Ong & Mann, 2005). Protein identification provides limited 
information to address biological questions. Quantitative proteomics has therefore been 
preferred over the last two decades. It consists of multiple categories however the 
majority belong to either top-down or bottom-up proteomic strategies. 
 
The main difference is that the top-down approach largely focuses on intact protein 
molecules resulting in 100% sequence coverage (Catherman et al., 2014). This is achieved 
by introducing intact protein ions into the mass spectrometer for fragmentation and 
identification; the yielding protein molecular mass and protein ion fragment ladders can 
be then used to obtain the complete primary structure of the protein (Chait, 2006). 
 
Bottom-up proteomics, as the prevailing proteomic approach, however focuses on 
multiple enzymatically digested peptides from intact protein mixtures of the crude 
protein extract. The resulting peptides are then analysed by mass spectrometry in two 
rounds. The first one determines the masses of the proteolytic peptides, and the second 
round identifies sequence of these peptide ions with the aid of specific peptide spectral 
library (Chait, 2006). This normally returns a sequence coverage of 5-70% but with better 
proteome coverage, sensitivity and enhanced ability to cope with complex samples 
(Kelleher, 2004; Toby et al., 2016; Yates et al., 2009). 
 
As the mainstream technique, bottom-up proteomics has three main approaches as 
defined according to the data acquisition modes, one is called data-dependent acquisition 
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(DDA), one is targeted data acquisition, and the third is data-independent acquisition (DIA) 
(Gillet et al., 2016). 
 
In the DDA mode, the precursor ions are chosen by the instrument depending on the 
abundance of peptides, and mass spectrum analysed with a database searching algorithm; 
this method has the highest breadth of sample identification, and the easiest instrument 
setup and data analysis among the approaches. 
 
In the targeted mode, limited precursor ions are customised based on a previous DDA 
identification regardless of their abundance; this method can select and fragment the 
same precursors repeatedly to obtain the best accuracy and reproducibility. 
 
In the DIA mode, similar to the targeted mode, all precursor ions within large and pre-
defined mass ranges are selected, fragmented, and analysed multiple times; this gives the 
DIA approach both a high peptide identification breadth like DDA and high sensitivity as 
in the targeted mode (Hu et al., 2016). The tendency in bottom-up proteomics is for 
greater reliance on LC-MS/MS instruments with higher sensitivity and reproducibility, and 
on use of the label-free based strategy. This is largely because the easiest and most 
straightforward technique better reflects the genuine composition of samples. DIA 
proteomics is an emerging approach, and as such is still in its development stage (Hu et 
al., 2016; Koopmans et al., 2018), and few DIA studies have been performed in animal 
models of regeneration, and none in deer antler. The main approaches used in deer antler 
proteomics include top-down, DDA, and targeted proteomics. These approaches have 
been summarised (Figure 1.3) and compared (Table 1.2). 
 
 Gel-based quantitative proteomic approaches 
Two-dimensional gel electrophoresis (2DE) was the first technique employed in proteomic 
research (Wasinger et al., 1995); it uses two-dimensional separation based on the 
isoelectric point of proteins by isoelectric focusing and then molecular weight separation 
in sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) gels (Cristea 
et al., 2004). Protein spots are excised before performing top-down proteomics. Two-
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dimensional fluorescence difference gel electrophoresis (2D-DIGE) is an advancement of 
2DE with better sensitivity and reproducibility due to the introduction of different 
fluorescent dyes (Cy2, Cy3 and Cy5) to allow multiplexing of samples, and pooled internal 
standards to improve spot matching across the 2DE gels (Arentz et al., 2015). 
 
 Gel-free quantitative proteomic approaches 
Bottom-up proteomics, as mentioned above, are the most commonly used gel-free-based 
approaches in recent times and include both labelled and label-free strategies. Among 
them, stable isotope labelling with amino acids in cell culture (SILAC) has been used to 
label samples from organism or cell culture by metabolically incorporating isotope-
labelled amino acids into proteins during translation (Ong et al., 2002; Zanivan et al., 2012). 
The in vivo labelling makes it unique among all approaches and can be applied to biological 
questions relevant to regulatory mechanisms only found in vivo, which others approaches 
cannot address (Sury et al., 2010). 
 
Isobaric tags for relative and absolute quantitation (iTRAQ) and tandem mass tag (TMT) 
are the main commercial in vitro approaches using labelling (Rauniyar & Yates, 2014). 
They label the digested peptides by different isobaric mass tags, and can label more 
samples than SILAC because of multiple tags developed. This means that they display 
similar proteome coverage and accuracy as SILAC but with higher throughput and less 
effort (Table 1.2). 
 
Label-free strategies include label-free quantification, targeted and DIA proteomics 
(Parker et al., 2016; Rauniyar, 2015). In label-based targeted proteomics (Table 1.2), a 
known concentration of labelled custom peptide is introduced for absolute quantification, 
rather than labelling of all the samples. Label-free proteomic approaches are normally 
considered to have the highest throughput and dynamic range (Table 1.2), as they are 
easier to perform and reflect the properties of samples better; however this can be at the 




It should be noted that there are no good or bad techniques. The merits and drawbacks 
of each approach need to be considered before choosing the most appropriate one based 
on the biological questions, experimental design, and sample properties. A standard 
workflow for quantitative proteomics is outlined (Figure 1.4). 
 
 
Figure 1.3 Classifications of quantitative proteomics. LC-MS, liquid chromatography–mass 
spectrometry; 2DE, two-dimensional gel electrophoresis; 2D-DIGE, two-dimensional 
fluorescence difference gel electrophoresis; SILAC, stable isotope labelling with amino 
acids in cell culture; iTRAQ, isobaric tags for relative and absolute quantitation; TMT, 
tandem mass tag; PRM/MRM, parallel/multiple reaction monitoring. 
 
































Wasinger et al., 
2013) 
Pros  
(Arentz et al., 2015; 
Boersema et al., 2009; 
Megger et al., 2014; 
Rauniyar, 2015; Shi et al., 
2016; Tiwari & Tiwari, 
2014) 
Cons  
(Arentz et al., 2015; 
Boersema et al., 2009; 
Megger et al., 2014; 
Rauniyar, 2015; Tiwari & 
Tiwari, 2014) 
2DE None 




1. Easy to handle. 
2. Suitable for MS analysis. 
1. Low throughput. 
2. Poor recovery of 
hydrophobic and 
membrane proteins. 
3. Difficulty in separation of 
proteins with extreme pI 
and molecular weight. 
4. High inter-gel variability. 
5. Large amount of sample 
needed. 
2D-DIGE Fluorescence 4 Medium Medium/Low 
1. Detection of isoforms 
and post-translational 
modifications. 
2. Good quantitation, 
sensitivity and 
reproducibility. 
3. High dynamic range. 
4. Minimised gel to gel 
variation compared to 
2DE. 
5. Thorough multivariate 
statistical analysis 
1. Expensive fluorescent 
reagents. 
2. Poor recovery of 
hydrophobic and 
membrane proteins. 
3. Difficulty in separation of 
proteins with extreme pI 
and molecular weight. 


































Wasinger et al., 
2013) 
Pros  
(Arentz et al., 2015; 
Boersema et al., 2009; 
Megger et al., 2014; 
Rauniyar, 2015; Shi et al., 
2016; Tiwari & Tiwari, 
2014) 
Cons  
(Arentz et al., 2015; 
Boersema et al., 2009; 
Megger et al., 2014; 




SILAC Metabolite 1 to 2 Medium High/Low 
1. Highly sensitive and 
precise quantification. 
2. Introduction of isotope 
label at the cell or 
organism level, which 
can diminish technical 
and biological variances. 
3. No limits in amount of 
sample labelled. 
4. Good reproducibility. 
1. Mainly suitable for cell 
culturing models, like 
mammal cell lines. 
2. Costly reagents. 
3. Time and cost consuming 
to reach full labelled 
amino acid incorporation. 
4. Labelled arginine might 
convert to proline. 
5. Low dynamic range. 
iTRAQ/TMT Chemistry 2 Medium 
Medium/Med
ium 
1. Applicable to versatile 
samples. 
2. Labelling of up to 8/16 
different samples using 
iTRAQ/TMT. 
3. No increased complexity 
at MS level. 
4. High accuracy. 
5. Reactivity towards to 
different amino acids. 
1. Chemical Reagents are 
not very stable. 
2. Expensive reagent. 
3. Maximum fold differences 
discovered are limited. 
4. Relatively low-mass tags 
and one single tandem 
mass spectrum may result 
in quantitative 
inaccuracies. 
5. Low dynamic range. 
Label-free 
quantification 
None 3 High Medium/High 
1. High throughput. 
2. Less samples needed 
and suitable for all kinds 
of samples. 
3. High proteome 
coverage. 
4. No labelling step in 
order to simplify 
workflow and decrease 
variances. 
5. Not much cost and time 
needed. 
1. High throughput and 
resolution LC-MS/MS 
instruments needed. 
2. Complex and upgrading 
algorithm required. 
3. Less accuracy and 
reproducibility compared 
to labelled approaches. 
4. Quality control needed for 











3 to 5 Low High/High 
1. Highly sensitive, 
quantitatively accurate 
and reproducible. 
2. High specificity. 
3. Protein detection is 
relatively rapid and 
straightforward. 
4. Enable the detection of 
low abundance 
proteins. 
5. Quantification of post-
translational 
modification. 
6. High dynamic range. 




1. Limited broad scale 
application because of 
difficulty in generating 
high-quality assay. 
2. Low proteome coverage. 
3. Detection interfered by 
sample complexity like 
high abundant proteins. 





Figure 1.4 Standard workflow for quantitative proteomics. Dash outline means not used 
in every quantitative approach, like label-free quantification; PCA, principal component 
analysis; HCA, hierarchical cluster analysis; GO, gene ontology; qRT-PCR, quantitative real-
time polymerase chain reaction; MRM, multiple reaction monitoring. 
 
 Understanding deer antler regeneration through proteomics 
Animal models of regeneration are very important in regenerative medicine. Complex 
networks and regulatory mechanisms are involved to ensure that regeneration is partially 
or completely retained and in some cases without attenuation as a result of aging 
(Rodriguez & Kang, 2020; Yun, 2015). The robust regeneration which has evolved in some 
animals could help to address why Homo sapiens do not retain this strong regenerative 
capacity. The “omics” approaches are of paramount importance in explaining complicated 
biological phenomena, like regeneration (Calciolari & Donos, 2020; Paczkowska et al., 
2020). Omics is a large field mainly focusing on the central dogmas of molecular biology 
including: genomics, transcriptomics, proteomics, and metabolomics (Aizat et al., 2018). 
These approaches can detect, discover and predict biomarkers, active factors, key 
biological processes and signalling pathways participating in regeneration (Calciolari & 
Donos, 2020). Protein regulation should be considered the critical component within the 
central dogma of molecular biology in terms of a functional effector. This is because even 
though gene expression is controlled at nucleic acid level, post-translational processing, 
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turnover and modifications mean that the final protein levels are seen as the “functional 
performers” (Aizat et al., 2018). Thus, understanding the proteome is the indispensable 
part for solving the puzzle of the mechanisms controlling regeneration. Deer antler, as the 
only known mammalian structure that can fully and annually regenerate, has a unique 
position in animal models of regeneration (Landete-Castillejos et al., 2019). Deer antler 
proteomics may shed new light on the mechanisms controlling mammalian regeneration. 
 
1.6 Deer antler proteomics 
Deer antler proteomic research started in 2004 (Table 1.3). There have been multiple 
approaches employed with many belongings to qualitative proteomics (9 out of 31). 
Quantitative proteomics (Figure 1.3) has predominantly used gel-based methodology (10 
out of 31), and included both 2DE (7) and 2D-DIGE (3). Studies employing LC-MS-based 
approaches, in association with deer antler research, have begun to emerge over the past 
five years. This suggests deer antler proteomics has been somewhat lagging behind 
mainstream proteomic development, with its focus on more advanced data-dependent 
acquisition approaches like SILAC and label-free quantification, as well as targeted data 
acquisition approaches like PRM/MRM (parallel/multiple reaction monitoring) in more 
recent years. 
 
Red deer (Cervus elaphus; 10 out of 31) and sika deer (Cervus nippon; 21 out of 31), have 
been the most well-studied (Table 1.3). Proteomic analysis of reindeer (Rangifer tarandus) 
antler has been reported on one occasion with the aim of developing methodology to 
distinguish reindeer from red and sika deer antlers, the only two types of medicinal antlers 
prescribed in the Chinese Pharmacopoeia (2015 edition) (Guo et al., 2019). The research 
thus reflects that red and sika deer antlers have high economic value. 
 
Antler samples analysed by proteomics can be classified into either direct or indirect 
samples (Table 1.3). The former accounts for the majority of studies where samples came 
from different antler regions, regeneration stages, and processing methods as either 
tissues or cells. Different regions refer to samples from “before antler formation” 
including antlerogenic and pedicle periosteum; or “during antler growing” including antler 
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tip (containing the stem cell rich growth centre), and other regions more proximal to tip 
rich in cartilage and new bone; or “after antler regeneration” as ossified hard antler. 
Different regeneration stages contained antler at the points of incipient-growing (10 or 
15 days), fast-growth (40 or 60 days) and the ossification (90 days onward) stage. In 
addition to sticks or samples of fresh antler, samples also came from different processing 
methods including fermentation, freeze-drying and traditional frying. A small number of 
proteomic studies performed using indirect samples were also identified. Their 
commonality was to analyse samples from other cell or animal models by addition of 
antler extracts (Yao et al., 2019a; Yao et al., 2019b). All the antler samples used for 
proteomic research aimed to address biological questions about which molecules and 
mechanisms are associated with the unique regeneration phenomenon and fascinating 
growth rate, and further what medicinal properties and bioactive effects deer antler has 
as a medicine ingredient and functional food. 
 
Proteomic results are commonly validated by selecting targets and examining their 
expression using other approaches; and in many journals this is a requirement. Western 
blot and qRT-PCR are the two most conventional techniques utilised for antler proteomic 
result validation (Table 1.3). More recently deer antler researchers have started to adopt 
targeted proteomics like MRM or PRM (Guo et al., 2019; Yao et al., 2019a; Yao et al., 
2019b). Targeted proteomics are believed as a more sensitive and accurate alternative to 
Western blot (Aebersold et al., 2013). Another approach is to test selected bioactive 
effects discovered from the proteomics, such as enzyme activity and pathway inhibition 
assays, and examine their impact on neurogenesis and angiogenesis (Haines et al., 2019; 
Pita-Thomas et al., 2017; Ruan et al., 2019; Sun et al., 2020; Yu et al., 2017). This is a very 
targeted way to validate both the antler proteomic results and address a well-defined 
biological question. 
 
Many differentially expressed proteins and potentially bioactive factors involved in 
regulating antler growth have been identified (Table 1.3). They belong to multiple 
biological processes, signalling pathways and protein-protein interaction networks 
indicating a complex mechanism underlying antler formation and regeneration. Deer 
antler proteomics have also identified numerous stem cell markers expressed in antler 
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including embryonic stem cell markers (POU5F1, SOX2, NANOG and MYC), mesenchymal 
stem cell makers (CD73, CD90 and CD105), and adult stem cell makers (CD29, CD44 and 
CD166) (Li et al., 2012; Wang et al., 2018a), suggesting that antler stem cells may be an 
intermediate stem cell type somewhere between embryonic and mesenchymal stem cells. 
These findings are further supported by Wang et al. (Wang et al., 2019a). PI3K-Akt 
signalling, has been consistently found as one of the most critical pathways widely 
involved in various stages of deer antler growth from initiation, regeneration to 
development (Dong et al., 2016a; Li et al., 2012; Ruan et al., 2019; Su et al., 2019; Sun et 
al., 2020; Wang et al., 2017b). The in-depth exploration for this process in antler could 
contribute to mammal structure regeneration. 
 
An ideal antler proteomic research platform requires a series of optimisations in the 
protein processing (Figure 1.4) so as to obtain the best results. Firstly, it is important to 
choose the most appropriate lysis buffer and protein extraction method, which is 
dependent on the sample properties. Determination of protein concentration is also 
critical in quantitative approaches, especially for 2DE, SILAC and iTRAQ. It is also important 
to note that some components in the extraction lysis buffer may be incompatible with the 
colorimetric protein assays, such as highly concentrated urea interferes with the Bradford 
assay (Kao et al., 2008); interestingly, some researchers still utilise this combination (Ding 
et al., 2013; Zhang et al., 2016). This may introduce inaccuracy to the quantitative results. 
Other optimisations include LC-MS/MS procedures, selection of databases and search 
engine parameters. 
 
Proteomic studies of deer antler - a non-model organism have some limitations due to 
their being no well-annotated genome and proteome databases, no available 
bioinformatic packages compatibly designed for deer species, and no specific reagents 
like antibodies for subsequent validation procedures (Heck & Neely, 2020; Kultz et al., 
2007). Although these factors can affect the accuracy and breadth of proteomic results to 
some degree, the field of antler proteomics has made remarkable progress particularly in 
the last 2-3 years. 
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Two of the fundamental sciences questions in deer antler biology are (1) what determines 
antler generation and regeneration and (2) what causes deer antler to have such a rapid 
growth rate? All the antler proteomic studies completed to-date can be more or less 
applied to these questions (Table 1.3). More comprehensive quantitative proteomic 
studies aimed at addressing these questions are however rare and yet to be undertaken. 
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Table 1.3 Key published research articles investigating deer antler proteomics. Results 
were obtained and selected from Scopus (English) and CNKI (Chinese) databases in April 
2020, by searching “deer antler proteomic/proteomics/proteome” in the “Article title, 
















1.7 Deer antler biomolecules discovered from other approaches 
Biological molecules regulated during deer antler regeneration have been identified 
through other platforms outside proteomics. These platforms mainly include nucleic acid 
identification such as genomic analysis, gene expression and microRNA. 
 
 Deer antler and genome sequencing 
Comparative genomics has been conducted on different deer species including reindeer, 
sika deer and roe deer (Chen et al., 2019; Lin et al., 2019; Wang et al., 2019b). An extra 
functional binding motif of the androgen receptor is exclusively found in reindeer in the 
CCND1 gene, and this motif may enhance CCND1 expression under low levels of androgen, 
suggesting one possible mechanism as to why female reindeer grow antlers (Lin et al., 
2019). A large-scale genome analysis of ruminants including deer, cows, goats and sheep 
also provides insights into the comprehensive genetic mechanisms underlying rapid antler 
regeneration. Deer antlers differ from other ruminant headgear, in that oncogenesis 
pathways are highly involved in fast growing antler with evidence of expression of 
positively selected proto-oncogenes (FOS, FAM83A and REL) and tumour suppression 
genes for TP53 signalling (Chen et al., 2019; Wang et al., 2019b). 
 
 Deer antler and in situ hybridisation 
In situ hybridisation (ISH) is often utilised for examining gene expression patterns in antler 
tissues. As in the deer antler proteomic research, red deer and sika deer are the most 
studied species using ISH. Only one study in another species is reported, showing reindeer 
highly express GDF10 in the majority of osteoblasts within the antler growth centre 
(Kapanen et al., 2002). Most ISH research has been performed on antler tips during the 
growth stages, except one which investigated the top, upper, mid and base parts of the 
whole red deer antler (Gu et al., 2007); intense signal for IGF1 gene expression was only 
detected in chondrocytes and osteoblasts from the top and upper parts. ISH results for 
PTHRP, involved in skin and bone development, and its receptor PTH1R, show that both 
are highly expressed in the dermal and cartilage layers of red and sika deer, suggesting 
conserved mechanisms are shared by these two deer species (Barling et al., 2004; 
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Faucheux et al., 2002; Guo et al., 2013). ISH has mainly focused on the investigation of 
gene expressed in each layer of the antler growth centre (Figure 1.2C). The dermal layer 
has been found to have positive signal for COL1A1, TGFBR1, MMP9/13, PTN and MATN2 
gene expression (Clark et al., 2006b; Korpos et al., 2005; Price et al., 1996; Wang et al., 
2013; Zhang et al., 2012). Only NGF, VEGF and PTN are positively correlated with blood 
vessel layer (Clark et al., 2006b; Li et al., 2007b). Reserve mesenchymal layer has high 
expression of COL1A1, SPARC, TPM1, ANXA2, FAM207A, PTN and MATN1-4 genes (Clark 
et al., 2006b; Gyurjan et al., 2007; Korpos et al., 2005; Molnar et al., 2007; Steger et al., 
2010). The precartilage layer, compared to the reserve mesenchymal layer, has several 
more expressed genes including: IBSP, MGP, VEGFA, KDR and COL2A1 (Clark et al., 2006b; 
Gyurjan et al., 2007; Korpos et al., 2005; Molnar et al., 2007; Steger et al., 2010). The 
highest number of genes are however found in the cartilage layer; they are the collagen 
families (COL1A1, COL2A1 and COL10A1), ossification indicators (IBSP, MGP and SPARC), 
TGFBR1, MMP9/13, ANGPT1/2, TEK, RAR and RXR families, BMP2, WNT4, TPM1, APOD, 
ANXA2, FAM207A, VEGFA, PTN and MATN1-4 genes (Clark et al., 2006b; Gyurjan et al., 
2007; Korpos et al., 2005; Molnar et al., 2007; Price et al., 1996; Steger et al., 2010; Wang 
et al., 2013; Zhang et al., 2018; Zhang et al., 2017b; Zhang et al., 2012). These genes have 
been linked to cell proliferation and differentiation in multiple processes including 
angiogenesis, neurogenesis, chondrogenesis and osteogenesis. PTN gene is the only one 
which has been found in every layer of the growth centre (Figure 1.2C), suggesting it is 
multifunctional in antler regeneration, thus warranting further investigation. 
 
 Deer antler and RNA sequencing 
Transcriptome sequencing is the most common approach outside proteomics for the 
discovery of deer antler biomolecules, and has mainly applied to reindeer, red deer, fallow 
deer and sika deer. Reindeer is the only deer species where antlers grow in both the male 
and female; transcriptome comparison of the mesenchyme layer (Figure 1.2C) from both 
genders detected thirty-one highly differentially expressed genes including signal 
transduction molecules PTN and MDK, transcription factors RUNX2 and SOX9, and 
extracellular matrix proteins LGALS1 and the collagen family (Bi et al., 2020). RNA-seq of 
the velvet skin of red deer antler tip found the growth factors TMSB10 and TPT1 as 
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potentially important in velvet skin regeneration (Yang et al., 2016). The key genes 
involved in proliferation (UHRF1) and mineralisation (S100A10) are identified from 
comparative transcriptomic profiles between fallow deer reserve mesenchymal cells and 
human mesenchymal stem cells (Ker et al., 2018). 
 
Sika deer account for the majority of RNA-seq studies, with the focus on its antler tip 
tissues. There are numerous differentially expressed genes identified from the antler 
growth centre layers (Figure 1.2C). Expression of the PTN gene is consistent with its ISH 
result with the highest levels found in reserve mesenchymal and precartilage layers (Clark 
et al., 2006b; Yao et al., 2018a). Most candidate genes, as also found with ISH, are 
recognised as participating in cell proliferation, angiogenesis, chondrogenesis and 
osteogenesis (Ba et al., 2019b; Yao et al., 2018a). Key identified pathways to-date include 
PI3K-akt, MAPK, Wnt and Hippo signalling which are highly upregulated in the reserve 
mesenchymal layer. Wnt signalling has also been found to be necessary in the precartilage 
layer indicating its roles in the maturation of chondrocytes and osteoblasts (Ba et al., 
2019b; Han et al., 2019). Transcriptomics conducted on the tip at different stages of 
growth, suggests that differential gene expression is negatively correlated with the 
growing stage, i.e. less up-regulated genes were found during rapid growing stage (60 
days) compared to initial growth (15 days) and the ossification stage (90 days) (Liu et al., 
2014; Yao et al., 2018c; Yao et al., 2019c; Yao et al., 2018d; Yao et al., 2012a; Yao et al., 
2012b; Zhao et al., 2013). SOX9 gene is one of the exceptions due to its highest expression 
level found in the rapid growing stage; it is regarded as a master regulator involved in 
chondrogenesis and osteogenesis (Yao et al., 2019c; Yao et al., 2018d; Yao et al., 2012a). 
 
Antlers has been compared for desirable traits, and those with extremely heavy weight 
compared to light weight sticks. The heavy antlers have high expression of genes 
associated with mineralisation (COL1A1, COL1A2, COL3A1, FN1, and MT-ATP6) (Hu et al., 
2019). A large scale transcriptomic comparison between different deer tissues (adrenal, 
antler, brain, heart, kidney, lung, liver, skeletal muscle, spleen and testes) harvested from 
juvenile to aged sika deer suggests ECM-receptor interaction and focal adhesion are 
characteristic processes of antler (Jia et al., 2016). The first single-cell transcriptome 
analysis in antlerogenic periosteum cells (Figure 1.2A) indicates they are likely to be a 
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homogeneous population expressing multiple markers of mesenchymal, embryonic, 
neural and cancer stem cells (Ba et al., 2019a). RNA-seq also suggests antler extract 
treatments may increase chondrocyte activity against oxidative, inflammatory and 
immune stresses (Yao et al., 2018b). 
 
 Deer antler and microRNA sequencing 
MicroRNAs are endogenous small non-coding RNAs (about 22 nucleotides long) that 
inhibit translation and post-transcriptional regulation of target mRNAs (Bartel, 2018). 
MicroRNA sequencing of deer antler has emerged in recent years. Similar to other 
approaches, research has mainly focused on antler tip tissues from both red and sika deer. 
Comparison between antler tips from initial and fast growing stages identifies several 
microRNAs involved in regulating antler chondrogenesis and osteogenesis, for example, 
miR-140 is highly increasing during the rapid growth stage, functioning by targeting the 
SOX9 gene (Yao et al., 2019c; Yao et al., 2018d). Numerous candidate microRNAs, such as 
miR-19a and 19b, have been discovered in the reserve mesenchyme and/or cartilage 
layers of the antler growth centre, and are likely to play a role in regulating antler 
development (Figure 1.2C) (Chen et al., 2015; Han et al., 2019; Yan et al., 2020). MicroRNA 
sequencing has also been conducted in parallel to the transcriptome sequencing of antlers 
with extreme heavy and light weights; these researchers found fourteen genes and six 
microRNAs linked to antler weight, and show a specific regulatory network encompassing 
the differentially expressed genes and microRNAs (Hu et al., 2019). Apart from 
investigations of antler tissues, microRNA expression profiles between potentiated and 
dormant pedicle periosteum (Figure 1.2B) reveal activities of Wnt, MAPK and TGF-beta 
signalling positively correlate with the activation status of antler stem cells (Ba et al., 2016). 
 
 Deer antler and pleiotrophin  
High expression levels of PTN have been found through both in situ hybridisation and 
transcriptome profiling within different layers of the antler growth centre (Figure 1.2C) 
indicating PTN could be a promising target involved in regulating antler regeneration 
(Clark et al., 2006b; Yao et al., 2018a). 
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PTN was first discovered as a neurite outgrowth-enhancing factor from juvenile rat brains 
in 1987 (Rauvala & Pihlaskari, 1987). It consists of 168 amino acids and is highly conserved 
across species including human, bovine and rat (Li et al., 1990). MDK, together with PTN, 
are the two family members of this heparin-binding growth factor family (Muramatsu, 
2014). PTN and MDK share about 50% homology in their amino acid sequences; they have 
similar N- and C-terminal domains. MDK gene expression has also been detected in the 
antler growth centre (Bi et al., 2020; Zhao et al., 2013). The PTN/MDK growth factor family 
have numerous biological functions via interactions with different receptors (Figure 1.5). 
PTPRZ is regarded as the key receptor for both PTN and MDK. It is a tyrosine phosphatase, 
whose activity is inactivated upon binding with PTN/MDK. This inhibition increases 
tyrosine phosphorylation of a series of PTPRZ’s substrates such as the ALK receptor 
tyrosine kinase (Herradon & Perez-Garcia, 2014). PTNs interaction with these receptors 
results in its ability to participate in a diverse range of biological processes (Appendix 1.1). 
The majority are cellular processes including cellular metabolism, proliferation, migration, 
differentiation, communication, division, and apoptosis. It is also linked to the 
development of a number of organs including the nervous system, heart, gland and 








Figure 1.5 Protein-protein interaction network between PTN/MDK and their main 
receptors. Receptors with known functions are selected (Papadimitriou et al., 2016; 
Sorrelle et al., 2017; Xu et al., 2014). The thickness of network edges indicates the strength 
of data support. Blue nodes are belonging to GO term (ID: 0008083) of “growth factor 
activity”; red nodes are in GO term (ID: 0071944) of “cell periphery” meaning the part of 
a cell encompassing the cell cortex, the plasma membrane, and any external 
encapsulating structures. Biological process enrichment results are listed in Appendix 1.1. 
The figure is made by STRING v11 (Szklarczyk et al., 2019) in default settings. 
 
Expression of PTN in deer antler has only been investigated at the RNA level, its protein 
expression levels and distribution are still unknown. A functional investigation for PTN in 




Deer antler initially develops from antlerogenic periosteum which contributes to the 
pedicle periosteum responsible for antlers annual regeneration cycles. Neural crest-
derived stem cells are involved in all these processes and drive the rapid antler growth, 
the only physiological structure regeneration model in mammals. Large-scale discovery 
approaches like genomics, transcriptomics and proteomics are drawing more attention 
and stimulating a paradigm shift in the way biomedical questions are addressed (Manzoni 
et al., 2018). They are also playing powerful and promising roles in exploring biological 
molecules and mechanisms underlying antler generation and regeneration. The present 
studies investigated the protein profiles of antler formation and development by 
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comparing antlerogenic and pedicle periosteum, and tissues from different stages of 




• There are significant differences regarding protein profiles between antlerogenic and 
pedicle periosteum cells. (Chapter 2) 
• Multiple differentially expressed proteins and biological processes are involved in 
antler regeneration stages including before, during and after antler growth. (Chapter 
3) 
• Pleiotrophin has similar protein expression patterns across the antler growth centre 
as seen for its mRNA, and has multiple functions achieved by interacting with different 
receptors. (Chapter 4) 
 
1.10 Aims 
• To investigate the differentially expressed proteins and molecular mechanisms 
underlying antler generation and regeneration. 








 Chapter 2: Quantitative proteomic 
analysis of deer antler stem cells as a 





A substantial portion of this chapter has been published in the following peer-reviewed 
journal article. 
Dong, Z., Coates, D., Liu, Q., Sun, H., & Li, C. (2019). Quantitative proteomic analysis of 
deer antler stem cells as a model of mammalian organ regeneration. Journal of 




The study presented in this chapter aimed to investigate differentially regulated proteins 
(DRPs) found in stem cell populations (n = 3) during antler generation and regeneration 
using 2D-DIGE. Western blot was used to validate the proteomics results. Comparative 
proteomics resulted in protein profiles which were similar for the biological replicates but 
different between the cells derived from two different stem cell niches involved in antler 
growth/regeneration and cells derived from facial periosteum. Ninety-two differentially 
expressed proteins were identified by MALDI-TOF MS. The study indicated that the 
epithelial-mesenchymal transition process may participate in the initiation of antler 
regeneration including the first stage of scar-less wound healing. Cell mobility was shown 
to be highly regulated during antler regeneration. Energy and nucleotide metabolism may, 
however, be less active in antler regeneration as compared to that in antler generation 
phase. These results provide new insights into the underlying mechanisms of stem cell-
based regeneration of mammalian organs. 
 
2.2 Introduction 
Regenerative medicine aims to replace, engineer or regenerate new tissue, and by so 
doing to restore normal functionality to tissues or organs after loss to trauma or damage 
by disease or aging (Mason & Dunnill, 2008). Research in this field investigates an 
organism's own repair systems with the prospect of understanding how to functionally 
restore damaged tissues and organs (Stocum, 2005). Undoubtfully, this is the ultimate 
solution for the re-establishment of damaged or diseased tissues or organs and will 
ultimately offer a more meaningful alternative to xenotransplantation from animal organ 
donors which have multiple issues (Kolber-Simonds et al., 2004), including ethics, 
transplant rejection and the risk of cross-species disease transmission (Meier et al., 2018). 
 
A major goal of regenerative research is to understand the molecular mechanisms directly 
associated with tissue and organ repair/regeneration. The discovery of a conserved and 
shared regenerative mechanism in animal models will assist the development of research-
led therapies. A powerful example is that of the Wnt signalling pathway which in both 
 40 
deer antler (Mount et al., 2006b) and planarian (Tanaka & Reddien, 2011), can reboot 
dormant or latent regenerative responses (Iismaa et al., 2018). Animal models of 
regeneration can thus provide clues to how stem cells are maintained and activated. 
 
Animal models of regeneration have been described in both invertebrates and 
vertebrates and result in either physiological or reparative regeneration. Regeneration 
driven from stem cells or attributed to the dedifferentiation or trans-differentiation of 
cells has been described in the literature (Iismaa et al., 2018; Lai & Aboobaker, 2018). 
Generally speaking, lower order animals have a higher regenerative potential and some 
invertebrates are capable of whole-body regeneration (Lai & Aboobaker, 2018). Deer 
antler is an example of physiological regeneration in a mammal (Kierdorf et al., 2007), and 
offers the opportunity to study the regulation of a large stem cell niche responsible for 
driving growth at 1-2 cm/day. It is, in fact, the only mammalian example of stem cell driven 
annual organ growth (Li & Chu, 2016). Antler regeneration is, at the initial stage, a scar-
less repair process which results in complete restoration of structure with function. 
Understanding the cellular mechanisms controlling this process could provide new 
approaches in regenerative medicine (Iismaa et al., 2018). 
 
When a deer approaches puberty, antlerogenic periosteum (AP), which is found overlying 
the lateral crests of the deer frontal bone, develops first into a pedicle and then an antler 
(Li & Suttie, 2001). Ectopic antlers have been successfully induced by transplanting the AP 
subcutaneously to deer nasal bone (Li & Suttie, 2001) or foreleg (Goss, 1983). More 
surprisingly, when AP was grafted on the head of a nude mouse it produced pedicle-like 
(Li et al., 2001), and even antler-like (Li et al., 2009a) bony protuberances. After casting of 
the first-year’s antler, it is the pedicle periosteum (PP) around the permanent bony 
protrusion on the deer skull that induces subsequent regrowth of antler. This has been 
confirmed by depletion of PP overlying the bone, which results in the loss of antler 
regeneration (Li et al., 2007a). Based on the degree of contact between the PP and the 
enveloping skin, the proximal two-thirds of the pedicle is referred to as the “dormant PP” 
(DPP) while the distal third is referred to as the “potentiated PP” (PPP) (Li & Suttie, 2003). 
AP/PP cells (APCs/PPCs), antler stem cells residing in periosteum, express key embryonic 
stem cell markers and have been induced into multiple cell types, such as chondroblasts, 
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adipocytes, osteoblasts, muscle precursor cells and neuronal-like cells (Berg et al., 2007; 
Li et al., 2009b; Price et al., 2005a; Rolf et al., 2008). In addition, mesenchymal/epithelial 
interactions between the AP/PP and the enveloping skin are essential for the initiation of 
antler generation/regeneration. Velvet skin may contribute to the niche which is 
important for the maintenance and regulation of antler stem cells (Li et al., 2009b). 
 
2D-DIGE is a two-dimensional electrophoresis-based and fluorescent dye-labelled 
quantitative proteomics. The use of an internal pooled standard can increase the 
quantification accuracy and statistical confidence (Alban et al., 2003). The multivariable 
statistical analyses are performed before mass spectrometry to filter out noise from 
technical and biological variations in order to concentrate on the underlying differences 
that reflect various disease or biological states (Diez et al., 2010). Currently, it remains 
unclear how the APCs, DPP cells (DPPCs) and PPP cells (PPPCs) are regulated at molecular 
level. The present study investigated the differentially expressed proteins through 2D-
DIGE, and the activated signalling pathways through bioinformatic analysis for different 
types of antler stem cells. Facial periosteum cells (FPCs) derived from the nasal bone of 
the deer head served as a control. The study aimed to elucidate the proteins and 
molecular mechanisms controlling stem cells during mammalian organ generation and 
regeneration. 
 
2.3 Material and methods 
 Tissue sampling and primary cell culture 
AP, PPP, DPP and FP (n = 3/tissue type) were harvested from the heads of sika deer (Cervus 
nippon) heads (Figure 2.1) using the method previously described by Li & Suttie (Li & Suttie, 
2003). Among them, the AP and PP (PPP/DPP) tissues were obtained respectively from 8-
month-old and 3-year-old male deer immediately after slaughter; the FP tissues were 
collected after sampling of the AP or the PP. Tissue was collected separately in the months 
of October and May (Northern hemisphere), under approval from the Animal Ethics 
Committee at the Institute of Special Wild Economic Animals and Plants, Chinese 
Academy of Agricultural Sciences (Permit Number: CAAS2015020). Primary cell 
populations for each of the tissues were achieved following established protocols (Li et 
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al., 2012; Sun et al., 2012). Briefly, each periosteum sample was cut into small pieces using 
two scalpels in a petri dish and digested in DMEM medium (Life Technologies, USA) 
containing 150 U/mL collagenase (Invitrogen, USA). Cells were then collected and grown 
in culture medium consisting of DMEM medium with 10% FBS (Gibco, USA), 100 U/mL 
penicillin and 100 μg/mL streptomycin. Cells were trypsinised when becoming sub-
confluent, transferred into T75 culture flasks (Nest Biotechnology, China), and grown until 
there were 1×105 cells/mL. A freezing medium (FBS + 10% DMSO; Sigma, USA) was used 
for cell cryopreservation with the cells stored in liquid nitrogen until required. All cells 
were used at P2 for subsequent experiments. 
 
 
Figure 2.1 Tissue sampling. When a deer reaches puberty, antlerogenic periosteum (AP) 
(A; red), which is situated over the frontal bone, grows into a bone protrusion, called 
pedicle, and this subsequently forms the first-year antler (B; Brown). The periosteum 
around the pedicle is called pedicle periosteum (PP) (B & C; Blue) and is characterised 
based on the degree of contact between the periosteum and enveloping skin. The distal 
third is tightly attached and referred to as potentiated pedicle periosteum (PPP); the 
proximal two thirds are loosely attached and called dormant pedicle periosteum (DPP) (C). 
Facial periosteum (FP) (B; Green) over the nasal bone between the two eye sockets was 
used as the control. 
 
Harvested cells were not further purified into sub-populations as it is currently unknown 
whether a single stem cell type or all cell types of periosteal tissue are necessary for antler 
generation and regeneration. Cells were retrieved from storage and grown in culture 
medium to sub-confluence (around 85%) in T75 flasks prior to use. 
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 Protein extraction and labelling 
Following the removal of the culture medium from the T75 flasks, the cells were 
trypsinised, centrifuged and re-suspended in cell wash solution (10 mM Tris (GE 
Healthcare, USA), 5 mM magnesium acetate (Sigma, USA), 1 mM PMSF (Roche, 
Switzerland)), centrifuged and washed again. The cell pellet was then re-suspended in 550 
μL lysis buffer (7 M Urea, 2 M Thiourea, 30 mM Tris, 4% (w/v) 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate (CHAPS), and 10 μL/mL protease inhibitor 
cocktail; GE Healthcare, USA). Stainless steel beads (0.5 mm in diameter) were added to 
the lysis buffer (0.5:1.0) and a Bullet Blender (Next Advance, USA) set at level 7 of speed 
for 1 min was used to break the cells open. The homogenate was further incubated for 3 
h on ice with shaking, to increase protein solubilisation before centrifuging at 12,000 g at 
4℃ for 15 min. The supernatants were collected, aliquoted and stored at - 80℃. 
 
Supernatants (50 μL) from each sample were cleaned and precipitated using a 2D Clean-
up kit (GE Healthcare, USA), and pellets re-suspended in 50 μL lysis buffer (7 M Urea, 2 M 
Thiourea, 30 mM Tris, 4% (w/v) CHAPS, pH 8.5). Protein concentration was measured 
using a RC DC Protein Assay (Bio-Rad, USA; Appendix 2.1). Proteins were labelled with 
CyDye DIGE Fluor minimal dyes (GE Healthcare, USA) following the manufacturer's 
instructions. CyDye (Cy2, Cy3 and Cy5; 1 μL at 400 pmol) was added to each of the 50 μg 
protein samples and incubated on ice in the dark for 30 min. The protein samples were 
labelled with Cy3 and Cy5, and the internal standard was made by mixing equal amounts 
(4.17 μg) of protein from each sample and labelling with Cy2. After incubation with the 
labels the reactions were stopped by adding 1 μL of 10 mM lysine (Sigma, USA) solution. 
 
 Two-dimensional differential gel electrophoresis 
An equal volume of 2× sample buffer (DeStreak Rehydration Solution, 2% IPG buffer, 20 
μL/mL protease inhibitor cocktail; GE Healthcare, USA) was added to the labelled protein 
sample and 24 cm pH 3 - 10 Non-Linear (NL) dry strips (GE Healthcare, USA) were 
rehydrated for 14 h using the IPGbox and IPGbox kit (GE Healthcare, USA). Isoelectric 
focusing (IEF) was performed at 20℃ in an Ettan IPGphor 3 (GE Healthcare, USA), using 
the following program: 250 V for 250 Vh, 500 V for 500 Vh, 500-1000 V for 800 Vh, 1000-
 44 
6000 V for 8000 Vh, 6000-10000 V for 8500 Vh, 10000 V for 34700 Vh, and 500 V for 1 h. 
The strips were then equilibrated for 15 min in 10 mL reducing solution (6 M urea, 50 mM 
Tris-HCl pH 8.8, 30% v/v glycerol, 2% w/v SDS and 50 mg DTT; GE Healthcare, USA), 
followed by 15 min in 10 mL alkylating solution (6 M urea, 50 mM Tris-HCl pH 8.8, 30% v/v 
glycerol, 2% w/v SDS and 450 mg iodoacetamide; GE Healthcare, USA) in the dark. The 
protein separation in the second dimension was carried out on an Ettan DALTsix unit (GE 
Healthcare, USA) with 12.5% polyacrylamide gels. Electrophoresis was run at 22℃, 2 
W/gel for 30 min, followed by 4.5 h at 17 W/gel. 
 
Preparative gels for MS analysis were conducted using the pool of all samples. For the IEF 
on a 24 cm pH 3-10 NL IPG strip, 900 μg of protein sample was focused with the following 
program: 250 V for 350 Vh, 500 V for 600 Vh, 500-1000 V for 900 Vh, 1000-4500 V for 
6500 Vh, 4500-8000 V for 7000 Vh, 8000 V for 42200 Vh, and 500 V for 1 h. 
 
 Image acquisition and 2D-DIGE data analysis 
Gels were scanned in a Typhoon FLA 9500 biomolecular imager (GE Healthcare, USA) with 
filters for each fluorophore: Cy2 (488/520 nm), Cy3 (532/580 nm) and Cy5 (633/670 nm), 
set to 100 μm resolution. Image cropping and multi-channel merging were carried out 
using ImageQuant TL 7.0 software (GE Healthcare, USA). The Differential in Gel Analysis 
module of the DeCyder 2D 7.2 (GE Healthcare, USA) was used for automatic spot 
detection and abundance measurement in each signal-channel gel, by comparing the 
normalised volume ratio of each spot from a Cy3- or Cy5-labeled sample to their 
corresponding Cy2 signal from the internal standard. Differential in Gel Analysis was 
conducted on all the signal-channel gels and data sets collectively analysed using the 
Biological Variation Analysis module (DeCyder 2D 7.2). Inter-gel matching and calculation 
of a standardised average volume ratio (AVR) for each protein spot among all the gels was 
carried out. This was achieved firstly by identifying a master gel with the largest number 
of spots among all the internal standard gels (labelled by Cy2). Statistical analysis was 
conducted for each change in AVR using one-way ANOVA (statistical significance set at p 
value < 0.05), along with corresponding post-hoc analysis. Protein spots from different 
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groups with ±1.2-fold change in the AVR and with a p value < 0.05 were considered 
significantly differentially expressed. 
 
Data was analysed using principal components analysis and hierarchical cluster analysis 
(Distance metrics: Pearson Correlation; Linkage method: Complete Linkage) in the 
Extended Data Analysis module of DeCyder 2D 7.2. Both analyses included all the protein 
spots with more than 85% presence among all the gels and the set of spots with significant 
difference among the four groups. 
 
 Protein identification 
Spots showing significant changes in protein abundance among groups were manually 
excised from the gel, washed in double-distilled water, then processed as follows. Spots 
were de-stained with 50 μL of 30 mM K3Fe(CN)6:100 mM Na2S2O3 = 1:1 (v:v), and digested 
with 50 ng of sequencing-grade trypsin (Promega, USA) overnight at 37℃. After vacuum 
centrifugation, peptides were resuspending in 2 μL 20% ACN, and 1 μL of peptide mixture 
spotted onto a MALDI target plate and allowed to air dry at room temperature before 
adding 0.5 μL of matrix, a supersaturated solution of α-cyano-4-hydroxy-transcinnamic 
acid (Sigma, USA) in 50% ACN/0.1% TFA; which was then left to air dry. 
 
A 5800 MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Canada) was operated 
in the positive reflector mode with an accelerating voltage of 2 kV. The scanning range 
was between 800 and 4000 Da. Eight of the most intense precursors with a minimum 
signal-to-noise of 50 were selected from each position. The CID-MS/MS spectra were 
acquired using a collision energy of 2 kV. 
 
Database searching against both the NCBI nr database as well as a database created by 
six-frame translation of our antler stem cell transcriptome database (Dong et al., 2016a), 
was performed using Mascot v2.2 (www.matrixscience.com). The database searching 
parameters were as follows: trypsin specificity; carbamidomethyl cysteine as a fixed 
modification and oxidised methionine as a variable modification; peptide mass tolerance: 
± 100 ppm; fragment mass tolerance: ± 0.4 Da; 1 missed trypsin cleavage site; and the 
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peptide charge state: 1+. Identifications were accepted as positive when a protein score 
C.I.% exceeded 95% and had at least one matching peptide with an ion score C.I.% 
exceeding 95%. 
 
 Bioinformatics analysis 
PANTHER v10.0 (http://www.pantherdb.org) was employed to perform functional 
classifications and enrichment analyses of Gene Ontology based on “biological process”, 
“molecular function”, and “protein class”, on the differentially expressed proteins 
between different groups (Mi et al., 2017). 
 
Pathway network groups of the differentially expressed proteins were enriched and 
visualised by ClueGO v2.3.2 and CluePedia v1.3.2 plugins in Cytoscape v3.4.0 (Bindea et 
al., 2013; Bindea et al., 2009; Shannon et al., 2003). The kappa score was used in ClueGO, 
as described by Huang et al. (Huang et al., 2007) to connect the pathway terms in the 
network. In the presentation of the data, node shapes represented the pathway database, 
i.e. diamond, ellipse, and hexagon were from the KEGG database, REACTOME database, 
and Wikipathways database, respectively. The main criteria used were as follows: the p 
value for each pathway term was calculated after a Bonferroni step down correction and 
only terms with p value < 0.05 were selected; the network specificity was set to medium; 
the kappa score, which was calculated based on the number of proteins shared between 
pathway terms, was set to 0.4; the leading group term was the one with the highest 
significance, and the group was named after it. 
 
 Protein identification validation by Western blot 
Six proteins identified by mass spectrometry were selected and validated using Western 
blot. Proteins (35 μg) from each of the groups (n = 3 samples/group), were loaded into 
the lanes of 5% stacking and 12% resolving SDS-PAGE gels and electrophoresed in Tris-
Glycine-SDS buffer (Beyotime Biotechnology, China) at 200 mA for 45 min. The resulting 
protein bands on the SDS-PAGE gels were transferred to polyvinylidene fluoride (PVDF) 
membranes (0.45 μm; Merck Millipore, USA) using transfer buffer (25 mM Tris, 192 mM 
glycine and 20% (v/v) methanol). The membrane was then blocked for 2 h at room 
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temperature with 5% skimmed milk in tris-buffered saline buffer containing 0.1% of 
Tween-20 (TBST; Bio-Rad, USA). Immunolabeling was conducted for 2 h at room 
temperature in TBST with the following antibodies: rabbit polyclonal anti-HSP90AB1 (0.13 
µg/mL; 11405-1-AP, Proteintech, China), rabbit polyclonal anti-HSPA5 (0.57 µg/mL; 
11587-1-AP, Proteintech, China), rabbit polyclonal anti-HNRNPK (0.25 µg/mL; 11426-1-AP, 
Proteintech, China), rabbit polyclonal anti-VIM (0.27 µg/mL; 10366-1-AP, Proteintech, 
China), rabbit polyclonal anti-LGALS1 (1.00 µg/mL; YT1836, ImmunoWay, USA), rabbit 
polyclonal anti-SPARC (0.24 µg/mL; 15274-1-AP, Proteintech, China) and mouse 
monoclonal anti-GAPDH (1:500-1:1000; AB-M-M001, Goodhere, China). After washing, 
the PVDF membranes were probed with goat anti-rabbit-HRP (1:2000; A0208, Beyotime 
Biotechnology, China) and goat anti-mouse-HRP (1:2000; A0216, Beyotime Biotechnology, 
China), separately for 1 h at room temperature. The blot was then developed using an ECL 
Western Blotting Substrate Kit (Pierce Biotechnology, USA) following the manufacturer's 
manual, and images were taken on a Mini Chemi 610 Plus imaging system 
(SAGECREATION, China). The resulting bands on each image were analysed and quantified 
with ImageJ (National Institutes of Health, USA). Statistical analysis of band intensities was 
evaluated using Student’s t-test in GraphPad Prism v7.0 (GraphPad Software, USA). 
 
2.4 Results 
 Analysis of protein expression profiles by DeCyder 
2D-DIGE proteomic analysis was performed on cell extracts from 12 biological samples 
(Table 2.1), corresponding to 4 experimental groups (n = 3 per group) referred to as: FPCs, 
APCs, DPPCs and PPPCs. The experiment was performed twice with randomly assigned 
sample pairing and labels (Table 2.1). All twelve 2D-DIGE gels in Table 2.1 under each 
channel and multiple channels can be found in Appendix 2.2. Among them, a 
representative image of the protein spots from a 2D-DIGE gel is shown in Figure 2.2. 2D-
DIGE images were subjected to computational analysis using DeCyder software and both 
multivariate and univariate analyses were applied to identify the similarity in protein 
expression profiles among experimental groups and the differences in protein abundance 




Table 2.1 CyDye labelling and sample combination for each 2D-DIGE experiment. Each 
sample (1 to 3) is a biological replicate. 
GEL Nº Cy2 
Experiment 1 Experiment 2 
Cy3 Cy5 Cy3 Cy5 
1 IS F1 P1 A2 D2 
2 IS A1 D1 F3 P3 
3 IS F2 P2 A3 D3 
4 IS D2 A2 D1 F1 
5 IS D3 F3 P1 A1 
6 IS P3 A3 P2 F2 
IS: Internal Standard (pooled of all the samples); A: Antlerogenic periosteum stem cells (APCs); F: Facial 
periosteum cells (FPCs); D: Dormant pedicle periosteum stem cells (DPPCs); P: Potentiated pedicle 
periosteum stem cells (PPPCs). 
 
 
Figure 2.2 Representative 2D-DIGE images of protein profiles (Gel 3 in experiment 1; Table 
2.1). In these images the protein samples of facial periosteum cells (FPCs), potentiated 
pedicle periosteum cells (PPPCs) and the internal standard (IS) were individually labelled 
with fluorescent dyes, mixed together and separated by 2D-DIGE followed by Typhoon 
image scanning. (A) IS made of pooled proteins from all samples labelled with Cy2 dye 
(Master gel); (B) Image of the FPC labelled with Cy3 dye; (C) Image of the PPPC labelled 
with Cy5 dye; and (D) Overlay gel of the FPCs, PPPCs and the IS. 
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The inter-gel spot matching from the two experiments revealed a total of 1278 and 1157 
well defined spots, with 85% of the proteins present in at least five of the six gels. The 
average abundance of each spot among the 18 images was calculated and significant 
differences were considered when the p value < 0.05, both in one-way ANOVA as well as 
in the post-hoc analysis. The 2D-DIGE analysis is outlined in Figure 2.3. 
 
 
Figure 2.3 Schematic overview of results obtained by 2D-DIGE and comparison of the 
protein profiles of cells isolated from the facial periosteum (F), antlerogenic periosteum 
(A), dormant pedicle periosteum (D) and potentiated pedicle periosteum (P). Black star: 
experiment 1; white star: experiment 2. 
 
 Multivariate statistics: principal component and hierarchical cluster analyses 
Multivariate statistics allowed an evaluation of the whole data set, thus conferring a 
biological interpretation of the results, which was based on the integral protein 
expression profile of samples. Principal components analysis and hierarchical clustering 
analysis (Pearson correlation) were carried out on 284 (Figure 2.4) and 164 (Figure 2.5) 
validated spots and these revealed significant differences among groups (p value < 0.05 
by one-way ANOVA). In both the initial and repeat experiment, the analysis identified 
three differentiated groups: the biological replicates from the FPCs (n = 3), the biological 
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repeats from the APCs (n = 3), and the DPPCs and PPPCs samples (n = 6) which were 
derived from pedicle periosteum and grouped together. 
 
 
Figure 2.4 Multivariate statistical analysis applied to the 284 differential spots obtained in 
the first 2D-DIGE experiment (ANOVA-1; p value < 0.05). (A) Two-dimensional score plot 
from the principal components analysis of the 12 biological replicates. (B) Heat-map with 
dendrograms from the hierarchical clustering analysis (Pearson correlation). Rows 
represent individual proteins and columns are the biological replicates (n = 3) as indicated 
at the bottom of the graph: facial periosteum cells (FPCs/F), antlerogenic periosteum cells 
(APCs/A), dormant pedicle periosteum cells (DPPCs/D) and potentiated pedicle 
periosteum cells (PPPCs/P). The colour in each block represents the protein expression 





Figure 2.5 Multivariate statistical analysis applied to the 164 differential spots obtained 
from the second 2D-DIGE experiment (ANOVA-1; p value < 0.05). (A) Two-dimensional 
score plot from the principal components analysis of the 12 biological replicates. (B) Heat-
map with dendrograms from the hierarchical clustering analysis (Pearson correlation). 
Rows represent individual proteins and columns are the biological replicates (n = 3) as 
indicated at the bottom of the graph: facial periosteum cells (FPCs/F), antlerogenic 
periosteum cells (APCs/A), dormant pedicle periosteum cells (DPPCs/D) and potentiated 
pedicle periosteum cells (PPPCs/P). The colour in each block represents the protein 
expression level, using a standardised log abundance scale ranging from negative (green) 
to positive (red) values. 
 
 One-way ANOVA and post-hoc analysis 
A total of 284 (first experiment) and 164 (second experiment for validation) differential 
spots were found, all of them displaying a p value < 0.05 by one-way ANOVA (Figure 2.3). 
The results of the first experiments were used for all subsequent analyses. To ensure 
accurate comparison of spots among gels, the correspondence of the 284 spots were 
manually validated through all the gels, and 92 spots were unambiguously confirmed and 
accurately identified by MS and database search (Figure 2.3). Details of the computational 
comparison of differential spots between different groups are compiled in Appendix 2.3. 
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 Identified differentially regulated proteins 
The 92 successfully identified spots corresponded to 63 differentially expressed proteins. 
In a comparison of the PPPCs vs. DPPCs, the post-hoc analysis showed that there was only 
one spot (spot No. 1235, p value = 0.0224) with a significant difference. However, the 
average ratio of this spot was only 1.13, and thus did not reach the threshold value of ±1.2 
set in this study (Appendix 2.3). Comparison of the APCs vs. FPCs found 23 DRPs, of which 
7 were up-regulated and 16 down-regulated in the APCs (Figure 2.6). While the PPC where 
considered as one group, differences of PPPCs and DPPCs to FPCs were analysed. There 
were 24 DRPs for both PPPCs and DPPCs compared to the FPCs and, of these, 12 were up-
regulated and 12 down-regulated. In addition, four up-regulated and four down-regulated 
proteins were only found in the PPPCs vs. FPCs; and eight up-regulated and four down-
regulated proteins were found in the DPPCs vs. FPCs only (Figure 2.7). 
 
 
Figure 2.6 Differentially expressed proteins in the antlerogenic periosteum cells (APCs) as 
compared to the facial periosteum cells (FPCs). Y axis denotes the p value with p = 0.05 
marked by a dotted line. X axis represents the up and down regulated proteins in the APCs 
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vs FPCs where ±1.2 fold regulation values are marked by lines. Red = up-regulated 




Figure 2.7 Differentially regulated proteins in pedicle periosteum cells (PPCs) vs. facial 
periosteum cells (FPCs). Y axis denotes the p value with p = 0.05 marked by a dotted line. 
X axis represents the up and down regulated proteins in the PPCs vs FPCs where ±1.2 fold 
regulation values are marked by lines. Red = up-regulated proteins > 1.2 and p value < 
0.05; green = down-regulated proteins < -1.2 and p value < 0.05. Circular dots mean 
proteins were significantly different in both the potentiated and dormant PPCs when 
compared to the FPCs; rectangular dots = only significantly different in the potentiated 
PPCs vs. FPCs; and triangular dots = only significantly different in the dormant PPCs vs. 
FPCs. 
 
The highest number of DRPs were detected when comparing the PPCs (PPPCs and DPPCs) 
to APCs. A total of 61 proteins were significantly up- or down- regulated (34 and 27, 
respectively) in both the PPPCs and DPPCs groups compared to the APCs. In addition, eight 
up-regulated and six down-regulated proteins were detected in the PPPCs vs. APCs alone 
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and nine up-regulated and one down-regulated protein detected in the comparison of 
DPPCs vs. APCs alone (Figure 2.8). 
 
 
Figure 2.8 Differentially regulated proteins in the pedicle periosteum cells (PPCs) vs. 
antlerogenic periosteum cells (APCs). Y axis denotes the p value with p = 0.05 marked by 
a dotted line. X axis represents the up and down regulated proteins in the PPCs vs APCs 
where ±1.2 fold regulation values are marked by lines. Red = up-regulated proteins > 1.2 
and p value < 0.05; green = down-regulated proteins < -1.2 and p value < 0.05. Circular 
dots mean proteins were significantly different in both the potentiated and dormant PPCs 
when compared to the APCs; rectangular dots = only significantly different in the 
potentiated PPCs vs. APCs; and triangular dots = only significantly different in the dormant 
PPCs vs. APCs. 
 
 Functional classification 
PANTHER 10.0 bioinformatics software was used to categorise the Gene Ontology of all 
the DRPs in biological process, molecular function and protein class (Figure 2.9). The DRPs 
in the three comparisons (APCs vs. FPCs, PPCs vs. FPCs, PPCs vs. APCs) were mapped. The 
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PPCs vs APCs comparison, which contained the largest number of DRPs, gave the largest 
number of classifications. 
 
 
Figure 2.9 Gene Ontology (GO) classification of the differentially expressed proteins using 
PANTHER 10.0. Percentages of GO terms in each category are displayed. 
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Within the classification of ‘biological process’, the DRPs were mainly (70% of the total 
processes) involved in “cellular process”, “metabolic process” and “cellular component 
organisation or biogenesis”, successively. In the APCs vs. FPCs comparison, there were no 
proteins involved in “response to stimulus” or “immune system process”. 
 
As to the classification based on molecular function, the majority of DRPs possessed 
“catalytic activity”, “structural molecule activity” and “binding function” in all the three 
comparisons; although the order in the APCs vs. FPCs was different. There were no DRPs 
with “antioxidant activity” or “channel regulator activity” found in the APCs vs. FPCs, and 
no “translation regulator activity” or “channel regulator activity” found in the PPCs vs. 
FPCs. 
 
Classification based on protein class resulted in the identification of five major categories 
in the PPCs vs FPCs and PPCs vs APCs: “cytoskeletal protein”, “chaperone”, “hydrolase”, 
“enzyme modulator” and “oxidoreductase” successively. In the APCs vs FPCs comparison, 
the top five categories were “cytoskeletal protein”, “enzyme modulator”, “nucleic acid 
binding”, “transporter” and “hydrolase”. The PPCs vs APCs comparison was unique in that 
it contained proteins that mapped to “cell adhesion molecule” and “extracellular matrix 
protein” but not to “transfer/carrier protein”. 
 
 Enriched pathways network analysis 
The pathway network groups that mapped with the differentially expressed proteins were 
enriched using the ClueGo plugin. The enrichment network of the DRPs with their 
expression level in each pathway (p value ≤ 0.05) was then created using the CluePedia 
plugin from the Cytoscape platform. In the APCs vs. FPCs (Figure 2.10), there were two 
groups and three independent pathways. In the “recycling pathway of L1” and 
“vasopressin-regulated water reabsorption”, all the enriched proteins were down-
regulated in the APCs. In the pathway groups – “smooth muscle contraction” and 
“leukocyte transendothelial migration”, the majority of enriched proteins were down-
regulated in the APCs. Only in the “prostaglandin synthesis and regulation pathway”, were 




Figure 2.10 Enriched pathway network groups for the differentially regulated proteins in 
the antlerogenic periosteum cells (APCs) vs. facial periosteum cells (FPCs) comparison. 
Pathways for the significantly up- and down-regulated proteins of the APCs are visualised 
as a functionally grouped network based on the kappa score (0.4); only the terms that 
have p value ≤ 0.05 are shown. The size of the nodes denotes the term significance. The 
most significant term of each group is highlighted, and the group is named after it. Nodes 
in different shapes (diamond: KEGG database; ellipse: REACTOME database; hexagon: 
Wikipathways database) represent specific pathways and are grouped based on their 
similarity. The proportions of up- or down-regulated proteins in each pathway are 
indicated by red or green respectively. 
 
When the PPCs vs. FPCs were compared, there were three enriched pathway network 
groups identified, “cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding”, 
“smooth muscle contraction” and “leukocyte transendothelial migration” (Figure 2.11 and 
Figure 2.12). Nearly all the enriched pathways had greater numbers of up-regulated 
proteins in the PPCs. An exception to this was in the pathway “the role of GTSE1 in G2/M 
progression after G2 checkpoint”, where 75% of the enriched proteins were down-




Figure 2.11 Enriched pathway network groups for the differentially regulated proteins in 
the pedicle periosteum cells (PPCs) vs. facial periosteum cells (FPCs) comparison. 
Pathways for the identified up- and down-regulated proteins of the PPCs are visualised as 
a functionally grouped network based on the kappa score (0.4); only the terms that have 
p value ≤ 0.05 are shown. The size of the nodes shows the term significance. The most 
significant term of each group is highlighted, and the group is named after it. Nodes in 
different shapes (diamond: KEGG database; ellipse: REACTOME database; hexagon: 
Wikipathways database) represent specific pathways and are grouped based on their 
similarity. The proportions of up- or down-regulated proteins in each pathway are 




Figure 2.12 CluePedia analyses of the differentially regulated proteins in the pedicle 
periosteum cells (PPCs) vs. facial periosteum cells (FPCs) comparison. In the functionally 
grouped network, pathways of the up- and down-regulated proteins in the PPCs and their 
associated proteins (smaller elliptic dots) are linked based on the kappa score (0.4). Only 
the terms that have p value ≤ 0.05 are shown. The size of the nodes shows the term 
significance. The most significant term of each group is highlighted, and the group is 
named after it. Nodes in different shapes (diamond: KEGG database; ellipse: REACTOME 
database; hexagon: Wikipathways database) represent specific pathways and are 
grouped based on their similarity. The proportions of up- or down-regulated proteins in 
each pathway are indicated by red or green respectively. 
 
The enriched pathway network groups in the PPCs vs. APCs comparison were mainly 
“chaperonin-mediated protein folding”, “smooth muscle contraction”, “parkin-ubiquitin 
proteasomal system pathway” and “cooperation of prefoldin and TriC/CCT in actin and 
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tubulin folding” (Figure 2.13 and Figure 2.14). Among them, there were more up-




Figure 2.13 Enriched pathway network groups for the differentially regulated proteins in 
the pedicle periosteum cells (PPCs) vs. antlerogenic periosteum cells (APCs) comparison. 
Pathways for the identified up- and down-regulated proteins of the PPCs are visualised as 
a functionally grouped network based on the kappa score (0.4); only the terms that have 
p value ≤ 0.05 are shown. The size of the nodes shows the term significance. The most 
significant term of each group is highlighted, and the group is named after it. Nodes in 
different shapes (diamond: KEGG database; ellipse: REACTOME database; hexagon: 
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Wikipathways database) represent specific pathways and are grouped based on their 
similarity. The proportions of up- or down-regulated proteins in each pathway are 
indicated by red or green respectively. 
 
 
Figure 2.14 CluePedia analyses of the differentially regulated proteins in the pedicle 
periosteum cells (PPCs) vs. antlerogenic periosteum cells (APCs) comparison. In the 
functionally grouped network, pathways of the up- and down-regulated proteins in the 
PPCs and their associated proteins (smaller elliptic dots) are linked based on the kappa 
score (0.4). Only the terms that have p value ≤ 0.05 are shown. The size of the nodes 
 62 
shows the term significance. The most significant term of each group is highlighted, and 
the group is named after it. Nodes in different shapes (diamond: KEGG database; ellipse: 
REACTOME database; hexagon: Wikipathways database) represent specific pathways and 
are grouped based on their similarity. The proportions of up- or down-regulated proteins 
in each pathway are indicated by red or green respectively. 
 
 Western blot validation 
The differences in abundance of differentially expressed proteins from the four samples 
were validated by western blot (Figure 2.15 and Appendix 2.4). Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used to normalise loading of the selected 
proteins. Consistent with the 2D-DIGE results no significant differences were detected 
between the PPPC and DPPC groups. In the comparisons for PPCs vs. FPCs and PPCs vs. 
APCs, all the results with significant difference in western blot had the same trend of 
expression level as their corresponding 2D-DIGE results. HSPA5 in the 2D-DIGE results had 
three spots with different expression trends in the comparison of DPPCs vs. FPCs, making 
interpretation of the results difficult. Vimentin (VIM) was a slight exception as it had 
similar levels in the APCs and FPCs by western blot analysis but was slightly up-regulated 
in the APCs when examined by 2D-DIGE; however, the elevated levels in the APCs and 
FPCs over PPPCs and DPPCs were consistent. Overall, the relative expression levels of the 




Figure 2.15 Western blot analysis of the differentially regulated proteins in the four groups. 
The same amount of protein of each biological replicate employed in 2D-DIGE was 
detected with (A): anti-HSP90AB1, anti-HSPA5, anti-HNRNPK, (B): anti-VIM, anti-LGALS1, 
and (C): anti-SPARC. Anti-GAPDH was used as the endogenous control. Band intensities 
were quantified using ImageJ. AP: antlerogenic periosteum cells; FP: facial periosteum 
cells; PPP: potentiated pedicle periosteum cells; DPP: dormant pedicle periosteum cells. 
Protein abundance in each experimental group is expressed as the mean value ± standard 





Understanding the regulation of stem cells and how these pools of multipotent cells are 
controlled is of importance in the field of regenerative biology. This study examined the 
different protein expression profiles of APCs and PPCs and compared them to FPCs as 
controls. The aim was to use the antler as a model to discover protein targets associated 
with maintenance and activation of stem cells and examine the protein networks and 
possible molecular mechanisms involved in regulating tissue/organ generation and 
regeneration. 
 
 Multivariate statistical analysis 
The hierarchical cluster analysis showed good overall agreement with the principal 
component analysis. Protein expression profiles were found to be different between the 
APCs and FPCs, while the DPPCs and PPPCs were very similar. FPCs and APCs are both 
derived from the periosteum over the cervine skull (Li & Suttie, 2001), in the vicinity 
geographically, and in the hierarchical cluster analysis they were mostly similar. The 
pedicle periosteum cells from the dormant (DPPCs; proximal two thirds) and potentiated 
regions (PPPCs; distal third) (Li et al., 2007c) clustered together, and in the subsequent 
analyses were considered as one group. The lack of difference between these stem cell 
groups suggests that the stem cell activation zone, responsible for the production of new 
antler at the most distal aspect of the pedicle, may be smaller than previously thought; 
alternatively, the 2D-DIGE method may not be sensitive enough to detect the low 
abundant proteins that involved in this activation. 
 
 Proteins and biological processes associated with antler generation 
The FPCs were collected over intramembranous bone and are known to contain resident 
mesenchymal stem cells capable of bone repair and regeneration (Lin et al., 2014; Wang 
et al., 2012). The antlerogenic periosteum is located in a unique region where the stem 
cells are capable of generating antler in the first year. There were more down-regulated 
proteins in the APCs when compared to the control FPCs, which was consistent with the 
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findings in the pathway groups. These results may suggest that antlerogenic periosteum 
tissue at the time of sampling was still metabolically quiescent. 
 
The majority of the APCs down-regulated proteins were mapped to the categories of 
“structural molecule activity” (39%) and “cytoskeletal protein” (39%) and consisted of 
actin cytoplasmic 1 (ACTB), moesin (MSN), actin aortic smooth muscle (ACTA2), alpha-
actinin-4 (ACTN4). Normally, cytoskeletal proteins function by regulating cellular 
proliferation (Almuzzaini et al., 2016), migration and motility (Honda et al., 1998; Lagresle-
Peyrou et al., 2016). This may indicate that, in the present experiment, the APCs had less 
cellular motility associated proteins compared with the FPCs. At the time of collection, 
the specialised antler stem cells of the antlerogenic periosteum were dormant and thus 
the presence of multiple down-regulated proteins was consistent with the biological 
status of the tissue. 
 
Prostaglandins are a group of active lipid signalling molecules, which are widely 
distributed in a large number of tissue types. They have multiple biological activities, such 
as promotion of inflammation (Crunkhorn, 2015), apoptosis and angiogenesis (Martel-
Pelletier et al., 2003). Prostaglandins have also been associated with regeneration 
processes in many kinds of tissues including: skin (Zhu et al., 2017), muscle (Ho et al., 
2017), cartilage (Otsuka et al., 2009), bone marrow, liver and colon (Zhang et al., 2015). 
The only enriched molecular pathway with more up-regulated proteins for the APCs was 
“prostaglandin synthesis and regulation” which suggests prostaglandins may play a role 
in the maintenance of the stemness for APCs. 
 
 Pedicle periosteum cells responsible for antler regeneration 
The PPCs which are responsible for driving annual antler regeneration were also 
compared to the FPCs. More differentially expressed proteins were found to be up-
regulated in the PPCs vs FPCs than when the APCs were compared to the FPCs. 
Cytoskeletal proteins (29% of the protein class) and nearly all the enriched pathway 
groups were largely up-regulated in the PPCs vs FPCs comparison. 
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Multiple pathways which contain proteins GNB1, GNB2, GNG4, and CCT7 were enriched 
in the pathway group “cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta 
folding”. In humans, there are 616 identified G protein-coupled receptors (GPCRs) (Venter 
et al., 2001), which transduce signals to intracellular heterotrimeric G proteins which are 
then catalytically activated (Gilman, 1987) to mediate the downstream effectors from 
multiple ligands, such as neurotransmitters, hormones, metabolites, and sensory signals 
(Birnbaumer, 1990). Some GPCRs are found to play very important roles in regenerative 
medicine, such as in nerve repair, bone healing and formation, myocardial regeneration 
and newt limb regeneration (Geng et al., 2014; Li et al., 2016; Mogha et al., 2016; Wang 
et al., 2015; Wattanachanya et al., 2015; Zuo et al., 2016). These results suggest there 
were more well-assembled heterotrimeric G proteins and well-folded GPCRs in the stem 
cells from the PPCs than in the facial periosteum derived cells. 
 
The only enriched pathway with more down-regulated proteins (75%) than up-regulated 
in the PPCs was “the role of GTSE1 in G2/M progression after G2 checkpoint”. In this 
pathway, GTSE1 binds MAPRE1 to promote cell migration (Scolz et al., 2012). Increased 
level of the MAPRE1 protein was found in the PPCs which is consistent with the PPCs 
having a greater capability to migrate and produce new antler. Notable was the down-
regulation of HSP90AA1 and HSP90AB1, the two cytosolic isoforms of HSP90 (Chen et al., 
2005), in the PPCs as detected by both 2D-DIGE and western blot. Considering the multiple 
functions of HSP90 (Jackson, 2013), this pathway warrants further investigation. 
 
Within the Reactome pathway, GTSE1 binds p21 with the aid of FKBPL and the chaperone 
protein HSP90 to form a stable quadruple cytosolic complex. This complex delaying G2/M 
onset rescues cells from G2 checkpoint-induced apoptosis (Bublik et al., 2010). In this 
research, the PPCs had higher expression of GTSE1 and p21 suggesting compared with the 
FPCs, PPCs were more likely to be in the G1 phase, a finding which was consistent with 
our previous work (Guo et al., 2015). 
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 Protein expression profiles in different types of antler stem cells 
There were more differentially expressed proteins, greater number of Gene Ontology 
classifications and more enriched pathways in the comparison of PPCs vs. APCs. 
Collectively, this may imply that compared to the APCs, the PPCs have unambiguously 
differentiated into another type of stem cells. Among the enriched pathway groups, the 
group entitled “smooth muscle contraction” had more up-regulated proteins. This 
“smooth muscle contraction” enrichment group was identified not only in the PPCs vs. 
APCs, but also from the other two comparisons conducted in this research. The up-
regulated protein CALD1 is an actin- and myosin-binding protein working as a bridge 
between actin and myosin molecules in both muscle and in non-muscle cells (Huber et al., 
1993; Janco et al., 2012), and is important in stabilising the cytoskeleton (Kremneva et al., 
2006). In antler stem cells, CALD1 may be associated with actin filaments like ACTA2 and 
ACTN4, the myosin protein like MYL6 and TPM family (TPM1-4), and with the help of the 
Ca2+/calmodulin complex, function to stabilise the cytoskeleton and increase cell motility. 
These proteins, when detected, were up-regulated in the PPCs as compared to the APCs. 
Another two enriched molecules found up-regulated in the PPCs were annexin A2 and A6. 
Annexins are a family of phospholipid-binding proteins which are controlled in a Ca2+-
dependent manner (Lizarbe et al., 2013). ANXA2 and ANXA6 bind to dysferlin and have a 
role in the rapid resealing of disrupted cell membranes both in skeletal muscle and 
cardiomyocytes (Lennon et al., 2003; Roostalu & Strahle, 2012). This implies ANXA2 and 
ANXA6 up-regulation in the PPCs may be involved in membrane repair and maintenance. 
PPCs provide the sole cell source for regenerating antlers (Li et al., 2007a), and these cells 
not only differentiate into bone lineage cells to build up antler tissue, but also may 
differentiate into cell types for building up blood vessels (Clark et al., 2006a). Antler blood 
vessels are unique in that they have unprecedented contract force when mechanically 
stretched (Goss, 1983). Therefore, one possible reason is that up-regulation of smooth 
muscle contraction in the PPCs may have laid the foundation for the future construction 
of the unique blood vessels. In addition, upregulation of these enriched differentially 
expressed proteins may also indicate that the antler stem cells had some muscle cell-like 
potential, such as executing aggressive and powerful cell motility. This finding is 
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consistent with the ability of the pedicle periosteum to regenerate antler on an annual 
basis. 
 
Neural crest stem cells are unique to developing vertebrate embryos and can differentiate 
into multiple tissue types such as neurons, glia, craniofacial cartilage, bone, teeth and 
smooth muscle (Huang & Saint-Jeannet, 2004). Antler stem cells have been conjectured 
to be derived from neural crest cells (Kierdorf & Kierdorf, 2002; Kierdorf et al., 2007; Price 
& Allen, 2004). The pedicle periosteum cells have also been experimentally defined as 
persistent neural crest-like stem cells (Mount et al., 2006a). The epithelial-mesenchymal 
transition (EMT) process is well known to play a key role in the migration and 
differentiation of the neural crest (Kerosuo & Bronner-Fraser, 2012; Thiery et al., 2009). 
The transcriptional master-regulator of EMT is the Slug protein (Nieto, 2002) and has been 
found in higher levels in the pedicle periosteum during the regenerative phase compared 
to the non-regenerative phase (Mount et al., 2006a), which suggests that EMT activation 
may be important for antler regeneration. In this research, SPARC, LGALS1 and S100A4 
(Wang et al., 2017a) were all found to be up-regulated in the PPCs comparing to the APCs. 
These proteins are all markers of EMT induction (Bacigalupo et al., 2015; Chang et al., 
2017; Chow et al., 2017; Hung et al., 2017; Schneider et al., 2008; Takigawa et al., 2017; 
Tang et al., 2017). This supports a role for EMT activation in antler wound healing (the 
very initial stage of antler regeneration) and regeneration. 
 
Less vimentin protein was detected by both 2D-DIGE and western blot in the PPCs as 
compared to the APCs. Vimentin is a major cytoskeletal component and often used as a 
marker of mesenchymal-derived cells (Dave & Bayless, 2014; Sharma, 2017) or cells 
undergoing EMT (Wang et al., 2018b). The significance of vimentin reduction and its 
effects on cell mobility and deformability warrants further research in relation to the 
regulation of the PPCs. 
 
The “pentose phosphate pathway” was one of few enriched pathways with all down-
regulated proteins in the PPCs comparing to the APCs. Together with PFKP from 
“glycolysis” and PCK2 from “gluconeogenesis”, this may indicate that carbohydrate 
metabolism was more active in the APCs. These glucose metabolism pathways produce 
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energy, such as ATP, and some products are important for cellular processes, like the 
NADPH and ribose 5-phosphate (R5P) from the pentose phosphate pathway (Kruger & 
von Schaewen, 2003). The two enzymes, TKT and TALDO1, enriched in the “pentose 
phosphate pathway” were both involved in its non-oxidative phase (Melendez-Hevia & 
Isidoro, 1985). 
 
DUT protein had the lowest level in the PPCs compared to the APCs (AVR = -3.24; p value 
= 0.045). DUT is an enzyme which participates in nucleotide metabolism, regulating the 
production of dUMP from dUTP, and as such plays a critical role in the fidelity of genomic 
replication and repair (Mol et al., 1996). In the APCs the DUT protein may create more 
R5P through the nucleotide salvage pathway. This would contribute to the stability of the 
genome and provide more substrate to the pentose phosphate pathway from unwanted 
dNTPs (Pollack et al., 1997). Interestingly, DUT was also highly up-regulated in the FPCs 
compared to the PPCs. The underlying mechanism between the different expression 
levels of DUT is worthy of further investigation. 
 
2.6 Conclusions 
This is the first comprehensive study of the protein profiles from the antler stem cells 
involved in antler generation and regeneration using a quantitative protein-labelling 
technique (2D-DIGE). The analyses of the differentially expressed proteins demonstrated 
multiple cell processes and signalling pathways were involved in regulating the 
maintenance and activation of stem cells fundamental to the development of antler as a 
complex organ. The EMT process was identified as a key element in the PPCs and may 
contribute to the initial stage of antler regeneration, i.e. scar-less healing and antler 
regeneration per se. This research points to the regulation of cytoskeletal proteins and 
particularly those involved in smooth muscle contraction being important in the PPCs, 
which are capable of antler regeneration and thus requiring high mobility. Energy 
metabolism within the PPCs may however be lower than that of the APCs or FPCs. In 
addition, DUT is a potential marker which differentiates APCs/FPCs from PPCs. The antler 
provides an exciting model for the study of mammalian neural crest derived stem cells, 
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Regeneration of Deer Antler: A Model of Mammalian Organ Regeneration. Journal of 
Proteome Research, 19(4), 1760-1775.  
 
The supporting data relating to the proteomics and bioinformatics analysis are 
documented with the published online manuscript and can be accessed via the following 




The study presented in this chapter aimed to investigate the differentially expressed 
proteins between stem cell tissues during different processes in antler regeneration. The 
mesenchymal stem cell (MSC) markers CD73, CD90, and CD105 were first examined within 
the antler tip. Label-free quantification was performed to investigate the protein profiles 
of antler stem cells under different stages of activation and included dormant pedicle 
periosteum (DPP), antler growth centre (GC), post-active stem cells from mid-beam antler 
periosteum (MAP), and deer facial periosteum (FP) as a control (n = 3 per group). PEAKS 
and Ingenuity Pathway Analysis software were used to analyse the proteomic data. Our 
research confirmed the central role of stem cell activation in the development of this 
mammalian organ by localising the MSC markers within the antler growth centre. Label-
free quantification revealed that the greatest number of unique proteins (87) were found 
in the growth centre. There were only 12 proteins found with expression levels that 
significantly differed between DPP and FP. Protein profiles of these two groups indicated 
that antler stem cells may use similar mechanisms to maintain dormancy within a stem 
cell niche. The number of significantly regulated proteins among DPP, MAP, and GC was 
153. Among them, the majority were upregulated in the growth centre. Activation of 
antler stem cells was associated with many biological processes and signalling pathways, 
such as Hippo and canonical Wnt signalling. This work identifies the key pathways, 




Regenerative medicine partnered with emerging technologies is increasingly developing 
promising solutions in treating congenital defects, injuries, and diseases (Dzobo et al., 
2018; Neves et al., 2016). Stem-cell-based regeneration offers promise in the clinical 
application of regenerative medicine (Ilic & Polak, 2011). In order to safely apply stem-
cell-based regeneration, it is first necessary to understand the activation and control of 
stem cells. Animal models with robust regenerative potential can provide important 
insights into the underlying mechanisms of stem cell regulation (Zhao et al., 2016). Among 
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them, antler is an ideal regenerative model to study the protein networks involved in 
maintenance of a stem cell niche, stem cell activation, and cellular differentiation. 
 
Annual antler regeneration occurs from permanent protuberances on the deer frontal 
bones called pedicles, with the stem cells located within the periosteal tissue (Li, 2012; Li 
et al., 2005). Pedicles are themselves formed from cranial neural-crest-derived cells 
(Kierdorf & Kierdorf, 2002), and antler stem cells in vitro express markers consistent with 
being MSC, as well as some embryonic stem cell (ESC) markers, indicating a unique 
phenotype (Wang et al., 2019a). Research has identified them as neural-crest-derived 
stem cells which retain the multi-lineage differentiation capacity necessary for antler 
regeneration (Dong et al., 2019; Kierdorf et al., 2009; Wang et al., 2019b). This makes 
antler stem cells a robust model to study the regulation of neural-crest-derived stem cells 
in human, such as dental pulp stem cells (Stevens et al., 2008). 
 
Deer antler regeneration follows an annual cycle which is testosterone level-dependent 
(Fennessy & Suttie, 1985; Price et al., 2005b). In early spring (September in the Southern 
hemisphere), and under relatively low testosterone levels, the ossified antler is cast (Price 
et al., 2005b). Antler casting is caused by osteoclastic resorption of the distal pedicle 
adjacent to the bony antler (Kierdorf et al., 2003). Dormant stem cells residing in the distal 
pedicle periosteum are then activated and form a new active stem cell pool on the distal 
surface responsible for regeneration of a new antler (Li, 2012; Li et al., 2005). In this 
“testosterone depleted environment”, the active stem cells form the antler growth centre 
and differentiate downward into cartilage and bone undergoing a process of 
endochondral ossification, with new antler formation occurring at up to 2 cm/day and as 
much as 30 kg within three months (October to December) (Goss, 1983, 1990; Kierdorf et 
al., 2003; Li & Suttie, 1994; Li et al., 2005; Price et al., 2005a). In February, with increasing 
testosterone levels, the dermal layers known as velvet skin shed exposing the underlying 
bare bony antler surface (Fennessy & Suttie, 1985). The testosterone levels continue to 
rise reaching a peak during the rutting season (March to June) (Fennessy & Suttie, 1985; 
Lincoln, 1971; Price et al., 2005b). Hard antler is retained under declining testosterone 
levels (July to August), until the next cycle of regeneration in early spring (Fennessy & 
Suttie, 1985; Price et al., 2005b). 
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Proteomics is recognised as one of the most promising approaches to investigate the 
molecular mechanisms, cellular functions, and biological processes involved in 
regeneration (Franco et al., 2013). Previous research investigating deer antler stem cell 
proteomics has largely focused on cells isolated in vitro due to technical constraints (Dong 
et al., 2016a; Dong et al., 2019; Li et al., 2012; Sui et al., 2020; Wang et al., 2018a). The 
studies include gel-based 2DE (Li et al., 2012; Park et al., 2004), 2D-DIGE (Dong et al., 2019), 
and labelled MS-based iTRAQ (Dong et al., 2016a) and SILAC (Sui et al., 2020) quantitative 
approaches. Emerging technology has enabled the use of label-free MS as a cost-effective, 
high-throughput, and quantitative method for the identification of relative protein 
expression profiles from samples. This has allowed a comparison of proteins expressed 
from different stem cell tissues in the antler. 
 
In this chapter, label-free quantification coupled with Ingenuity Pathway Analysis (IPA) 
was utilised to investigate the protein pathways and networks of dormant, active, post-
active, and control facial periosteum tissue-derived stem cell niches during antler 
regeneration. This research aimed to identify unique regulated proteins and discover the 
key regulators, signalling pathways, and mechanisms during stem cell activation in antler 
as a model of mammalian organ regeneration. Large animal models of regeneration are 
challenging to undertake; however, to fully understand human regeneration, it is 
important to study protein regulation in mammalian stem-cell-based systems. This study 
adds value to the proteomics research field of regenerative animal models and allows 
comparison with other stem-cell-based regenerative models. 
 
3.3 Material and methods 
 Experimental design and statistical rationale 
Tissue samples (n = 3 animals per group) were collected before and during antler 
regeneration, including mid-beam antler periosteum (MAP), antler growth centre (GC), 
dormant pedicle periosteum (DPP), and facial periosteum (FP) (Figure 3.1). 
Immunohistochemistry was used to investigate the location of MSCs within the growth 
centre (n = 3 biological replicates) to ensure the stem cells were accurately sampled. 
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Label-free proteomics was conducted on 12 samples from the four groups after protein 
extraction and digestion, with each sample run three times by LC-MS/MS. 
 
 
Figure 3.1 Deer antler regeneration model. (A) Schematic diagram of deer antler: facial 
periosteum (FP), dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), 
and growth centre (GC). (B) Deer antler growth is driven from stem cells residing in the 
reserve mesenchyme layer (RM); other layers include dermis (D), blood vessel (BV), 
precartilage (PC), transition zone (TZ), and cartilage (C). 
 
A Venn diagram was created in Venny (v2.1) (Oliveros). Multivariate statistical analyses, 
including principal component analysis (PCA) and heatmaps with hierarchical clustering 
analysis, were performed on significantly regulated proteins, 12 from DPP vs. FP, and 153 
from DPP vs. MAP vs. GC using R (v 3.5.2) (R Core Team, 2018). To conduct the PCA, R 
packages of “FactoMineR (v1.42)” (Le et al., 2008), “factoextra (v1.0.5)” (Kassambara & 
Mundt), “magrittr (v1.5)” (Bache & Wickham, 2014), “ggpubr (v0.2.3)” (Kassambara, 
2017), and “ggplot2 (v3.2.1)” (Wickham, 2016) were used. Hierarchical clustering analysis 
used R packages for “ComplexHeatmap (v1.20.0)” (Gu et al., 2016) and “circlize (v0.4.8)” 
(Gu et al., 2014) with Pearson correlation and Ward’s methods (Meunier et al., 2007). 
Bioinformatics analysis was further carried out using IPA (QIAGEN Bioinformatics, release 
date: Feb 8, 2019). The enrichment of GO pathways and identification of upstream 
regulators and protein-protein interaction networks were used to interpret the 
mechanisms involved in stem cell activation during antler regeneration. Three biological 
replicates from each group were used in stain-free Western blot. All proteomics and stain-
free Western blot data were evaluated by Student’s t test (between DPP and FP) and one-
way ANOVA with post-hoc Tukey HSD test (between DPP, MAP, and GC). A statistical 
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significance rate was set at p value of < 0.05. Graphs are presented as the mean ± SD using 
GraphPad Prism (v8.2.1). 
 
 Deer antler tissue collection 
All tissues were initially taken by a certified person under the direction of a vet. Specific 
samples were collected afterwards. Considering the practice of velveting was not 
interfered, ethical approval was therefore not required. In detail, DPP and FP (n = 3 each) 
were harvested in February from red deer (Cervus elaphus) heads immediately after 
slaughter at a local abattoir (Duncan New Zealand Venison, Dunedin, New Zealand). MAP 
and GC (n = 3 each) were collected from commercially harvested velvet antler 
(approximately 50-60 days of growth) of red deer (Cervus elaphus) in December at a deer 
research farm (AgResearch Invermay, New Zealand). GC sampling used the method 
previously validated by Li et al. (Li et al., 2002) in which the reserve mesenchymal (RM) 
and precartilage (PC) layers of active stem cells were dissected (Figure 3.1A). MAP, as a 
periosteal derivate of antler growth centre, was made up of strips (width = 0.5 cm and 
length = 3 cm) of mid-antler periosteum, collected between the first and second tines of 
antler at the time of commercial harvesting. DPP with dormant stem cells was collected 
in strips of periosteum from the proximal region of the pedicle. FP was collected from the 
nasal bone between the two eye sockets, as strips of periosteum, and used as a control 
tissue. One slice of growth centre containing all layers (Figure 3.1B), from each antler, was 
fixed in 30 mL 10% neutral buffered formalin (LabServ, New Zealand) for 24 h and then 
transferred into PBS (Gibco, USA) for immunohistochemical analysis. All periosteum and 
GC tissues were snap-frozen in liquid nitrogen and stored at -80℃ for subsequent use. 
 
 Immunohistochemical detection of mesenchymal stem cell markers 
Immunohistochemical detection for CD73, CD90, and CD105 was performed on serial 
sections (4 μm in thickness) of paraffin-embedded antler tip tissues. Morphology was 
examined with haematoxylin-eosin staining. The detailed methodology for 
immunohistochemistry conducted on the bench can be found in Appendix 3.1. In brief, 
immunohistochemistry for CD90 and CD105 was conducted on sections dewaxed in 
xylene (×3) and then hydrated. Heat retrieval was performed with citrate buffer (0.01 M) 
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at 95-100℃ for 10 min in a water bath. Slides were incubated for 30 min with 20% goat 
serum (Sigma, USA) and 1% BSA (Sigma)/PBS to block nonspecific binding sites and 
incubated at 4℃ overnight using primary antibodies of CD90 (5 µg/mL, Abcam, USA) and 
CD105 (10 µg/mL, Bioss Antibodies, USA) in a diluent of 5% goat serum + 1% BSA/PBS. 
Washing was followed by incubation in goat F(ab')2 anti-rabbit IgG - H&L (Biotin) (5 µg/mL, 
Abcam) for 1 h and endogenous peroxidase blocking with 0.3% hydrogen peroxide (Sigma) 
in methanol. Immunohistochemical detection was then performed using a Vectastain Elite 
ABC Strep HRP Kit (Vector laboratories, USA) followed by a DAB chromogen (Sigma). 
Haematoxylin was used as a counterstain for CD105 only. Immunohistochemistry for 
CD73 was conducted with a rabbit anti-CD73 antibody (10 µg/mL, Abcam) using an 
automated BenchMark XT platform (Ventana Medical Systems, USA). Matched IgG 
controls were conducted on all tissues. Images were taken with an Aperio Digital Slide 
Scanner (Leica Biosystems, Germany) and analysed by Aperio ImageScope software 
(v12.3.2, Leica Biosystems). 
 
 Protein extraction and digestion 
The detailed methodology can be found in Appendix 3.2. In brief, tissue homogenisation 
was performed on 50 mg of each sample in a randomised order. Lysis buffer (pH 8.0) 
contained 7 M urea (Fisher Chemical, USA), 2 M thiourea (Acros Organics, USA) and 1× 
protease inhibitors (ROCHE, Switzerland). After homogenisation, samples were 
centrifuged at 20,000 g for 30 min (4℃). The supernatant was then filtered using a 0.45 
μm centrifugal spin filter (Grace, USA). Lysates were mixed with 9 volumes of heating 
buffer (2% SDS (Fisher Chemical, USA), 0.1 M Tris (Scharlau, Spain) and 50 mM DTT (Sigma), 
pH 7.6). After incubation at 95℃ for 5 min and centrifuging at 20,000 g for 20 min, 10 μL 
aliquots of sample were mixed with 90 μL LC-MS grade water (Fisher Chemical). The 
protein concentration was then determined using a Qubit protein assay kit (Thermo Fisher 
Scientific, USA) combined with a Qubit fluorometer (Thermo Fisher Scientific). SDS-PAGE 
gels were also run to evaluate the protein extraction efficiency and protein quantification. 
The gels were scanned in a fluorescence module using the Cy5 channel (around 640V) in 
a Typhoon FLA 9500 (GE Healthcare, USA) and analysed by ImageQuant TL software (GE 
Healthcare). Linear regression was performed using GraphPad Prism (v8.2.1). 
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A filter-aided sample preparation (FASP) protocol was used to prepare extracted proteins 
for LC-MS/MS (Wisniewski, 2017). In short, a homogenate of each sample equivalent to 
25 μL of the reference sample was mixed with 9 volumes of heating buffer. After heating, 
homogenates were transferred into 30 kDa Microcon centrifugal ultrafiltration units 
(Merck Millipore Ltd., Ireland). After the bulk of the liquid had passed through the 
ultrafilter, buffer exchange was conducted with UA-solution (8 M urea and 0.1 M Tris, pH 
8.5). Next, 100 μL of 50 mM iodoacetamide (IAA, Sigma, USA) in UA-solution was added 
and incubated on an orbital shaker at 300 rpm for 20 min (25℃) in the dark. The alkylation 
reaction was stopped by centrifuging the IAA solution through ultrafiltration units at 
14,000 g for 15 min. After exchange to the digestion buffer (0.05 M ammonium 
bicarbonate (AMBIC, VWR International, USA)), protein digestion was conducted with 3% 
sequencing grade modified trypsin [w/v] (Promega, USA), 10% acetonitrile (ACN, Fisher 
Chemical), and 87% 0.05 M AMBIC (working solution was equivalent to 3 μg trypsin for 
each sample) and incubated at 37℃ overnight. The trypsin digestion solution was 
collected by centrifuging at 14,000 g for 5 min and quenched by adding 5 μL pure formic 
acid (FA, Fisher Chemical). The digested peptide samples were purified using detergent 
removal spin columns (Thermo Fisher Scientific) and dried in a CentriVap vacuum 
centrifuge (Labconco, USA). After resuspension in 50 μL of 0.1% FA/2% ACN, the solutions 
were stored at -20℃. 
 
 LC-MS/MS analysis 
Three replicate injections of each sample were analysed on an Impact II UHR QTOF (Bruker, 
Germany) coupled with an UltiMate 3000 RSLCnano UHPLC (Thermo Fisher Scientific) 
using a nanoBooster-equipped CaptiveSpray electrospray ionisation source (Bruker, 
Germany). To enrich the peptide samples, they were first loaded in 0.1% FA onto a trap 
column (5 mm × 300 µm inner diameter containing 5 µm C18 PepMap100 beads, Thermo 
Fisher Scientific) for 2 min at a flow rate of 5 µL/min. The peptides were then separated 
on a ProntoSIL analytical column (15 cm long, 100 µm inner diameter, filled with 3 µm 
C18AQ beads, nanoLCMS Solutions, USA) at a flow rate of 5 µL/min. Peptides were eluted 
using a multi-part linear gradient from 2% to 20% B over 55 min and then rising to 45% B 
over a further 20 min. Solvent A was 0.1% FA, and solvent B was 0.1% FA in ACN. The 
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settings for data-dependent acquisition were as follows: one MS scan from 150 to 2200 
m/z at 2 Hz followed by MS/MS scans of the top 5 precursor ions at 1-20 Hz using 
collisional induced dissociation (CID) with dynamic exclusion (charge exclusion: 2-5 
preferred, singly charged excluded; dynamic exclusion: 60 s, with ions reconsidered if 
intensity increased more than 3-fold within the exclusion period). 
 
 Protein identification and label-free quantification 
The MS/MS raw data were analysed using PEAKS Studio X software (Bioinformatics 
Solutions Inc., Canada). An initial search was performed using an in-house database 
provided by AgResearch (Lincoln, New Zealand), and this was followed by multi-round 
searches (against spectra with promising de novo sequences still present after the 
previous search) of a Pecora database (canonical and isoform; Swiss-Prot 7,117 sequences; 
TrEMBL 110,438 sequences; downloaded from UniProt Jan 28, 2019), and finally a Homo 
sapiens database (Canonical and isoform; Swiss-Prot 20,414 sequences; TrEMBL 149,057 
sequences; downloaded from UniProt Jan 28, 2019). The AgResearch in-house database 
comprised 222,613 non-redundant sequences that were derived from four sources: (A) 
two red deer and elk nucleotide databases containing 92,918 and 13,287 expressed 
sequence tag (EST) contig sequences (63,454,351 and 6,875,407 residues, respectively), 
which had been annotated by BLAST searches of the NCBI nr protein database; (B) the 
longest open reading frames (ORFs) from red deer lymph node mRNA; (C) all deer 
sequences from UniProt and NCBI (downloaded April 2014); and (D) all reviewed and 
unreviewed Bos taurus sequences from UniProt release 2016_10. Redundancy was 
removed from the database using Microsoft Excel. The parameters for the PEAKS 
database search were as follows: trypsin (semi-specific); maximum missed cleavages per 
peptide, 2; mass tolerance for precursor mass and fragment ion, 15 ppm and 0.05 Da. In 
the PEAKS PTM search, 313 built-in (UniMod) modifications with maximum allowed 
variable PTM of 3 per peptide were first chosen. An optimised PEAKS PTM search was 
then performed based on the first-round result with the modifications restricted to those 
having 10 or more hits in the initial PTM search. The FDR was estimated using the decoy 
fusion method (Tran et al., 2019), and a threshold FDR ≤ 0.5% was set. Proteins with at 
least one unique peptide and having significant peptides were considered as identified. 
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To quantify the relative levels of protein abundance between different groups, three 
technical replications of each sample (36 LC-MS/MS runs) were analysed using the label-
free quantification feature of PEAKS X software. Feature detection was separately 
performed on each sample by the expectation-maximisation based algorithm. The 
features of the same peptide from all replicates of each sample were aligned through the 
retention time alignment algorithms (Lin et al., 2013). Mass error tolerance was set at 20 
ppm and retention time tolerance at 3 min. Normalisation factors of the samples were 
obtained by the total ion current (TIC) of each sample/the TIC of the reference sample 
which was automatically chosen by PEAKS. Quantification of the protein abundance level 
was calculated using the sum area of the top three unique peptides. The protein 
abundance levels were separately compared for biological replicates between DPP vs. FP, 
and DPP vs. MAP vs. GC. 
 
 Ingenuity pathway analysis 
Bioinformatic analysis of the data set was carried out using the IPA package (Release Date: 
Feb 8, 2019). To analyse the unique GC proteins, the Ingenuity Knowledge Base was used 
as the reference set and only experimentally observed evidence was selected. Functional 
enrichment and upstream regulator prediction used the Fisher’s Exact p value. The 
generation of mechanistic networks within the upstream regulator analysis used the 
default setting with a p value < 0.01. 
 
Differentially expressed proteins between GC, DPP, and MAP with p value < 0.05 (one-
way ANOVA with post-hoc Tukey HSD test) were analysed. Protein lists from comparisons 
of GC vs. DPP, GC vs. MAP, and DPP vs. MAP were treated as “three observations”. Protein 
expression as defined by fold change was used as the core analysis type with the Ingenuity 
Knowledge Base as the reference set. When comparing the three observations, a p value 
was set at ≤ 0.01 and z-score (absolute value) ≥ 2. Analysis revealed that comparisons of 
GC vs. DPP and GC vs. MAP were similar, which resulted in the production of a combined 
mechanistic network, regulator effects network and protein interactions network to 
interpret the biological mechanisms between GC and DPP/MAP. 
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 Stain-free Western blot 
Western blot using stain-free technology uses detection of the total protein of the loaded 
sample for normalisation, and this has been shown to provide more reliable and accurate 
results compared to normalisation using a housekeeping protein (Gurtler et al., 2013). In 
this study, the detailed methodology (anti-CALR/CSRP1/PRELP/NPM1 presented as an 
example) can be found in Appendix 3.3. In brief, 9 μL of the sample lysate (n = 3 per group), 
also used in the label-free quantification, was mixed with 3 μL of 4× Laemmli loading 
buffer (Bio-Rad, USA). After heat denaturation, all samples were loaded into ‘Any kD Mini-
PROTEAN TGX Stain-Free Protein Gels’ (Bio-Rad) along with Precision Plus Protein 
WesternC (Bio-Rad) and All Blue Prestained (Bio-Rad) protein standards. After running the 
SDS-PAGE gels, proteins were detected with UV-activation and imaged using a Gel Doc 
XR+ imaging system (Bio-Rad) with Image Lab software (v5.2.1, Bio-Rad). The proteins 
were then transferred onto Immun-Blot Low Fluorescence PVDF membranes (Bio-Rad) 
and imaged in the Gel Doc XR+ imaging system (Bio-Rad) to assess transfer efficiency. 
Primary antibodies were incubated at 4℃ overnight and included anti-HMGB1 (0.5 μg/mL, 
Santa Cruz, USA), anti-PRELP (1.9 μg/mL, Abcam), anti-CSRP1 (3.14 μg/mL, Abcam), anti-
YWHAB and YWHAZ (1 μg/mL, Abcam), anti-NPM1 (0.4 μg/mL, Santa Cruz), anti-CALR (≤9 
μg/mL, Abcam), and anti-CTNNB1 (0.0126 μg/mL, Abcam). Secondary anti-rabbit (Sigma) 
and anti-mouse (Abcam) IgG antibodies were used at 1:20,000 and 1:5,000 dilution 
respectively. Chemiluminescence imaging of the WesternC Blotting Standards was 
conducted with addition of 1 μL of StrepTactin-HRP conjugate (Bio-Rad) to every 10 mL of 
secondary antibody solution. Blots were developed using the Clarity Western ECL 
substrate (Bio-Rad). Image capture was performed with an Odyssey Fc imaging system (LI-
COR, USA) and Image Studio software (v5.2, LI-COR). The intensity of total protein within 
each lane and the detected protein bands were analysed and quantified by Image Studio 
Lite software (v5.2.5, LI-COR). 
 
 Data availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the iProX partner 
repository (Ma et al., 2019) with the dataset identifier PXD016824. 
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3.4 Results 
 Immunohistochemistry for MSC markers 
All three MSC markers (CD73, CD90, and CD105) were detected within different layers, 
from the distal to the proximal regions of the antler tip growth centre (Figure 3.2, Figure 
3.3, and Figure 3.4). No haematoxylin counterstaining was performed for anti-CD73 and 
anti-CD90 due to their nuclear localisation. The detection for CD73, CD90, and CD105 in 
serial sections indicated the intra-cellular co-location of the three proteins, and further 
screened where the mesenchymal stem cells locate. Within the RM and PC layers, most 
cells were positive and the overall intensity was stronger when compared to the cartilage 
layer. CD73 was more obvious in association with blood vessels and hypertrophic 
chondrocytes in the cartilage layer. The dermis contained positive cells particularly 
evident in association with hair follicles and blood vessels. Representative rabbit match 
concentration IgG controls with or without counterstaining showed that there were only 





Figure 3.2 Immunohistochemical localisation of CD73 (brown) in the deer antler tip. The 
layers labelled are indicated in Figure 3.1(B). (A) is from dermis; (B) is across dermis, blood 
vessel and reserve mesenchyme; (C) is from reserve mesenchyme; (D) is across reserve 
mesenchyme and precartilage; (E) is from precartilage, and (F) is from cartilage. Scale 









Figure 3.3 Immunohistochemical localisation of CD90 (brown) in the deer antler tip. The 
layers labelled are indicated in Figure 3.1(B). (A) is from dermis; (B) is across dermis, blood 
vessel and reserve mesenchyme; (C) is from reserve mesenchyme; (D) is across reserve 
mesenchyme and precartilage; (E) is from precartilage, and (F) is from cartilage. Scale 









Figure 3.4 Immunohistochemical localisation of CD105 (brown) in the deer antler tip. The 
layers labelled are indicated in Figure 3.1(B). (A) is from dermis; (B) is across dermis, blood 
vessel and reserve mesenchyme; (C) is from reserve mesenchyme; (D) is across reserve 
mesenchyme and precartilage; (E) is from precartilage, and (F) is from cartilage. 
Haematoxylin was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; BV, blood 








Figure 3.5 Immunohistochemical localisation of IgG controls of MSCs markers (A) Rabbit 
IgG control without haematoxylin counterstaining for anti-CD90. (B) Rabbit IgG control 
with haematoxylin counterstaining for anti-CD105. Scale bar = 100 μm. 
 
 Evaluation of protein quantification 
The protein content of each sample, in the four groups as measured by Qubit assay, was 
also evaluated by their band intensity after SDS-PAGE gel electrophoresis (Figure 3.6 and 
Figure 3.7). The SDS-PAGE result revealed that the total protein profiles of three biological 
replicates were similar within each tissue group but different among groups, especially 
between the periosteum and growth centre. This suggested good sample repeatability. 
The linear regression analysis showed good correlation between Qubit protein 
quantification and SDS-PAGE band intensity of each sample (Figure 3.8 and Appendix 3.4). 




Figure 3.6 SDS-PAGE gel of protein extracts from the four tissue groups. Facial periosteum 
(FP), mid-beam antler periosteum (MAP), dormant pedicle periosteum (DPP), growth 




Figure 3.7 Band intensity analysis of four tissue groups by ImageQuant TL. Colour of each 




Figure 3.8 Linear regression analysis between the normalised concentration of protein 
quantified by Qubit assay (y axis) and band intensity in SDS-PAGE gel (x axis). Each spot 
represents a biological replicate in each tissue group. Red is growth centre (GC); Green is 
dormant pedicle periosteum (DPP); Orange is mid-beam antler periosteum (MAP); Aqua 
is facial periosteum (FP). 
 
 Quality assessment of label-free quantification 
To evaluate the quality of MS/MS data, Pearson’s correlation of FP vs. DPP (Appendix 3.5), 
and DPP vs. MAP vs. GC (Appendix 3.6), was conducted on the identified proteins. The 
Pearson’s correlation scores for all three technical replicates were equal to or more than 
0.98. Correlation plots showed a high technical reproducibility from the mass 
spectrometer. The protein profiles between FP and DPP were similar with correlation 
coefficients of more than 0.77 (Appendix 3.5), and the majority more than 0.9, between 
these groups. 
 
 Identification of proteins from different sample groups 
GC contained the highest number of identified proteins (586). DPP (485) and MAP (490) 
were found to have similar numbers of identified proteins, while FP (474) contained the 
lowest number (Figure 3.9). When comparing the proteins identified in the GC, DPP, MAP, 
and FP, the highest number of unique proteins were found in GC (87) while few unique 




Figure 3.9 Venn diagram showing the total number of differentially expressed proteins 
identified between groups. Facial periosteum (FP), dormant pedicle periosteum (DPP), 
mid-beam antler periosteum (MAP), and growth centre (GC). The details can be seen in 
Table S2 (https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00026). 
 
The top 10 canonical pathways and molecular/cellular functions were identified for the 
87 unique GC proteins. These pathways were events predominantly related to translation 
and cellular activities (Figure 3.10A). The top upstream regulators were identified as 
transcription regulators (6 out of 10) (Figure 3.10A). In the IPA mechanistic network, 
endothelial PAS domain protein 1 (EPAS1), catenin beta-1 (CTNNB1), and insulin-induced 
gene 1 protein (INSIG1) were identified as the main upstream regulators (Figure 3.10B). 
Sterol regulatory element binding transcription factor 1 and 2 (SREBF1 and SREBF2) and 
forkhead box protein O4 (FOXO4) were identified as upstream intermediaries for the 




Figure 3.10 Ingenuity pathway analysis (IPA) for proteins only found in the growth centre. 
(A) The top 10 enriched canonical pathways, molecular/cellular functions, and upstream 
regulators with p values < 0.05 (dashed line). (B) Combined mechanistic network between 
the predicted upstream regulators (orange) and proteins (grey) unique to the growth 
centre. 
 
 Multivariate statistics analysis 
The protein expression profiles were statistically analysed using principal components 
analysis and hierarchical clustering analysis of the 12 (FP vs. DPP; Figure 3.11A and C) and 
153 (DPP vs. MAP vs. GC; Figure 3.11B and D) significantly regulated proteins. The protein 
profiles of dormant antler stem cells tissue (n = 3) and facial periosteum (n = 3) were 
similar (Appendix 3.5). The 12 significantly regulated proteins were, however, capable of 
distinguishing these two groups (Figure 3.11A and C). In the comparison of DPP vs. MAP 
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vs. GC, the GC was clustered independently with predominantly up-regulated proteins 
(Figure 3.11B and D). DPP (n = 3) and MAP (n = 3) samples clustered into one group. 
 
 
Figure 3.11 Multivariate statistical analysis applied to the regulated proteins with p values 
< 0.05. (A, B) Principal component analysis of three biological replicates from different 
groups. (C, D) Heatmap with hierarchical clustering analysis. Pearson correlation and 
Ward's method to both protein groups (rows) and samples (n = 3; columns) as indicated 
at the bottom of the graphs: facial periosteum (FP), dormant pedicle periosteum (DPP), 
mid-beam antler periosteum (MAP), and growth centre (GC). The details can be seen in 
Tables S6 and S9. 
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 Ingenuity pathway analysis 
The IPA comparison module was used to compare the enrichment of canonical pathways, 
molecular/cellular functions, and upstream regulators involving all the significantly 
regulated proteins between DPP, MAP, and GC groups (Figure 3.12). Within the top 
canonical pathways, the majority were up-regulated with a z-score of ≥ 2 in GC compared 
to DPP and MAP; the exception was “HIPPO signalling”, which was down-regulated with 
z-score of -2, in GC. In the “molecular and cellular functions” analysis, most functions were 
up-regulated in GC vs. DPP/MAP. Functions relevant to both non-programmed and 
programmed cell death, namely “necrosis” and “apoptosis”, were, however, highly down-
regulated in the GC. The functions of “nucleotide synthesis and metabolism” were found 
to be up-regulated in both GC and MAP compared to DPP. Analysis of the “upstream 
regulators” indicated the majority were activated in GC and/or MAP as compared to DPP. 
Presenilin 1 (PSEN1) and presenilin 2 (PSEN2) were the only two “upstream regulators” 




Figure 3.12 IPA comparison analysis of differentially expressed proteins between groups. 
The top items with p values less than 0.01 and the highest sum of absolute z-score values 
in canonical pathways, molecular/cellular functions, and potential upstream regulators 
are listed in order. The blocks with z-score values less than ±2 had a white dot indicating 
lack of regulation. Dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), 
and growth centre (GC). The details can be seen in Table S13 
(https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00026). 
 
Comparative analysis of the regulated proteins showed that the growth centre stem cells 
were most commonly associated with up-regulation of signalling pathways, 
molecular/cellular functions and the activation of upstream regulators, demonstrating its 
central role in antler regeneration. 
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 Analysis of mechanistic networks and regulator effects 
Mechanistic networks produced by IPA were utilised to predict the molecular mechanisms 
of the significantly regulated proteins. All predicted enriched upstream regulators were 
activated in the GC (Figure 3.13). Nine were intranuclear in location, one cytoplasmic, two 
membrane-associated, and five extracellular. Among them, tumour protein p53 (TP53), 
Myc proto-oncogene protein (MYC), CTNNB1, and hypoxia-inducible factor 1 alpha (HIF1A) 
were the most upstream hub proteins in the integral mechanistic network. Significantly 
regulated proteins fell into a variety of categories such as growth factors, enzymes, and 
kinases. The top canonical pathways enriched from the mechanistic network (Figure 3.13) 
primarily focused on cell regulation/activation, “cellular differentiation in cancer and 




Figure 3.13 Combined mechanistic network between the predicted upstream regulators 
(orange; absolute z-score values > 2) and regulated proteins (red/green) from GC vs. 
MAP/DPP. The enriched canonical pathways with more than 10 molecules are shown in 
Table 3.1. Dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), and 








Table 3.1 Enriched canonical pathways from combined mechanistic network (Figure 3.13) 
with molecules more than 10. 
 
A regulator effects network was created by connecting the possible upstream regulators 
and enriched downstream effects through the significantly regulated proteins. Most 
regulator effects with high consistency scores between GC vs. MAP and GC vs. DPP were 
similar (Table S14; https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00026). However, 
ID 5 and 11 from the comparison of GC vs. MAP were unique regulators/functions (Table 
S14; https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00026). In the combined 
regulator effects network (Figure 3.14), cysteine- and glycine- rich protein 1 (CSRP1) was 
identified as the only regulated protein with different expression trends between GC vs. 
MAP and GC vs. DPP. This molecule had interactions with upstream regulators, namely 
inositol polyphosphate multikinase (IPMK), serum response factor (SRF) and the 
progesterone receptor (PGR), and downstream functions involved in neuronal 
development and movement (red circles in Figure 3.14). 
 
Top 10 pathway name Molecules 
Hepatic fibrosis / Hepatic stellate 
cell activation 
A2M, COL12A1, COL1A2, COL2A1, COL3A1, EGF, EGFR, HGF, IL6, MYL6, 
SMAD3, SMAD4, TGFB1, TGFBR1 
Glucocorticoid receptor signalling 
A2M, ACTB, FGG, HSP90AA1, HSP90B1, HSPA5, HSPA8, IL6, SMAD3, 
SMAD4, STAT3, TGFB1, TGFBR1 
Regulation of the Epithelial-
mesenchymal transition pathway 
CTNNB1, EGF, EGFR, HGF, Hif1, HIF1A, SMAD3, SMAD4, STAT3, TGFB1, 
TGFBR1 
Sirtuin signalling pathway 
ATP5F1A, ATP5F1B, Hif1, HIF1A, LDHB, MYC, PGAM1, PGK1, SP1, STAT3, 
TP53 
Colorectal cancer metastasis 
signalling 
CTNNB1, EGF, EGFR, IL6, MYC, SMAD3, SMAD4, STAT3, TGFB1, TGFBR1, 
TP53 
Cardiac hypertrophy signalling 
(Enhanced) 
ATF6, CALM1 (includes others), CTNNB1, GATA4, GNAI2, IL6, MYC, STAT3, 
TGFB1, TGFBR1 
Molecular mechanisms of cancer CTNNB1, GNAI2, Hif1, HIF1A, MYC, SMAD3, SMAD4, TGFB1, TGFBR1, TP53 
Osteoarthritis pathway 
ANXA2, COL2A1, CTNNB1, Hif1, HIF1A, SMAD3, SMAD4, SP1, TGFB1, 
TGFBR1 
Protein kinase A signalling 
CALM1 (includes others), CTNNB1, GNAI2, MYL6, SMAD3, SMAD4, TGFB1, 
TGFBR1, YWHAE, YWHAZ 
Acute phase response signalling A2M, ALB, APOA1, APOA2, FGA, FGG, HNRNPK, IL6, STAT3, TF 
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Figure 3.14 Regulator effects network (ID 5 and 11) between GC vs. MAP. The comparison 
of the regulator effects between GC vs. MAP and DPP is shown in Table S14 
(https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00026). CSRP1 is the only regulated 
protein having different expression trends between GC vs. MAP and DPP. It is upregulated 
in GC vs. MAP but downregulated in GC vs. DPP, both with lack of significance. The 
upstream regulators and downstream effects having relations with CSRP1 are highlighted 
in the red circles. Dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), 
and growth centre (GC). 
 
 The protein-protein interaction network 
Protein-protein network analysis was employed to identify key regulators from the 
proteins differentially expressed in GC vs. MAP/DPP (Figure 3.15A). Calreticulin (CALR) 
was found to be a hub protein within the network (Figure 3.15A) with significant up-
regulation in GC compared to DPP and to MAP (8.04- and 5.29- fold, respectively). In the 
androgen signalling pathway (Figure 3.15B), up-regulation of CALR inhibited the binding 
of androgen receptor to its DNA-responsive element. This was consistent with the IPA 
prediction based on the overall expression of significantly regulated proteins (Figure 
3.15B). The androgen receptor within the nucleus of GC stem cells may therefore be 




Figure 3.15 Representative protein-protein network from GC vs. MAP/DPP. (A) Network 1 
of the differentially expressed protein-protein interactions from GC compared to DPP and 
MAP. Experimental fold change and p value of CALR in each group of comparisons are 
shown. (B) The position and function of CALR in androgen signalling. Legend refers to A 
and B. Dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), and 
growth centre (GC). 
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 Stain-free Western blot validation 
Western blot was used to validate the protein levels of selected differentially expressed 
proteins: high- mobility group box 1 (HMGB1; Figure 3.16A), proline- and arginine- rich 
end leucine- rich repeat protein (PRELP; Figure 3.16B), CSRP1 (Figure 3.16C), 14-3-3 beta 
and zeta (YWHAB/Z; Figure 3.16D), nucleophosmin 1 (NPM1; Figure 3.16E), CALR (Figure 
3.16F), and CTNNB1 (Figure 3.16G). Stain-free detection of total protein was used to 
normalise the loading of samples between groups (Figure 3.16H). No signal for HMGB1 
(Figure 3.16A) was detected in FP, DPP, or MAP, and no signal for PRELP (Figure 3.16B) 
was found in MAP and GC. Due to the zero detection, statistical analysis was not 
undertaken for these two proteins. Overall, the relative expression levels of the 
differentially expressed proteins in the four groups between label-free proteomics and 




Figure 3.16 Stain-free Western blot analysis of the differentially expressed proteins in the 
four groups. (A) Anti-HMGB1, (B) Anti-PRELP, (C) Anti-CSRP1, (D) Anti-YWHAB and YWHAZ 
(YWHAB/Z), (E) Anti-NPM1, (F) Anti-CALR, and (G) Anti-CTNNB1. (H) The total protein 
loading was used to normalise between samples. Protein abundance is presented by the 
mean value ± standard deviation in normalised protein levels. Facial periosteum (FP), 
dormant pedicle periosteum (DPP), mid-beam antler periosteum (MAP), growth centre 
(GC), marker-1 (M1), and marker-2 (M2). * p value < 0.05, ** p value < 0.01, *** p value 




This is the first proteomic study using label-free quantification of “in situ” derived antler 
stem cell niches to investigate mammalian stem-cell-driven organ regeneration. It 
investigated the unique and regulated proteins from dormant stem cells in the pedicle 
periosteum, activated stem cells in the growth centre at the tip of the antler, post-active 
mid-beam antler periosteum, and control facial periosteum cells. The latter cells were 
considered to have regenerative osteogenic capability (Duchamp de Lageneste et al., 
2018) but not the enhanced capacity of the antler stem cell niches which can drive 
endochondral bone formation at up to 2 cm/day (Kierdorf & Kierdorf, 2012). 
 
Stem cells from antler have largely been characterised in vitro, using cells cultured from 
the RM layer within the GC, which have been found to express markers consistent with 
being MSCs (Seo et al., 2014; Wang et al., 2019a). The localisation of antler stem cells in 
vivo with the MSC markers CD73, CD90, and CD105 (Dominici et al., 2006) has not 
previously been conducted. In the present study, immunohistochemistry for the MSC 
markers identified the GC stem cell niche within the antler tip as concentrated in the RM 
layer but stem cells were also found in the PC layer and to a lesser extent in the cartilage 
layer (Li et al., 2009b). The identification of MSCs within different layers of the antler GC 
thus suggests the stem cell niche constitutes both perivascular and interstitial cells within 
the RM and PC regions. Interestingly, among these three MSC markers, CD73 and CD105 
were only detected via immunohistochemistry and not label-free quantification. Others 
have also reported that ESC markers are associated with the antler stem cells such as 
Oct4, Nanog, and SOX2 (Li, 2012); however, in this current proteomics study they were 
not detected. These discrepancies may be attributed to the filter-aided sample 
preparation (FASP) as well as the sensitivity and coverage of the mass spectrometry. 
 
Label-free proteomic results in this study were confirmed using stain-free Western blot. 
Normalisation of Western blot is often performed using “housekeeping proteins”, such as 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Dong et al., 2019) or beta-actin 
(ACTB) (Sui et al., 2020). However, in this study both were up-regulated in the GC 
compared to the MAP or DPP, making them unsuitable candidates. A single housekeeping 
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protein control also results in a high coefficient of variation across biological replicates 
(Janes, 2015). Stain-free Western blot using total protein normalisation has been 
employed in a series of proteomics experiments as an alternative methodology (Abril et 
al., 2015; Aloui et al., 2019; Fernandez-Cisnal et al., 2017; Menotta et al., 2018) and 
addresses current limitations associated with sample normalisation (Gurtler et al., 2013). 
Stain-free Western blots of HMGB1, PRELP, CSRP1, YWHAB/Z, NPM1, CALR, and CTNNB1 
were used to explore different expression profiles across groups and key differentially 
expressed proteins. The results were consistent with findings from the label-free 
proteomic analysis thus validating the latter methodology. 
 
Potential unique markers of dormant, active and post-active stem cells were identified. 
The unique proteins found only in dormant stem cells of the DPP included sushi repeat 
containing protein X-linked (SRPX), which is associated with tumour suppression via 
apoptosis induction (Tambe et al., 2004; Tambe et al., 2007); collagen type XXV alpha 1 
chain (COL25A1), which is neuron-specific with anti-amyloidogenic function (Hashimoto 
et al., 2002; Osada et al., 2005); and haptoglobin (HP), which is involved in immune 
regulation (Fasano, 2011). Proteins unique to the post-active MAP stem cells include S100 
calcium binding protein A7 (S100A7), which is part of the S100 family previous identified 
in antler growth (Ker et al., 2018; Wang et al., 2017a), and plasmin-2 (LCP1), associated 
with hematopoietic stem cells (Eckfeldt et al., 2005). Among the 87 unique proteins from 
the active stem cells in the GC, high mobility group protein B1 (HMGB1) is a 
multifunctional redo-sensitive protein with cellular compartment-specific functions (Yang 
et al., 2013); annexin A8 (ANXA8) was previously detected in proteomic studies from both 
red deer antler tip (Park et al., 2004) and chondrocytes treated with sika deer antler 
extract (Yao et al., 2019b), indicating its potential role in cell proliferation and migration; 
the only two heat shock proteins detected heat shock 60 (HSPD1) and 70 (HSPA9) are 
mitochondrial chaperonins (Levy-Rimler et al., 2001; Shan & Cortopassi, 2016), suggesting 
an increase in the intensity of the energy and protein metabolism of the growth centre; 
and nestin (NES) is recognised as a marker of neural crest stem cells (Achilleos & Trainor, 
2012). This study has thus found several proteins that could be used to identify and target 
the activation status of stem cells. 
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The protein profiles of DPP and FP were remarkably similar, suggesting that stem cells in 
the antler periosteum may use mechanisms similar to those used by the facial periosteum 
cells to maintain a dormant stem cell niche. There were, however, 12 significant 
differentially expressed proteins between DPP and FP, which discriminated the two 
groups. The first principal component of the PCA had a value of 77.5% with the groups 
clustering highly independently as determined by these 12 regulated proteins. This study 
is in marked contrast to other studies comparing DPP and FP protein profiles after in vitro 
culture of the cells (Dong et al., 2019; Wang et al., 2018a), in which large numbers of 
significantly regulated proteins have been found. Consistent with this study, was the 
regulation of collagen type VI alpha 3 chain (COL6A3) previously reported to be associated 
with the maintenance of cell stemness (Cescon et al., 2015; Wang et al., 2018a). It is 
probable that in vitro culture of the DPP and FP stem cells results in disruption of the stem 
cell niche and activation of the cells with corresponding change in pattern of protein 
expression. The current study on tissue repositories of stem cells is a more authentic 
model, and the 12 regulated proteins are worthy of further investigation. 
 
A comparison of dormant, active, and post-active stem cell niches was undertaken. PRELP 
was the most abundant significantly regulated protein in the DPP with fold regulations of 
14.03 and 19.72 compared to the MAP and GC, respectively. Western blot confirmed its 
expression levels, with the dormant stem cell niche containing the highest levels. A 
relationship between PRELP and periosteal stem cell niches is not well-documented. This 
molecule is, however, known to function in anchoring basement membranes to the 
underlying connective tissue (Bengtsson et al., 2002). PRELP may thus be involved in the 
maintenance of dormancy by decreasing cell motility and thus maintaining a niche. 
 
The GC contained the greatest number of highly regulated proteins in this study. The 14-
3-3 proteins in the GC were significantly upregulated, and as such Hippo signaling is 
predicted to be inactivated with the attenuation of apoptosis during antler regeneration. 
The Hippo signaling pathway has an important role in controlling organ size in animals 
through the regulation of cell proliferation and apoptosis (Heallen et al., 2013; Yu et al., 
2015). Yes associated protein 1 (YAP1) is the critical transcriptional regulator within this 
pathway (Hilman & Gat, 2011). By inducing phosphorylation and inactivating YAP1, the 
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14-3-3 proteins, especially 14-3-3 ζ (YWHAZ), can negatively regulate the Hippo pathway 
and inhibit apoptosis (Basu et al., 2003; Freeman & Morrison, 2011; Zhang et al., 2017a). 
This is the first report of a pathway involved in antler size. The degree of regulation of the 
Hippo pathway may thus be a marker of antler size. 
 
CTNNB1 is an indispensable downstream component in the canonical Wnt signalling 
pathway (Rao & Kuhl, 2010). CTNNB1-dependent Wnt signalling participates in many 
biological processes, including embryogenesis, organogenesis and regeneration, 
tumorigenesis, and stem cell maintenance and differentiation (Katoh & Katoh, 2007; 
Komiya & Habas, 2008; Wang & Wynshaw-Boris, 2004; Whyte et al., 2012). With the 
activation of HIF1A, canonical Wnt signalling is reported to be involved in regulating stem 
cells and contributing to angio-osteogenesis (Costa et al., 2017) and injury 
repair/regeneration (Whyte et al., 2012). Previous research on the deer antler stem cells 
has found that within the antler GC, CTNNB1 had strong immunohistochemical staining 
within the stem cells of the mesenchymal growth zone, and CTNNB1-dependent Wnt 
signalling was implicated in the regulation of stem cell survival and differentiation during 
antler regeneration (Mount et al., 2006b). In the current study, CTNNB1 was predicted as 
the activated upstream regulator in the mechanistic networks of both the unique proteins 
found in the GC and the regulated proteins in GC vs. MAP/DPP. Western blot also 
confirmed its significant upregulation in the GC compared to the other stages of antler 
regeneration. CTNNB1-dependent Wnt signalling is thus a strong candidate pathway 
responsible for the activation and maintenance of the active stem cell niche responsible 
for rapid antler regeneration. 
 
HIF1A was identified as the most upstream regulator in the mechanistic network between 
GC and MAP/DPP. HIF1A was predicted to activate NPM1 directly and indirectly through 
the MYC. NPM1 was one of the most significantly upregulated molecules in the 
comparison of GC vs. MAP/DPP. Its upregulation through HIF1A may help to protect 
against cell death (Li et al., 2004), which coincides with the inhibition of apoptosis in the 
GC. In the mechanistic network of the unique GC proteins, the predicted most upstream 
regulator was endothelial PAS domain protein 1 (EPAS1). Through EPAS1 and its effect on 
CTNNB1, most downstream factors were connected and regulated. EPAS1 is also known 
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as hypoxia-inducible factor 2 alpha (HIF2A) and is activated in low oxygen environments 
(Ema et al., 1997; Jain et al., 1998; Tian et al., 1997). Thus, both of the key regulators - 
HIF1A and EPAS1- are activated in response to hypoxia (Hu et al., 2003), indicating antler 
growth may be hypoxia-driven, resulting in the activation of proteins and signalling 
pathways, such as NPM1 and CTNNB1-dependent Wnt signalling. 
 
CSRP1 is the only regulated protein with altered expression levels between GC vs. MAP 
and GC vs. DPP. In the label-free quantification and Western blot, the expression of CSRP1 
in DPP vs. FP, MAP, and GC was consistent. The primary differences in regulator effects 
between GC vs. MAP and DPP were the enrichment of IPMK/SRF/PGR as upstream 
regulators and then downstream functions associated with neurite outgrowth. CSRP1 was 
the only protein connecting these upstream regulators and neurite outgrowth and as such 
may be a key to this process. CSRP1 is known to be involved in neuronal growth and 
regeneration and in the antler large neurons track in the subdermal connective tissue 
region rather than the regenerating bone (Li et al., 2007b; Ma et al., 2011; Ma et al., 2012). 
The highest expression level detected was in the DPP, indicating CSRP1 may be involved 
in neurite maintenance in association with the dormant stem cells. 
 
CALR has been identified as a calcium-binding protein in the endoplasmic reticulum and 
involved in multiple biological processes, such as protein folding and the regulation of 
calcium homeostasis (Gold et al., 2010; Ostwald & MacLennan, 1974). Emerging evidence 
indicates that its function is compartment-dependent (Gold et al., 2010; Michalak et al., 
2009), and the presence of CALR in the nucleus results in binding with androgen receptor 
and inhibition of androgen receptor downstream transcriptional activity (Dedhar et al., 
1994). In the current study, CALR was highly up-regulated in the active antler stem cells, 
while the lowest expression was in the dormant antler stem cells. CALR was also one of 
the hub proteins in the top protein-protein interaction network between GC and 
MAP/DPP, and predicted to inhibit the binding between androgen receptor and the DNA-
responsive element of androgen signalling. Annual antler regeneration is androgen level-
dependent (Price et al., 2005b) and occurs in spring under relatively low androgen levels. 
High CALR levels may further inhibit the androgen receptor resulting in active stem cells; 
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conversely, low expression of CALR in the pedicle may help retain dormancy. Thus, CALR 
may be a primary regulator of androgen-dependent antler regeneration. 
 
3.6 Conclusions 
MSC markers were identified within the antler tip indicating that the region of the antler 
stem cell niche was more widespread than normally believed as concentrated in the 
reserve mesenchyme. Unique markers for stem cell niches at different stages of activation 
were identified. Activation of antler stem cells was possibly associated with up-regulation 
of several key molecular/cellular functions and pathways, such as Wnt signalling. Hippo 
pathway may contribute to antler size regulation, and CALR may play a key role in 
androgen-dependent antler regeneration. This research sheds new light on the control 
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Growing deer antler contains a stem cell niche that can drive endochondral bone 
regeneration at up to 2 cm/day. Pleiotrophin (PTN), as a multifunctional growth factor, is 
found highly expressed at the mRNA level within the active antler stem cell tissues (Clark 
et al., 2006b). The study presented in this chapter aimed to map the expression patterns 
of PTN protein and its receptors in growing antler and investigate the effects of PTN on 
antler stem cells in vitro. Immunohistochemistry was employed to localise PTN/midkine 
(MDK) and their functional receptors - PTPRZ, ALK, NOTCH2 and integrin αVβ3 on serial 
slides of the antler growth centre. PTN was found to be the dominantly expressed growth 
factor in the PTN/MDK family. High expression of PTPRZ and ALK co-localised with PTN, 
was found suggesting a potential interaction. The high levels of PTN and PTPRZ reflected 
the antler stem cell activation status during the regenerative process. When antler stem 
cells were cultured in vitro under the normoxic conditions, no PTN was expressed and 




The ability to completely regenerate organs in adult mammals is rare (Seifert & Voss, 
2013). The annual full regeneration of deer antler makes it unique among mammals and 
evidence to date indicates this is a stem cell-based process (Wang et al., 2019a). Antler 
regeneration occurs in yearly cycles involving growth, calcification, antler skin (velvet) 
shedding with retention of the bony antler and finally casting of the antler to allow the 
next year’s growth (Goss, 1983). Regeneration is initiated from a pool of dormant stem 
cells residing in the periosteum of the permanent bony extension on the deer skull termed 
the pedicle (Li et al., 2007a). Each year stem cells from the distal pedicle periosteum form 
an active growth centre in the antler tip. This active stem cell niche is responsible for 
growth of the new antler at rates of up to 2 cm/day (Li, 2012). During the rapid growth 
phase, the antler tip consists of a number of distinct distal to proximal layers. These are 
skin, mesenchyme, precartilage, cartilage, and bone infiltrated with blood vessels. A high 
density of mesenchymal stem cells has been identified within the mesenchymal and 
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precartilage layers (Dong et al., 2020). Deer antler is therefore an ideal regenerative 
model to investigate the factors involved in development of an active stem cell niche, and 
the processes of rapid cellular growth and differentiation. 
 
Pleiotrophin (PTN) mRNA has been identified as being highly up-regulated within the 
undifferentiated cells of the antler tip mesenchyme and the maturing chondroblasts of 
the precartilage region in the growing antler (Clark et al., 2006b). PTN was first discovered 
as a neurite outgrowth-enhancing factor from young rat brains (Rauvala & Pihlaskari, 
1987). The human, bovine and rat PTN genes have been sequenced (Li et al., 1990; 
Merenmies & Rauvala, 1990) and encode proteins of 168 amino acids. The inter-species 
conservation of amino acid sequences is remarkable and, to the best of our knowledge 
the highest of any of the known cytokines (Hampton et al., 1992; Li et al., 1992; Li et al., 
1990). PTN is capable of various functions including cell proliferation, survival, 
differentiation and migration, stem cell maintenance and tumorigenesis (Himburg et al., 
2012; Xu et al., 2014). Together with its other family member midkine (MDK), they are 
heparin-binding growth factors (Muramatsu, 2014), have ca. 50% homology in their amino 
acid sequences, and contain similar conserved C- and N-domains. Mouse models with 
either PTN or MDK genes knocked out, exhibit similar moderate abnormalities (Kaplan et 
al., 2003; Sakurai et al., 2001); however, mice with both PTN and MDK simultaneously 
knocked out display severe abnormalities (Herradon et al., 2005; Muramatsu et al., 2006; 
Sone et al., 2011; Zou et al., 2006); thus suggesting that the functions of PTN and MDK are 
complementary. 
 
PTN regulates multiple physiological and pathological processes by binding with diverse 
receptors (Xu et al., 2014). It has been identified as the most potent natural ligand for 
receptor-type tyrosine-protein phosphatase zeta (PTPRZ) with strong inhibition of its 
phosphatase activity (Fukada et al., 2006; Meng et al., 2000). Anaplastic lymphoma kinase 
(ALK) is a tyrosine kinase and was regarded as an “orphan receptor” until it was found to 
be a substrate for PTPRZ and activated through the PTN/PTPRZ signalling axis (Deuel, 2013; 
Stoica et al., 2001). Notch receptor 2 (NOTCH2) is one of the four known notch receptors 
in mammals (Fleming, 1998), and acts as a receptor for MDK under both physiological 
(Huang et al., 2008) and pathological (Kishida et al., 2013) conditions. No evidence 
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supports a direct interaction between PTN and NOTCH2, however PTN has overlapping 
expression with NOTCH2 during ocular development (Cui & Lwigale, 2019) and activates 
Notch signalling during hematopoietic stem cell expansion (Himburg et al., 2010). Integrin 
αVβ3 is comprised of integrin subunit alpha V (ITGAV) and integrin subunit beta 3 (ITGB3) 
(Hynes, 2002). It has been found to exclusively bind with PTN rather than MDK, and 
functions as a receptor in PTN-induced endothelial cell migration, through PTPRZ (Mikelis 
et al., 2009). 
 
Previous study shows that the PTN gene is highly expressed in the deer antler tip and 
could have a putative role in angiogenesis and chondrogenesis (Clark et al., 2006b). There 
is however no research investigating cervine PTN at the protein level. In this chapter, 
cervine PTN protein was localised during different stages of antler regeneration. MDK, 
also a member of the PTN/MDK growth factor family, coupled with their main receptors 
were also localised on serial sections from the antler growth centre. The effects of 
exogenous PTN were investigated in vitro on antler derived stem cells. Identification and 
investigation of active factors from regenerating antlers may have significant impact on 
the field of regenerative medicine. 
 
4.3 Material and methods 
 Tissue collection and sample preparation 
All tissues were collected from red deer (Cervus elaphus). They were initially taken by a 
certified person under the direction of a vet. Specific samples were collected afterwards. 
Considering the practice of velveting was not interfered, ethical approval was therefore 
not required. In detail, dormant pedicle periosteum (DPP; n = 3) and facial periosteum (FP; 
n = 3) were harvested for protein extraction from deer heads immediately after slaughter 
in late summer (February in the southern hemisphere), at a local abattoir (Duncan New 
Zealand Venison, Dunedin, New Zealand). DPP (n = 3) tissues for primary cell culture were 
harvested at the time of antler induction in late spring (November). Mid-beam antler 
periosteum (MAP) and growth centre (GC) tissues (n = 3 each) were obtained from 
commercially harvested velvet antler (approximately 50-60 days of growth) at a deer 
research farm (AgResearch Invermay, New Zealand). GC sampling used the methodology 
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previously validated by Li et al. (Li et al., 2002), in which the reserve mesenchymal (RM) 
and precartilage (PC) layers of the growth centre were dissected for protein extraction 
and primary cell culture (Figure 4.1). DPP containing the dormant stem cells was collected 
as strips of periosteum from the proximal region of the pedicle for protein extraction and 
primary cell culture (Li & Suttie, 2003). MAP was collected as strips of mid-antler 
periosteum from antler at the time of commercial harvesting. FP was collected from the 
nasal bone periosteum, between the two eye sockets, and used as a control tissue. 
 
 
Figure 4.1 Deer antler stem cells during regeneration. (A) Schematic diagram of deer 
antler. Facial periosteum (FP), dormant pedicle periosteum (DPP), mid-beam antler 
periosteum (MAP), growth centre (GC). (B) Masson’s Trichrome staining of GC. Boxes 
indicate different layers as (A) dermis with hair follicles; (B) across dermis, major blood 
vessels and reserve mesenchyme; (C) reserve mesenchyme; (D) reserve mesenchyme and 
precartilage; (E) precartilage and (F) cartilage. (C) Schematic diagram of different tissue 
layers as derived from the Masson’s Trichrome staining of a growing antler tip. D, dermis; 
BV, blood vessel layer; RM, reserve mesenchyme; PC, precartilage; TZ, transition zone; C, 
cartilage. 
 
Tissues for morphology and immunohistochemistry were fixed in 10% neutral buffered 
formalin (LabServ, New Zealand) for 24 h, then transferred into PBS (Gibco, USA). Paraffin-
embedding of the tissues was conducted and 4 μm serial sections obtained. Tissue for 
primary cell culture was collected using sterile instruments after preparing the 
surrounding area with povidone-iodine Prep Pads and 70% alcohol cotton balls. Protein 
analysis tissues were snap-frozen in liquid nitrogen, and stored at −80℃. 
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 Masson’s trichrome staining 
After dewaxing and hydration of the antler tip tissues, Masson’s trichrome staining was 
performed using the method reported by Bancroft & Stevens (Bancroft & Stevens, 1991). 
Sections were observed under an Eclipse TE2000 Inverted Microscope (Nikon, Japan), and 
images were captured by an Aperio Digital Slide Scanner (Leica Biosystems, Germany). 
 
 Immunohistochemistry 
Immunohistochemical detection for PTN, MDK, PTPRZ, ALK, NOTCH2, ITGAV and ITGB3 
was performed on 4 μm serial sections of paraffin-embedded antler tip tissue (Appendix 
4.1). Morphology was examined after haematoxylin-eosin staining. An example of the 
detailed methodology for immunohistochemistry conducted on the bench can be found 
in Appendix 3.1. In brief, immunohistochemistry for MDK, NOTCH2, ITGAV and ITGB3 was 
conducted on sections dewaxed in xylene (×3) and then hydrated. Heat retrieval was 
performed with citrate buffer (0.01 M) at 95-100℃ in a water bath. Slides were incubated 
for 30 min with 20% goat serum (Sigma, USA) and 1% BSA (Sigma)/PBS to block nonspecific 
binding sites and incubated at 4℃ overnight using primary antibodies (Appendix 4.1) in a 
diluent of 5% goat serum + 1% BSA/PBS. Washing was followed by incubation in goat 
F(ab')2 anti-rabbit IgG - H&L (Biotin) (5 µg/mL, Abcam, USA) for 1 h and endogenous 
peroxidase blocking with 0.3% hydrogen peroxide (Sigma) in methanol. Detection was 
then performed using a Vectastain Elite ABC Strep HRP Kit (Vector laboratories, USA) 
followed by a DAB chromogen (Sigma). Immunohistochemistry for PTN, PTPRZ and ALK 
was conducted using an automated BenchMark XT platform (Appendix 4.1; Ventana 
Medical Systems, USA). Matched IgG controls were conducted on all tissues (Appendix 
4.8). Haematoxylin was used as the counterstain. Images were taken with an Aperio 
Digital Slide Scanner (Leica Biosystems) and analysed by Aperio ImageScope software 
(v12.3.2, Leica Biosystems). 
 
 Antler powder protein extraction 
Antler powder was obtained from three manufacturers produced by either traditional, 
freeze drying, or freeze drying after cryogenic processing. The detailed methodology can 
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be found in Appendix 4.2. In brief, two sets of 0.1 g samples (n = 3 per set) from each 
antler powder were suspended in 1 mL cold PBS with 1× EDTA-free protease inhibitor 
cocktail (Roche, Switzerland). One set was placed on an orbital shaker (100 rpm/min) for 
2 h inside an ice box. A second set was sonicated on ice for 3 × 15 sec with an amplitude 
of 50% using an ultrasonic homogeniser (Branson Ultrasonics, USA). The total protein 
content in the supernatants were collected and quantified using a DC protein assay (Bio-
Rad, USA). 
 
 Enzyme-linked immunosorbent assay (ELISA) 
Quantitation of PTN in the supernatants derived from the antler powder extracts was 
performed using an ELISA (catalog no. MBS455121, Mybiosource, USA) as per the 
manufacturer’s instruction (Appendix 4.2). Results were normalised to the total protein 
content. 
 
 Isolation and culture of antler stem cells 
DPP strips containing the dormant stem cells (n = 3; Figure 4.1A) and the reserve 
mesenchymal and precartilage layers of the growth centre, containing the active stem 
cells (n = 3; Figure 4.1B,C), were dissected and collected. The detailed methodology can 
be found in Appendix 4.3. In brief, after washing with sterile PBS, tissues were cut into 
fine pieces for subsequent explant culture in 6-well plates (Thermo Fisher Scientific, USA). 
The supplemented culture media consisted of high glucose DMEM with 10% fetal bovine 
serum (FBS), 100 U/mL Penicillin, 100 µg/mL Streptomycin, 250 ng/mL Amphotericin B 
and 50 µg/mL Gentamicin (All from Life Technologies, USA) referred to hereafter as 
DMEM/10% FBS. Subsequent to the cells migrating out of the tissues but prior to reaching 
confluency, the media and tissue pieces were removed and attached cells were 
trypsinised for passaging. Dormant pedicle periosteum cells (DPPCs) and growth centre 
cells (GCCs) were then separately seeded into T25 culture flasks (Greiner Bio-One, Austria) 
and cultured at 37℃ with 5% CO2. After reaching 70% confluency, the cultured cells were 
cryopreserved with 90% FBS and 10% DMSO (Sigma) in liquid nitrogen, for further use. 
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 Quantitation of osteogenesis 
For osteogenic differentiation and quantitation, the detailed methodology can be found 
in Appendix 4.4. In brief, DPPCs and GCCs were seeded into 24-well plates (Greiner Bio-
One) at a cell density of 6000 cells/cm2. The following day (Day 0), the medium was 
changed to either the normal medium (DMEM/10% FBS; as above) or osteogenic medium 
containing DMEM/10% FBS with the addition of 100 µM L-ascorbic acid 2-phosphate 
(Sigma), 10 nM dexamethasone (Sigma) and 5 mM β-glycerophosphate (Sigma). Normal 
and osteogenic media were changed every 48 h. After 7, 14 and 21 days, cells were fixed 
with 70% ice-cold ethanol. Osteogenic mineralisation was determined using an 
Osteogenesis Quantitation kit (Merck, Germany). Cell images, after Alizarin Red S staining, 
were captured using an Eclipse TE2000 Inverted Microscope (Nikon). 
 
 Osteogenesis as determine by alkaline phosphatase production 
The detailed methodology for quantitative analysis of alkaline phosphatase (ALP) activity 
can be found in Appendix 4.5. In brief, GCCs were seeded into 48-well plates (Greiner Bio-
One) at a cell density of 3 × 104 cells/cm2. The following day (Day 0), media were changed 
to DMEM/10% FBS with 100 ng/mL BMP-2 (PeproTech, USA) to induce osteogenesis as 
recently demonstrated by Ker et al. (Ker et al., 2018). Recombinant human PTN (rhPTN, 
catalog no. 252-PL, R&D systems, USA) was added at 0, 1, 102, 104 or 105 pg/mL. Medium 
was changed every 48 h with addition of fresh growth factors. After 6 days, cells were 
trypsinised (Life Technologies) and collected. ALP activity (Abcam) was detected as per 
the manufacturer’s instructions. 
 
 Cell viability 
The detailed methodology can be found in Appendix 4.6. In brief, GCCs were seeded into 
96-well plates (Thermo Fisher Scientific) at the cell density of 6000 cells/cm2. The 
following day (Day 0), two different media formulations were applied. One was DMEM 
high glucose plus 1% FBS, 100 U/mL Penicillin, 100 µg/mL Streptomycin, 250 ng/mL 
Amphotericin B, 50 µg/mL Gentamicin and rhPTN at 0, 1, 10, 102, 103, 104, 5×104 or 105 
pg/mL. The other one was DMEM high glucose plus 10% FBS, 100 U/mL Penicillin, 100 
 114 
µg/mL Streptomycin, 250 ng/mL Amphotericin B, 50 µg/mL Gentamicin and 5×104 pg/mL 
rhPTN. PrestoBlue cell viability reagent (Thermo Fisher Scientific) was added 4 h prior to 
every media change and incubated at 37℃ with 5% CO2. At 24, 48, 72 and 96 h 
fluorescence were read with an excitation/emission wavelength of 560/590 nm using a 
Synergy 2 Multi-mode Microplate Reader (BioTek, USA). 
 
 F-actin staining 
After removing the media in the cell viability assay at 96 h, F-actin staining of GCCs under 
different PTN concentrations was performed (Appendix 4.6). Cells were fixed in 10% 
neutral buffered formalin for 15 min and incubated with Alexa Fluor 647 Phalloidin 
(Thermo Fisher Scientific) for 45 min in the dark. DAPI (Thermo Fisher Scientific) was used 
as a nuclear counterstain. Fluorescence images were acquired using an EVOS M5000 Cell 
Imaging System (Thermo Fisher Scientific) equipped with Cy5 and DAPI light cubes for 
Alexa Fluor 647 Phalloidin and DAPI staining respectively. 
 
 Sequence alignment 
BLAST Needleman-Wunsch Global Alignment in NCBI (Altschul et al., 1997) was performed 
to compare human and red deer PTN and MDK sequences. The amino acid sequences of 
human PTN (Accession No. P21246) and MDK (Accession No. P21741) were obtained from 
the UniProt database. Sequence for deer PTN was translated from the corresponding 
transcript sequence (Clark et al., 2006b) and MDK (Accession No. OWK18060.1) obtained 
from the NCBI GenBank. 
 
 Stain-free Western blot 
Western blot for PTN and PTPRZ was conducted on the four tissue groups. An example of 
the detailed methodology for stain-free Western blot can be found in Appendix 3.3. In 
brief, tissue lysate (9 μL) from RM and PC layers of the growth centre, MAP, DPP and FP 
(n = 3 per group) were mixed with 3 μL of 4× Laemmli loading buffer (Bio-Rad, USA). rhPTN 
(50 ng) was used as the positive control. After heat denaturation, all samples were loaded 
into ‘Any kD Mini-PROTEAN TGX Stain-Free Protein Gels’ (Bio-Rad) along with Precision 
 115 
Plus Protein WesternC protein standards (Bio-Rad). After running the SDS-PAGE gels, 
proteins were detected with UV-activation and imaged using a Gel Doc XR+ Imaging 
System (Bio-Rad) with Image Lab software (v5.2.1, Bio-Rad). The proteins were then 
transferred onto Immun-Blot Low Fluorescence PVDF membranes (Bio-Rad), and imaged 
in a Gel Doc XR+ Imaging System (Bio-Rad) to assess transfer efficiency. Anti-PTN (0.4 
μg/mL, catalog no. SC74443, Santa Cruz, USA) was incubated at 4℃ overnight. Secondary 
anti-mouse IgG-HRP conjugate antibody (Abcam) was used at 1:5,000 dilution. 
Chemiluminescence imaging of the WesternC Blotting Standards was conducted with 
addition of 1 μL of StrepTactin-HRP conjugate (Bio-Rad) to every 10 mL of secondary 
antibody solution. Blots were developed using Clarity Western ECL substrate (Bio-Rad). 
Image capture was performed with an Odyssey Fc Imaging System (LI-COR, USA) and 
Image Studio software (v5.2, LI-COR). The images were analysed and quantified in ImageJ 
(v1.52q, National Institutes of Health, USA). The intensity of total protein within each lane 
was used for sample normalisation. After the detection for anti-PTN, the PVDF membrane 
was stripped with buffer containing 62.5 mM Tris (pH 6.8, Thermo Fisher Scientific), 2% 
SDS (Thermo Fisher Scientific) and 100 mM β-mercaptoethanol (Sigma) at 50℃ for 40 min. 
Anti-PTPRZ (0.8 μg/mL, catalog no. MBS2034104, Mybiosource) was incubated at 4℃ 
overnight followed by a secondary anti-rabbit IgG-HRP conjugate antibody (Sigma) at 
1:20,000 dilution. 
 
PTN detection in the antler powders derived from different drying technologies was 
conducted on the extracts obtained from either stirring for 2 h or sonication at an 
amplitude of 50% for 3 × 15 sec, both in ice. Extracts were ultra-filtered with Amicon Ultra-
0.5 centrifugal filter devices (3 kDa, Millipore, USA) to obtain 10 times concentrated 
samples. rhPTN (50 ng) and tissue lysate from RM and PC layers of the growth centre were 
used as positive controls. 
 
For PTN and PTPRZ detection in DPPCs and GCCs, supernatant was collected from cells 
cultured in normal and osteogenic media at 7 and 21 days, using the medium defined in 
Section 4.3.7. Cell lysates were extracted using M-PER mammalian protein extraction 
reagent (Thermo Fisher Scientific). rhPTN (50 ng) and tissue lysates from RM and PC layers 
of the growth centre were used as positive controls. 
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 Statistical analysis  
The quantitative data were presented as the mean ± standard deviation. One sample t 
test was performed to compare the data between two groups, and one-way analysis of 
variance (One-way ANOVA) with post-hoc Tukey HSD test was performed to compare the 
data among multiple groups. All statistical analyses were carried out by GraphPad Prism 
(v8.2.1). A p value of < .05 was considered statistically significant. 
 
4.4 Results 
 PTN protein was more highly expressed than MDK during antler regeneration in 
vivo 
Stain-free Western blot and immunohistochemistry were performed to investigate PTN 
expression levels during antler regeneration. PTN was found in high levels within the 
active stem cell layers of the growth centre during rapid regeneration and only detected 
at low levels in tissues from other stages (Figure 4.2A, Appendix 4.7 and Figure 4.3). When 
investigated by immunohistochemistry, PTN was highly expressed in the reserve 
mesenchyme and precartilage layers of the growth centre with only light staining in the 
dermal endothelial cells and mature chondrocytes of the cartilage layer (Figure 4.3A-F and 
Appendix 4.8). Amino acid sequence alignment between deer PTN and MDK showed 
homology (43% identity) similar to the comparison between human PTN and MDK (42% 
identity) (Figure 4.4A,C and Table 4.1). Dot matrix plots of both comparisons further 
confirmed the sequence conservation between human and deer (Figure 4.4B,D). 
Immunohistochemistry for MDK, the other member of the PTN/MDK family, was 
performed. MDK was mainly associated with blood vessels within the growth centre layers 
(Figure 4.5 and Appendix 4.8). Within the dermal and blood vessel layers, positive cells 
were associated with hair follicles and major blood vessels (Figure 4.5A,B); this contrasted 





Figure 4.2 Stain-Free Western blot to investigate the expression levels of pleiotrophin 
(PTN) (A) and protein tyrosine phosphatase receptor type Z (PTPRZ) (B) in the four tissue 
groups. Total protein loading was used to normalise between samples. Normalised 
protein abundance is presented as the mean value ± standard deviation. One-way ANOVA 
with post-hoc Tukey HSD test was performed. Fifty ng recombinant human PTN (rhPTN) 
was used as a positive control. FP, facial periosteum; DPP, dormant pedicle periosteum; 
MAP, mid-beam antler periosteum; RM+PC, reserve mesenchymal and precartilage layers 




Figure 4.3 Representative immunohistochemical images of pleiotrophin (PTN) localisation 
(brown) in deer antler (n = 3). The images are from the distal (A) to the proximal (F) region 
of the antler tip as indicated in Figure 4.1B. (A) dermis with hair follicles; (B) across dermis, 
major blood vessels and reserve mesenchyme; (C) reserve mesenchyme; (D) reserve 
mesenchyme and precartilage; (E) precartilage and (F) cartilage. (G and H) PTN expression 
in mid-beam antler periosteum (MAP). (I) PTN in dormant pedicle periosteum (DPP). D = 
dermis and epidermal region and P = periosteum next to bone. Haematoxylin was used as 
a counterstain. Scale bar (A-F, H) = 100 μm; scale bar (G) = 2 mm; scale bar (I) = 400 μm. 
HF, hair follicle; BV, blood vessel; RM, reserve mesenchyme; PC, precartilage; CT, 












Figure 4.4 Amino acid sequence alignments of human and red deer origin PTN and MDK 
using BLAST Needleman-Wunsch Global Alignment. (A,B) Sequence alignment between 
human PTN and MDK. (C,D) Sequence alignment between deer PTN and MDK. (E,F) 
Sequence alignment between human and deer PTN. The alignment results are presented 
in Table 4.1. Dot matrix plots (B,D,F) indicate regions of similarity based on the sequence 
alignments (A,C,E). 
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Table 4.1 Protein sequence alignment of human and red deer pleiotrophin (PTN) and 
midkine (MDK). 
 Human PTN vs. MDK Deer PTN vs. MDK Human PTN vs. Deer PTN 
Score 352 344 861 
Identities 71/168(42%) 71/167(43%) 161/168(96%) 
Positives 100/168(59%) 98/167(58%) 162/168(96%) 
Gaps 25/168(14%) 25/167(14%) 1/168(0%) 
 
 
Figure 4.5 Representative immunohistochemical images of midkine (MDK) localisation 
(brown) in deer antler (n = 3). The images are from the distal (A) to the proximal (F) region 
of the antler tip as indicated in Figure 4.1B. (A) dermis with hair follicles; (B) across dermis, 
major blood vessels and reserve mesenchyme; (C) reserve mesenchyme; (D) reserve 
mesenchyme and precartilage; (E) precartilage and (F) cartilage. Haematoxylin was used 
as a counterstain. Scale bar = 100 μm. HF, hair follicle; BV, blood vessel; RM, reserve 








 PTPRZ and ALK were found as highly expressed receptors for PTN/MDK in the 
antler growth centre 
Immunohistochemical localisation of the PTN/MDK receptors PTPRZ and ALK were 
conducted on serial sections. PTPRZ and ALK were co-expressed with intense positive 
signal throughout the growth centre from the dermis to cartilage layers (Figure 4.6, Figure 
4.7 and Appendix 4.8). The co-expression was particularly obvious in hair follicles and 
pericytes around blood vessels. ALK was only detected within the cell nucleus. 
Immunohistochemistry for NOTCH2 detected low level expression mainly in association 
with hair follicles (Figure 4.8A and Appendix 4.8) and the hypertrophic chondroblasts of 
the cartilage zone (Figure 4.8F and Appendix 4.8); the distinctly stained band could be a 
high density of positive expression in between the connective tissues and the 
hypertrophic chondrocytes (Figure 4.8F). Integrin subunit alpha V (ITGAV) and integrin 
subunit beta 3 (ITGB3) immunohistochemistry detected fewer areas with positive signal 
when compared to the other receptors (Figure 4.9, Figure 4.10 and Appendix 4.8). Positive 
staining was associated with the hair follicles and around blood vessels. The 
representative mouse and rabbit match concentration IgG controls had only background 
staining (Figure 4.11). Low power imaging revealed that in the dermal and blood vessel 
layers MDK displayed a similar expression pattern to PTPRZ and ALK (Figure 4.12). In all 





Figure 4.6 Representative immunohistochemical images of protein tyrosine phosphatase 
receptor type Z (PTPRZ) localisation (brown) in deer antler (n = 3). The images are from 
the distal (A) to the proximal (F) region of the antler tip as indicated in Figure 4.1B. (A) 
dermis with hair follicles; (B) across dermis, major blood vessels and reserve mesenchyme; 
(C) reserve mesenchyme; (D) reserve mesenchyme and precartilage; (E) precartilage and 
(F) cartilage. Haematoxylin was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; 











Figure 4.7 Representative immunohistochemical images of ALK receptor tyrosine kinase 
(ALK) localisation (brown) in deer antler (n = 3). The images are from the distal (A) to the 
proximal (F) region of the antler tip as indicated in Figure 4.1B. (A) dermis with hair follicles; 
(B) across dermis, major blood vessels and reserve mesenchyme; (C) reserve mesenchyme; 
(D) reserve mesenchyme and precartilage; (E) precartilage and (F) cartilage. Haematoxylin 
was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; BV, blood vessel; RM, 











Figure 4.8 Representative immunohistochemical images of notch receptor 2 (NOTCH2) 
localisation (brown) in the deer antler (n = 3). The images are from the distal (A) to the 
proximal (F) region of the antler tip as indicated in Figure 4.1B. (A) dermis with hair follicles; 
(B) across dermis, major blood vessels and reserve mesenchyme; (C) reserve mesenchyme; 
(D) reserve mesenchyme and precartilage; (E) precartilage and (F) cartilage. Haematoxylin 
was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; BV, blood vessel; RM, 











Figure 4.9 Representative immunohistochemical images of integrin subunit alpha V 
(ITGAV) localisation (brown) in deer antler (n = 3). The images are from the distal (A) to 
the proximal (F) region of the antler tip as indicated in Figure 4.1B. (A) dermis with hair 
follicles; (B) across dermis, major blood vessels and reserve mesenchyme; (C) reserve 
mesenchyme; (D) reserve mesenchyme and precartilage; (E) precartilage and (F) 
cartilage. Haematoxylin was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; 











Figure 4.10 Representative immunohistochemical images of integrin subunit beta 3 
(ITGB3) localisation (brown) in deer antler (n = 3). The images are from the distal (A) to 
the proximal (F) region of the antler tip as indicated in Figure 4.1B. (A) dermis with hair 
follicles; (B) across dermis, major blood vessels and reserve mesenchyme; (C) reserve 
mesenchyme; (D) reserve mesenchyme and precartilage; (E) precartilage and (F) 
cartilage. Haematoxylin was used as a counterstain. Scale bar = 100 μm. HF, hair follicle; 











Figure 4.11 Immunohistochemical localisation of IgG controls (A) Mouse IgG control (4 
µg/mL) and (B) Rabbit IgG control (5 µg/mL). Haematoxylin was used as a counterstain. 
Scale bar = 100 μm. 
 
 
Figure 4.12 Overview of immunohistochemical localisation for PTN, MDK and their 
receptors in the antler tip growth centre (n = 3). Layers are as indicated. Rabbit IgG control 
(5 µg/mL) is shown as a representative negative control (NC). Haematoxylin was used as 
a counterstain. D, dermis; RM, reserve mesenchyme; PC, precartilage; TZ, transition zone; 
C, cartilage. Scale bar = 5 mm. 
 
 PTPRZ co-existed with PTN during antler stem cell activation 
As the main receptor for PTN, expression levels of PTPRZ together with PTN were 
examined in different antler regeneration stages (Figure 4.2 and Appendix 4.7). Both PTN 
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and PTPRZ had the highest expression levels in the reserve mesenchymal/precartilage 
layers, in which the active antler stem cells reside (Dong et al., 2020). Quantitative analysis 
showed the expression levels of PTN and PTPRZ were significantly lower (p value < .01) in 
the non-active antler stem cell tissues including MAP (post-active stem cells), DPP 
(dormant stem cells) and FP (control facial periosteum cells) when compared to the 
mesenchymal/precartilage layers. Western blot results thus indicated that PTN and PTPRZ 
levels were positively correlating to the antler stem cell activation status. 
 
 PTN protein detected in antler powder extracts 
The presence of PTN protein in whole stick antler, commercially harvested during the 
rapid regeneration period (50-60 days of growth), was further determined. PTN 
concentration, as determined by ELISA, was normalised using the levels of extracted 
protein from antler powders with different processing methods (Figure 4.13A-C and 
Appendix 4.9). Freeze-dried antler powders contained the highest level of PTN as a 
proportion of total protein. The mean PTN concentration in samples extracted using 
sonication was nearly twice that obtained from buffer extraction. Western blot confirmed 
the presence of one band consistent at the correct molecular weight in both sonicated 
and buffer extracted freeze-dried antler powder (Figure 4.13D). These results thus 
indicate a processing/extraction method to obtain PTN from whole antler sticks and that 
PTN may be one of the important growth factors not only within the growth centre but 




Figure 4.13 Pleiotrophin (PTN) detection in antler powders. (A) Total protein 
quantification. Antler powders were obtained from traditional, freeze dried, and 
cryogenic/freeze dried methods. Total protein was obtained by buffer extraction or 
sonication. (B) PTN concentration as detected by ELISA. (C) Normalised PTN concentration 
as detected by ELISA. Total protein (A) was used for normalisation. (D) PTN abundance as 
detected by Western blot. Tissue lysate from reserve mesenchymal and precartilage 
layers (RM+PC) in the growth centre and 50 ng recombinant human PTN (rhPTN) were 
used as positive controls. All data are presented as the mean value ± standard deviation. 
Trad, traditional; Freeze, freeze dried; Cryo, cryogenic/freeze dried; M, marker; BE, buffer 
extraction; S, sonication. 
 
 Osteogenesis of antler stem cells 
Osteogenic differentiation of antler stem cells cultured from dormant pedicle periosteum 
(DPPCs; Figure 4.14A and Appendix 4.10) and growth centre (GCCs; Figure 4.14B and 
Appendix 4.10) cells were evaluated by Alizarin Red S (ARS) staining. Both DPPCs and GCCs 
formed bone nodules in osteogenic medium but not in normal medium. There was an 
increase in cellular mineralisation in osteogenic medium compared to normal medium, 
however a larger variance in calcium production was observed in the osteogenic medium. 
Interestingly, the mean values for the ARS concentration in normal medium for both 
DPPCs and GCCs were similar for 7, 14 and 21 days. 
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Figure 4.14 Alizarin Red S (ARS) staining of dormant pedicle periosteum cells (DPPCs) and 
growth centre cells (GCCs). DPPCs (A) and GCCs (B) under normal and osteogenic media 
were stained with ARS at 7, 14 and 21 days. ARS concentration is presented as the mean 
value ± standard deviation. Cell images were taken at 21 days after ARS staining. Scale bar 
(4×) = 200 μm; scale bar (10×) = 100 μm. 
 
 Effect of PTN on the proliferation and osteogenesis of active antler stem cells in 
vitro 
In order to investigate the effect of PTN on antler stem cells in vitro, PTN expression levels 
in cell culture supernatants and lysates were firstly investigated using Western blot. No 
PTN protein was detected in either DPPCs/GCCs supernatants or their lysates (Figure 
4.15A,B). DPPCs and GCCs cell lysates were also investigated for the presence of the PTPRZ 
receptor. Only low-level expression was detected as compared to the active stem cell 
tissues (Figure 4.15B). Amino acid sequence alignment revealed a high similarity between 
human and deer PTN with an identity score of 96% (Figure 4.4E,F; Table 4.1). The effects 
of recombinant human PTN (rhPTN) on osteogenesis and proliferation of the active antler 
stem cells (GCCs) was further evaluated. 
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To investigate the effects of rhPTN on the osteogenic differentiation of GCCs, the relative 
levels of alkaline phosphatase were measured after 6 days of treatment (Figure 4.15C and 
Appendix 4.11). Four concentrations of rhPTN were investigated and alkaline 
phosphatases levels were not significantly different from the control cells without rhPTN. 
Proliferation assays were also conducted on the GCCs cultured in 1% FBS using seven 
different rhPTN concentrations. A significant reduction in proliferation was detected as 
early as 24 h (p = 0.0016; Figure 4.15D and Appendix 4.12) and 48 h (p = 0.0015; Figure 
4.15D and Appendix 4.12). A biphasic effect on proliferation was found, in which low and 
high doses of rhPTN reduced proliferation while 1 ng/mL of rhPTN had no significant effect. 
F-actin staining of the GCCs at 96 h indicated no evidence of nodule formation or 
morphological differences in the cells cultured in rhPTN (Figure 4.15E). F-actin staining of 
GCCs cultured in 1% or 10% FBS with 5×104 pg/mL rhPTN both displayed similar 
morphologies suggesting that low FBS content in the media did not cause differentiation 




Figure 4.15 Proliferation and osteogenic differentiation of deer antler stem cells. (A) 
Western blot analysis of pleiotrophin (PTN) in the deer antler stem cell supernatants. 
Sample numbers 1 to 4: culture media from growth centre cells (GCCs). Numbers 1 and 3 
were from normal media at 7 and 21 days, and numbers 2 and 4 were from osteogenic 
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media at 7 and 21 days. Sample numbers 5 to 8: culture media from dormant pedicle 
periosteum cells (DPPCs). Numbers 5 and 7 were from normal media at 7 and 21 days, 
and numbers 6 and 8 were from osteogenic media at 7 and 21 days. Fifty ng recombinant 
human PTN (rhPTN) was used as a positive control. (B) Western blot analysis of the 
expression levels of PTN and PTPRZ in the deer antler stem cell lysates. Two tissue lysates 
from reserve mesenchymal and precartilage layers (RM+PC-1/2) in the growth centre and 
50 ng rhPTN were used as positive controls. (C) Osteogenic differentiation detection of 
GCCs at 6 days. All cell lines were cultured with 100 ng/mL BMP-2 and four PTN 
concentrations as indicated for 6 days. Data are presented as the mean value ± standard 
deviation. Dotted line is control cells without PTN. One-way ANOVA with post-hoc Tukey 
HSD test was performed and statistical significance of one-way ANOVA is presented. (D) 
Cell viability of GCCs cultured in 1% FBS under seven PTN concentrations at 24 h, 48 h, 72 
h and 96 h. Data are presented as the mean value ± standard deviation. Dotted line is 
control cells cultured in 1% FBS without PTN. One-way ANOVA with post-hoc Tukey HSD 
analysis was performed (Appendix 4.12), with significance shown as an asterisk. One 
sample t test was used to compare PTN treated and control cells (Appendix 4.12) with 
significance shown as a hashtag. (E) F-actin staining of GCCs under different PTN 
concentrations shown in (D) at 96 h. All cells were grown in 1% FBS unless otherwise 
indicated. Red indicates F-actin staining and blue indicates DAPI staining. M, marker. */# 
p value < .05, **/## p value <.01, *** p value <.001. Scale bar = 400 μm. 
 
4.5 Discussion 
Deer antler is a unique model of mammalian organ regeneration in which activated stem 
cells drive rapid endochondral bone growth in a controlled manner. Antler has been 
shown to differentially express PTN mRNA in a suppression subtraction hybridisation 
library with the PTN transcript also highly expressed by in situ hybridisation within the 
active stem cell centre of the growing antler tip (Clark et al., 2006b). This makes PTN 
potentially a key regulator involved in antler regeneration. In the current study, the 
expression of PTN protein was investigated in different antler regeneration stages 
including the whole stick of growing antler, all layers within the antler tip growth centre, 
post-active stem cells in the mid-beam antler periosteum, dormant stem cells in the 
pedicle periosteum and control facial periosteum cells. The research also further 
investigated the functions of PTN in antler stem cells in vivo and in vitro. PTN was 
identified as the most highly expressed growth factor, of the PTN/MDK family, within the 
antler growth centre. Detection for PTN in different antler tissues revealed its dominant 
expression in tissues associated with rapid antler regeneration, rather than dormant stem 
cell niches. The results therefore confirmed that PTN may be a critical growth factor 
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participating in the regulation of rapid antler regeneration, and was potentially involved 
in maintaining dormancy of the antler stem cell niches in vivo. 
 
PTN’s functions were investigated by detecting its potential receptors on serial sections 
of growth centre tissues. As a member of the receptor-type protein-tyrosine phosphatase 
family (Levy et al., 1993), PTPRZ’s phosphatase activity can be inactivated by the binding 
of either PTN or MDK (Fukada et al., 2006; Kadomatsu et al., 2013). The inactivation of 
phosphatase activity causes an increase of tyrosine phosphorylation in the substrates of 
PTPRZ with influences on multiple physiological and pathological processes, such as 
angiogenesis, osteogenesis and tumorigenesis (Lamprou et al., 2014; Papadimitriou et al., 
2016). The expression of PTPRZ is specifically upregulated by hypoxia inducible factor 2α 
(HIF-2α) but not 1α, in both normal and tumour cell lines (Wang et al., 2005; Wang et al., 
2010). In the current study, the expression of MDK in the dermal and blood vessel layers, 
as well as PTN in the other layers of the growth centre, showed co-localisation with PTPRZ 
immunohistochemistry, suggesting PTPRZ could act as their receptor during rapid antler 
regeneration. 
 
ALK, as a downstream tyrosine kinase, is activated as a result of ligand induced 
dimerisation of the D1 domain in PTPRZ, an action most commonly attributed to PTN but 
also MDK binding (Deuel, 2013; Xia et al., 2019). The activated ALK is ligand-dependent 
and involved in numerous biological processes, such as nerve development and tissue 
repair (Wellstein, 2012). ALK is mainly found in the cytoplasm but also in the nucleus when 
fused with nucleophosmin (NPM) (Minoo & Wang, 2012). NPM provides a nuclear 
localisation domain and results in increased trafficking of ALK to the nucleus (Bischof et 
al., 1997). The fusion of NPM-ALK deregulates the kinase activity of ALK and induces a 
series of physiological and pathological processes including proliferation and 
tumorigenesis (Chiarle et al., 2008). This study found co-expression of PTPRZ with nuclear 
expression of ALK, indicating the tyrosine phosphorylation of ALK and its subsequent 
chaperoning to the nucleus via NPM. NPM was also recently reported to be highly 
expressed in active antler stem cells (Dong et al., 2020). Thus, NPM-ALK fusion in the 
nucleus could contribute as a rate limiting proliferative step for stem cells during 
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endochondral bone formation and not just for glioblastoma’s as was previously reported 
(Powers et al., 2002). 
 
Our results showed that the MDK-PTPRZ-ALK signalling axis may be involved in 
angiogenesis, based on their co-expression around blood vessels (Choudhuri et al., 1997). 
The expression profile of PTN within the growth centre suggests the PTN-PTPRZ-ALK 
signalling axis may participate in multiple processes including neurogenesis (Perez-Pinera 
et al., 2007), chondrogenesis (Bouderlique et al., 2014), and regulation of the stem cell 
niche (Himburg et al., 2012; Himburg et al., 2014). Specific substrate activation of PTPRZ 
may thus be the key to bridge upstream PTN/MDK dimerisation and phosphatase 
inactivation, and the downstream processes such as the ALK-NPM fusion and the 
activation of processes critical to rapid antler regeneration. 
 
The NOTCH2 receptor has mainly been documented for its interactions with MDK rather 
than PTN (Xu et al., 2014); and activation by MDK reported to induce cell plasticity and 
motility in epithelial-mesenchymal transitioning and tumorigenesis (Gungor et al., 2011; 
Huang et al., 2008). Within the antler growth centre, positive staining around blood 
vessels for NOTCH2 was only faintly detected and the expression was not as widespread 
as for MDK. A similar expression pattern between MDK and NOTCH2 was however 
observed within the precartilage layer. The strongest positive signal for NOTCH2 was 
found within the cartilage layer including hypertrophic chondrocytes, and between the 
connective tissues and the hypertrophic chondrocytes. Interestingly, it was the PTN ligand 
rather than MDK, which was highly expressed in the cartilage layer. This co-localisation 
between PTN and NOTCH2 indicates their potential interaction, as has previously been 
found during ocular development (Cui & Lwigale, 2019) and hematopoietic stem cell 
expansion (Himburg et al., 2010). A role for NOTCH2 and PTN in cartilage maturation is 
novel and warrants further investigation. 
 
ITGAV/ITGB3 which form a dimer, were detected separately in this study. They have 
previous been reported to function as receptors for PTN, inducing endothelial cell 
migration through PTPRZ (Mikelis et al., 2009). Within the antler both integrins were only 
detected around blood vessels, consistent with a pro-angiogenic role. It was noted that 
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their expression pattern in the blood vessels was almost identical to MDK. This suggests 
MDK may potentially interacted with ITGAV/ITGB3 and other angiogenic molecules such 
as VEGF during rapid angiogenesis in the antler (Clark et al., 2006b). 
 
PTPRZ was identified as the critical receptor between PTN and its downstream effects 
within the growth centre. The detection of PTPRZ and PTN were then extended into four 
antler tissues from the different regenerative stages. PTPRZ has three main splice variants 
including two transmembrane isoforms PTPRZ-A and PTPRZ-B, and the secretory isoform 
PTPRZ-S. These isoforms are known to be regulated in different ways during development 
(Nishiwaki et al., 1998). In this study, the anti-PTPRZ antibody was raised against the 
sequence Leu32 to Glu189 in the N terminus of PTPRZ. In the Western blot, the strongly 
stained upper bands were most likely extracellular fragments of PTPRZ-B (ZB-ECF) and the 
lower bands Z-ECF70, a common domain in the three isoforms (Chow et al., 2008; 
Fujikawa et al., 2017). The ZB-ECF was mainly found in the active antler stem cell tissues 
indicating PTPRZ-B could be the dominant PTPRZ isoform functioning in rapid antler 
regeneration. The extracellular domain of PTPRZ-B contributes to receptor-binding and 
functions associated with cell adhesion and migration (Bourgonje et al., 2014). CTNNB1 is 
a known downstream cell adhesion molecule activated through dimerisation of the 
PTN/PTPRZ complex (Meng et al., 2000). Tyrosine phosphorylated CTNNB1 is also 
correlated with cadherin-mediated cell adhesion (Balsamo et al., 1996). Constitutive 
expression of PTN dramatically disrupts CTNNB1-mediated adhesion and increases cell 
migration (Meng et al., 2000; Xia et al., 2019). The expression pattern of CTNNB1 in 
different antler regeneration stages has been reported and is consistent with PTN and 
PTPRZ expression (Dong et al., 2020), i.e. the active stem cells have the highest expression 
levels, the dormant stem cells the lowest. Post-active stem cells have higher expression 
levels than the dormant stem cells but without significance. The expression levels of PTN, 
PTPRZ and CTNNB1 therefore reflected the stem cell activation status. Taken together, 
the PTN-PTPRZ-CTNNB1 signalling axis may be involved in regulating cell adhesion and 
migration during endochondral bone formation in the antler, especially given that 
CTNNB1 is an essential part of Wnt signalling and stem cell renewal (Rao & Kuhl, 2010; 
Wang & Wynshaw-Boris, 2004). Further research is required to investigate the interaction 
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between PTPRZ and CTNNB1 as well as the phosphorylation status of CTNNB1 within the 
growth centre. 
 
In vitro studies revealed that cells harvested from both dormant and active antler stem 
cell niches, and cultured in osteogenic media, had the potential to become osteoblasts, 
one of the main cell types in the growing antler. A search for PTN in cell lysates and 
supernatants indicated no PTN was expressed from antler stem cells in vitro. In addition, 
only low levels of PTPRZ (ZB-ECF) were found in cell lysates. This result was surprising 
considering the very high levels of PTN and PTPRZ in vivo in the active antler stem cells. 
The dormant antler stem cells did not produce PTN either in vivo or in vitro. When 
exogenous PTN was added to investigate its function in the cultured active antler stem 
cells, the results showed exogenous PTN did not contribute to osteogenesis but may 
maintain cell stemness in vitro. This is consistent with PTN’s critical role on hematopoietic 
stem cell maintenance (Himburg et al., 2018). The lack of PTN expression may be 
explained by the recent finding that both HIF-1α and HIF-2α have been identified, using 
label-free proteomics, as the most upstream regulators within the active antler stem cells, 
suggesting that the active stem cell niche is in fact hypoxic during rapid antler 
regeneration (Dong et al., 2020). In other systems, hypoxia results in increased expression 
of PTN and PTPRZ (Antoine et al., 2005; Wang et al., 2005; Wang et al., 2010; Wang et al., 
2014). The high expression levels of PTN and PTPRZ in vivo may therefore reflect the 
presence of a hypoxic niche within the growth centre. 
 
4.6 Conclusions 
Our study revealed the potential functions of PTN in antler stem cells in vivo and in vitro. 
The PTN/PTPRZ complex may activate downstream pathways including NPM-ALK and 
CTNNB1, and regulate cell proliferation and migration during the rapid antler 
regeneration (Figure 4.16). NOTCH2 may also bind with PTN inducing bone remodelling. 
PTN may have an effect on the maintenance of stemness rather than differentiation under 
normoxic in vitro culture of antler stem cells. Hypoxic culture for the active antler stem 
cells in vitro is a promising future direction for investigating PTN’s expression and function 
in antler regeneration. 
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Figure 4.16 Schematic representation of the hypothetical mechanism shows potential 














5.1 General discussion 
The detailed discussion for each study can be found in the individual chapters. The general 
findings and discussions about these studies are presented here. 
 
 Relations between antler generation and regeneration proteomic studies 
2D-DIGE was used to compare protein profiles between antler generation and 
regeneration (chapter 2); label-free quantification further identified the differentially 
expressed proteins in different stages of antler regeneration (chapter 3). There was an 
identical comparison in the two studies, which was between dormant pedicle periosteum 
and control facial periosteum but using different sample types, i.e. cell (chapter 2) and 
tissue (chapter 3). Slightly more differentially expressed proteins were found in the cell 
samples compared to the tissue samples, but consistent in both sample types was the 
finding of more upregulated proteins in the dormant pedicle periosteum. Interestingly, 
both studies identified different proteins; this could be a result of using different samples 
and/or proteomic approaches. The closest identified proteins were PRDX4 and PRDX2, 
which were from the comparison of cells and tissues respectively. Both PRDX proteins 
belong to the peroxiredoxin family with higher expression levels in the dormant pedicle 
periosteum indicating antler stem cells may have high demand of antioxidant defence and 
redox signalling activation (O'Flaherty, 2014) in vivo and in vitro. 
 
In both studies, the epithelial−mesenchymal transitioning process was enriched, 
suggesting this process may participate in both the initiation of antler regeneration and 
regulation of rapid growth. Other processes identified included cellular movement and 
metabolism processes like glycolysis and nucleotide metabolism. They were more active 
in the antler growth centre than the samples from other stages including before and after 
antler regeneration. Antler regeneration during the rapid growth stage was therefore 
experiencing a very intense developmental process. 
 
The normally used “housekeeping proteins” such as GAPDH and ACTB were likewise 
upregulated in the active antler stem cell tissues. Thus, in the label-free quantification, 
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stain-free Western blot with total protein normalisation was chosen as an alternative to 
the conventional Western blot used in the 2D-DIGE to verify proteomic results. 
 
These two antler proteomic studies employed advanced quantitative approaches, with 
cervine transcriptome and in-house protein databases, and powerful bioinformatics 
software including Cytoscape and IPA to maximally address working with limited deer 
proteome data. This research adds significantly to other antler proteomic studies (Table 
1.3), sheds new light on mammalian regeneration, and provides many promising 
directions for further investigation. 
 
 Relationship between antler proteomic studies and PTN expression and function 
investigation 
In this research project, PTN protein was detected in antler stem cell tissues using several 
approaches including Western blot, immunohistochemistry and ELISA (chapter 4). This 
confirmed the presence of PTN during antler regeneration from different perspectives. 
No PTN was however identified from either of the proteomic studies (chapters 2 and 3). 
There are two possible reasons why it was not detected in the 2D-DIGE quantitative 
proteomics (chapter 2). One is the samples used in this study were from tissue culture, of 
which the stem cell microenvironments could have changed once collecting from the 
organisms and culturing in the media. The expression of PTN may therefore be altered. 
The other is PTN may be indeed absent in the initiation stages of antler regeneration 
considering that PTN cannot be detected in the dormant pedicle periosteum cells, and 
had scarcely expression in vivo either (chapter 4). Still, speaking of absence in the MS 
result, it does not have to mean PTN is not present in the antler stem cells; one possibility 
is that the dynamic range of protein expression in cells may be not covered by the MS 
identification (Corthals et al., 2000; Zubarev, 2013). 
 
Label-free quantification unlike 2D-DIGE utilised the same antler tissues as the PTN 
expression and function investigation. However, PTN protein in the antler growth centre 
tissues was only detected by immunohistochemistry and Western blot (chapter 4) and not 
in the label-free quantification (chapter 3). This was most probably caused by the sample 
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preparation for mass spectrometry. The filter-aided sample preparation used in the label-
free quantification employed filtration units with molecular weights cut offs of 30 kDa. 
Heating can denature proteins resulting in larger Stokes’ radii than their native forms 
(Wisniewski, 2018); proteins with low molecular weights like PTN (18 kDa) (Rauvala, 1989) 
may still pass through the membrane of the filtration unit. This highlights one of the main 
shortcomings of current proteomic methodology; and that conventional approaches like 
2D-DIGE and label-free quantification can be dramatically affected by sample processing, 
mass spectrometry analysis and proteomic software algorithms, therefore cannot cover 
and identify all the proteins in the loading samples. 
 
5.2 Conclusions 
The main goal of this research project was to explore the molecular mechanisms 
underlying antler generation and regeneration. The hypotheses of this project were ⑴ 
There are significant differences regarding protein profiles between antlerogenic and 
pedicle periosteum cells. ⑵  Multiple differentially expressed proteins and biological 
processes are involved in antler regeneration stages including before, during and after 
antler growth. ⑶  Pleiotrophin has similar protein expression patterns across antler 
growth centre as its mRNA, and has multiple functions achieved by interacting with 
different receptors. 
 
Quantitative proteomic platforms were first optimised and established for protein profile 
comparisons between different antler stem cell samples. The following conclusions can 
be drawn from the studies presented in this thesis: 
1. Numerous biological processes and molecular pathways are involved in regulating 
the maintenance and activation of stem cells fundamental to the development of 
antler as a complex mammalian structure. The epithelial-mesenchymal transition 
process may contribute to the initial stage of antler regeneration, i.e. wound 
healing and antler regeneration per se. The smooth muscle contraction pathway 
participates highly in antler regeneration due to the massive mobility required. 
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Metabolism processes may however be less active in antler regeneration as 
compared to those in the antler generation phase. 
2. There are various potential biomarkers identified from stem cell niches at different 
stages of activation, as well as functional and control proteins, pathways and 
upstream regulators associated with stem cell regulation during antler 
regeneration. Antler stem cells may use similar mechanisms to maintain dormancy 
within a stem cell niche. Down-regulation of Hippo signalling may be involved in 
the size of the growing antler. CALR may play a key role in antler regeneration 
which is regulated by cyclical modulation of androgen levels. 
3. PTN is the dominant growth factor of PTN/MDK family in the active antler stem 
cell tissues because of its higher expression at the protein level. PTN-PTPRZ 
signalling may activate downstream pathways including NPM-ALK chimeric 
tyrosine kinase and CTNNB1, and regulate cell behaviours during rapid antler 
regeneration. PTN might have an effect on the maintenance of stemness rather 
than differentiation under normoxic in vitro culture of antler stem cells. 
4. Deer antler is therefore a valuable mammalian model to investigate proteins and 
functional pathways that control tissue regeneration of neural crest-derived stem 
cells. 
 
5.3 Future directions 
A number of points and findings of this thesis warrant further investigation: 
1. Protein profile comparisons between animal models of regeneration with similar 
regenerative capacities like deer antler, salamander limb and zebrafish fin could 
unlock the common mechanisms contributing to regeneration. 
2. Employing integrative omics including genomics, transcriptomics, proteomics and 
metabolomics could address deer antler biology questions in a more 
comprehensive manner. 
3. Functional proteomics like post-translational modification profiling is still an 
untouched area in deer antler proteomics; this approach would add more 
information in relation to protein function, localisation and stability, compared to 
conventional proteomics. 
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4. It would be interesting to investigate when the epithelial−mesenchymal 
transitioning process is activated and how it is involved in regulating antler 
regeneration initiation and maintenance. 
5. How Hippo signalling affects growing antler size should be further explored. 
6. Studies investigating the interaction between CALR and androgen receptor in 
different antler stem cell populations during regeneration and their downstream 
effects would explain how antler growth is controlled by androgen levels. 
7. Hypoxic culture for the active antler stem cells in vitro should be conducted to 
investigate if PTN’s expression during rapid regeneration is regulated by hypoxia. 
8. Is CTNNB1 modulated by the PTN-PTPRZ signalling axis and what functions does 
this signalling possess in the active antler stem cell tissues? 
9. Although human and deer origin PTN protein sequences are very similar, it would 
be worth studying if there are any differences in their effects on antler stem cells 
and human neural crest derived stem cells like dental pulp stem cells. 
10. Functional investigation experiments regarding effects of PTN on antler stem cell 
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Appendix 1.1 Enrichment of biological process from STRING (v11.0). “PTN” is 















Appendix 2.1 RC DC protein assay (Modified from Bio-Rad protocol) 
➢ List of main reagents 
Component Company Cat No. 
RC Reagents Package Bio-Rad  5000119 
DC Protein Assay II Bio-Rad 5000112 
 
➢ Procedure 
• Add 5 µL of DC Reagent S to each 250 µL of DC Reagent A. This solution is referred to 
as Reagent A’. Each standard and sample require 127 µL of Reagent A’. 
• Prepare 4 dilutions of BSA standard from 0.2 mg/mL to 1.5 mg/mL protein shown in 
Table 1. A standard curve should be prepared each time the assay is performed. (For 
best results, the standards should always be prepared in the same buffer as the 
sample.) 
Table 1. Dilutions of protein standards 
No. BSA conc. (mg/mL) Volume of BSA solution (µL) Volume of Urea buffer (µL) Total volume (µL) 
1 1.5 
1.5 from stock BSA (100 
mg/mL) solution 
98.5 100 
2 0.75 30 from No. 1 30 60 
3 0.375 25 from No. 2 25 50 
4 0.2 16 from No. 3 14 30 
 
• Pipet 25 μL of standards, samples and blank (only with 25 μL lysis buffer, used to be 
subtracted from the readings of standards and samples) into clean, dry microfuge 
tubes. 
• Add 125 μL RC Reagent I into each tube, vortex. Incubate the tubes for 1 min at room 
temperature (RT). 
• Add 125 μL RC Reagent II into each tube, vortex. Centrifuge the tubes at 15,000 g for 
3-5 min. 
• Discard the supernatant by inverting the tubes on clean, absorbent tissue paper. Allow 
the liquid to drain completely from the tubes. Then do a second wash. 
• Add 125 μL RC Reagent I into each tube, vortex. Incubate the tubes for 1 min at RT. 
• Add 40 μL RC Reagent II into each tube, vortex. Centrifuge the tubes at 15,000 g for 3-
5 min. 
• Discard the supernatant by inverting the tubes on clean, absorbent tissue paper. Allow 
the liquid to drain completely from the tubes. 
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• Add 127 μL Reagent A’ to each microfuge tube, vortex. Incubate tubes at RT for 5 min, 
or until precipitate is completely dissolved. Vortex before proceeding to the next step. 
• Add 1 mL of DC Reagent B to each tube and vortex immediately. Incubate at RT for 15 
min. 
• After the 15 min incubation, transfer each of samples and standards into 96 well plate 
with 200 μL in triplicate, absorbances can be read at 750 nm. The absorbances will be 
stable for at least 1 hour. 
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Appendix 2.2 All twelve 2D-DIGE gels under each channel and multiple 






















































































































































































Appendix 2.3 Details of the computational comparison of protein expression 
profiles of FPCs, APCs, DPPCs and PPPCs performed with the EDA module of 
DeCyder software (GE Helthcare). Manually validated spots displaying 
significant statistical differences (p < 0.05 in one-way ANOVA) are shown. For 
each spot in each pair, the average volume ratio (AV. Ratio) and the statistical 











Appendix 2.4 Western blot raw and normalised data for Figure 2.15. 
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Samples (n = 4) 
Figure 2.15B 
Intensity Normalisation 
VIM LGALS1 GAPDH VIM LGALS1 
AP 
1.05E+04 7.22E+02 4.70E+03 2.25E+00 1.54E-01 
8.40E+03 6.73E+02 4.80E+03 1.75E+00 1.40E-01 
5.91E+03 8.97E+02 3.14E+03 1.88E+00 2.86E-01 
9.23E+03 1.56E+03 4.29E+03 2.15E+00 3.63E-01 
FP 
5.94E+03 7.77E+02 2.76E+03 2.15E+00 2.81E-01 
4.44E+03 9.95E+02 3.25E+03 1.37E+00 3.06E-01 
6.45E+03 6.39E+02 5.79E+03 1.11E+00 1.10E-01 
7.58E+03 5.45E+02 2.17E+03 3.50E+00 2.52E-01 
PPP 
1.41E+03 1.46E+03 1.72E+03 8.19E-01 8.49E-01 
1.32E+03 1.36E+03 1.76E+03 7.52E-01 7.73E-01 
6.85E+02 2.16E+03 1.36E+03 5.04E-01 1.59E+00 
4.29E+03 1.88E+03 3.01E+03 1.42E+00 6.24E-01 
DPP 
1.10E+03 1.65E+03 2.51E+03 4.40E-01 6.60E-01 
1.61E+03 2.87E+03 2.37E+03 6.80E-01 1.21E+00 
1.41E+03 4.15E+03 2.73E+03 5.18E-01 1.52E+00 
3.47E+03 1.42E+03 2.52E+03 1.38E+00 5.61E-01 
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Appendix 3.1 CD90/CD105 immunohistochemical protocol. 
➢ List of main reagents 
Component Company Cat No. 
Anti-CD90 Abcam ab92574 
Goat F(ab')2 Anti-Rabbit IgG - H&L (Biotin) Abcam ab6012 
Tween-20 Bio-Rad 1706531 
Anti-CD105 Bioss bs-0579R 
Rabbit IgG, Solid Phase Absorbed Dako X0936 
PBS  Life Technologies SALB010 
Bovine Serum Albumin Sigma-Aldrich A7906-50g 
Goat Serum Sigma-Aldrich G9023 
30% (w/w) Hydrogen Peroxide Solution Sigma-Aldrich H1009 
DAB Enhanced Liquid Substrate System 
Tetrahydrochloride 
Sigma-Aldrich D3939 
VECTASTAIN Elite ABC HRP Kit Vector Laboratories PK-6100 
 
➢ Experimental design 
Table 1. Antibodies and IgG control used in this experiment 
Primary antibody Isotype matched control Secondary antibody 
Anti-CD90, rabbit 
monoclonal, isotype: IgG, 
stock: 0.072 mg/mL.  
Anti-CD105, rabbit 
polyclonal, isotype: IgG, 
stock: 1 mg/mL. 
Rabbit IgG, solid phase 
absorbed, stock: 1 mg/mL. 
Goat anti-rabbit (Biotin), 
1 mg/mL, dilution range 














Table 2. Slide labelling 
 Slide No. Slide name Label 
1  319 T2 - 12 CD90 
2 326 T1 - 10 CD90 
3 367 T2 - 10 CD90 
4 319 T2 - 10 Rabbit IgG 
5 326 T1 - 8 Rabbit IgG 
6 367 T2 - 8 Rabbit IgG 
7 319 T2 - 13 CD105 
8 326 T1 - 11 CD105 
9 367 T2 - 11 CD105 
10 319 T2 - 18 Rabbit IgG 
11 326 T1 - 16 Rabbit IgG 
12 367 T2 - 16 Rabbit IgG 
 
➢ Reagent preparation 
1. Antigen retrieval solution, 600 mL 
• Dilute 0.1 M citrate buffer (pH6.0) to 0.01 M (working concentration) before use 
by adding 60 mL of 10× concentrate to 540 mL of dH2O. 
2. 1% BSA/PBS, 5.7 mL 
• Measure 57 mg BSA and add 5.7 mL PBS. BSA acts as a carrier protein and helps 
minimise background staining. 
3. Blocking serum (20% Goat serum with 1% BSA/PBS), 2000 µL 
• 2000 µL = 400 µL Goat serum + 1600 µL 1% BSA/PBS. 
4. Primary antibody diluent (5% Goat serum with 1% BSA/PBS), 2100 µL 
• 2100 µL = 105 µL Goat serum + 1995 µL 1% BSA/PBS. Store on ice before use. 
5. Primary antibody and IgG control, 150 µL/slide 
Table 3. Primary antibody (Ab) and IgG control preparation 
Primary Ab or IgG control How to make 
CD90 (1:14.4) = 5 µg/mL 1:14.4 dilution = 34.72 µL CD90 Ab + 465.28 µL Ab Diluent 
Rabbit IgG (1:200) = 5 µg/mL 1:200 dilution = 2.5 µL Rabbit IgG + 497.5 µL Ab Diluent 
CD105 (1:100) = 10 µg/mL 1:100 dilution = 5 µL CD105 Ab + 495 µL Ab Diluent 
Rabbit IgG (1:100) = 10 µg/mL 1:100 dilution = 5 µL Rabbit IgG + 495 Ab Diluent 
 211 
6. Wash buffer (0.1% tween-20 and 0.5% milk powder in PBS), 650 mL 
• Add 3.25 g of skim milk powder and 650 µL of Tween-20 into 650 mL PBS. 
7. Secondary antibody diluent (5% Goat serum with 1% BSA/PBS), 1990 µL 
• 1990 µL = 99.5 µL Goat serum + 1890.5 µL 1% BSA/PBS. Store at 4℃. 
8. Secondary antibody, 150 µL/slide 
• 1:200 dilution = 10 µL Secondary Ab + 1990 µL Secondary Ab diluent. 
9. Hydrogen peroxide solution (0.3% H2O2 in Methanol), 100 mL 
• IMMEDIATELY BEFORE USING, add 1 mL of 30% H2O2 to 100 mL methanol in the 
measuring cylinder.   
10. Vectastain Elite ABC Kit Strep HRP solution, 2080 µL 
• Add 40 µL A to 2000 µL PBS - mix; add 40 µL B to the mixture - mix, then wait 30 
min before use. 
11. DAB chromogen, 2060 µL 




1. Dewaxing and Rehydration of the Slides (Xylene - Graded Ethanol) 
• Xylene  5 min, 5 min, 10 min 
• 100% Ethanol  5 min 
• 90% Ethanol  5 min 
• 70% Ethanol  5 min 
• 50% Ethanol  5 min 
• 2× dH2O  2 min each 
2. Antigen Retrieval 
• Set a water bath to 98oC. Place dewaxed slides in a metal rack containing PBS. Pre-
heat the antigen retrieval buffer in a large beaker within the water bath until it 
reaches 95-100℃. Place the rack with slides into the beaker for 10 min. The 
temperature inside the beaker should maintain between 95-100℃ during the 10 
min. Remove the rack and wash the slides 2× 5 min in PBS (with gentle shaking). 
• Use a wax pen to draw around sections. 
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3. Immunohistochemical Staining 
• All incubations need to be carried out in a humidified chamber to avoid drying of 
the tissue. 
• Add blocking serum on all slides for 30 min at room temperature (RT). 
• Drain slides on tissue paper for a few seconds. 
• Apply diluted CD90 primary antibody on slides No. 1-3. 
• Apply diluted CD105 antibody on slides No. 7-9. 
• Apply diluted isotype matched control (Rabbit IgG) on slides No. 4-6 and No. 10-12. 
• Incubate overnight in a humidified chamber (PBS) at 4℃. 
 
DAY TWO 
4. Rinse Slides with Wash Buffer 
• Place all slides in a rack in a 100 mL container.  Rinse with wash buffer 3× for slides 
No. 1-6 on shaking: 5 min, 20 min, 20 min; 3× for slides No. 7-12 on shaking: 10 min, 
30 min, 30 min. Do separately. 
5. Incubate Diluted Secondary Ab 
• Apply diluted secondary antibody on all the slides. 
• Incubate for 1 hour in humidified chamber at RT. 
• Wash with 3 changes of PBS for 5 min, 10 min, 10 min. 
6. Endogenous Peroxidase Blocking 
• Incubate slides in the hydrogen peroxide solution for 10 min (No shaking required). 
• Wash with 3 changes of PBS for 5 min each time. 
7. Detection 
• Add Vectastain Elite ABC Kit Strep HRP solution to the slides (150 µL per slide) and 
incubate all slides for 30 min at RT in the humidified chamber. 
• Wash with 3 changes of PBS for 5 min, 10 min, 10 min. 
Note: Prepare Vectastain ABC complex 30 min ahead of use. 
• Apply 150 µL of DAB Chromogen onto each slide for a maximum of 3 min reaction. 
Tip excess through funnel into DAB waste flask. dH2O wash: 3× 5 min. 
Note: DAB is a carcinogen, handle with care. The DAB mixture should be prepared no more than 
10 min before use. Reaction time depends on the amount of brown precipitation, no more than 3 
min. Do not dry slides during this step. 
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8. Haematoxylin Staining and Dehydration 
• Haematoxylin  2 dips (of 2 sec) - for CD90 (Slides No. 1-6); jump to “50% Ethanol” 
directly for CD105 (Slides No. 7-12). 
• Run under cold tap water until clear 
• Scott’s tap water  1 min 
• Running cold tap water 
• 50% Ethanol  2 min 
• 90% Ethanol  2 min 
• 100% Ethanol  2 min 
• Xylene  2× 5 min 
9. Mount with DPX 
• Place the slides in the fume cupboard for at least 1 hour before imaging. 
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Appendix 3.2 Protein extraction and sample preparation protocol. 
➢ List of main reagents and consumables 
Component Company Cat No. 
Thiourea Extra Pure 99% Acros 138910010 




4-20% Criterion TGX Precast Midi Protein 
Gel 
Bio-Rad 5671093 
Precision Plus Protein All Blue Prestained 
Protein Standards 
Bio-Rad 1610373 
Coomassie Brilliant Blue G-250 Bio-Rad 1610406 
Protein LoBind Tube 0.5 mL Eppendorf 30108094 
Protein LoBind Tube 1.5 mL Eppendorf 30108116 
Protein LoBind Tube 5.0 mL Eppendorf 30108132 
epT.I.P.S. Reloads, PCR clean, 0.1 - 10 µL Eppendorf 30073746 
epT.I.P.S. Reloads, PCR clean, 2 - 200 µL Eppendorf 30073800 
epT.I.P.S. Standard, Eppendorf Quality, 
0.1 - 5 mL 
Eppendorf 30000978 
Acetonitrile, Optima LC/MS Grade Fisher Chemical A955-4 
Ethanol Absolute, for HPLC Fisher Chemical 10428671 
Formic Acid, 99.5+%, Optima LC/MS 
Grade 
Fisher Chemical A117-50 
Water, Optima LC/MS Grade Fisher Chemical W6-4 
Sodium Dodecyl Sulfate, 99+%, for 
Electrophoresis 
Fisher Chemical 10509770 
Urea, Extra Pure, SLR Fisher Chemical  10142740 
pH Indicator Paper Sticks 0 to 14  Fisherbrand 10642751 
pH Indicator Paper Sticks 4.5 to 10 Fisherbrand 10333501 




Formic Acid Eluent Additive for LC-MS Honeywell Fluka 56302-10X1ML 
9 mm R.A.M. Ribbed Cap, Black, 
PTFE/Silicone Lined 
JG Finneran 5395-09 
250 µL Glass Big Mouth Conical Limited 
Volume Insert, Precision-Formed 
Mandrel Interior, w/Bottom Spring 
JG Finneran 4025BS-629 
2 mL Clear, Glass, 9mm Screw Thread, 
Box 100 
JG Finneran 32009-1232 
Kimwipes Science Wipes 110x210 mm 
34120, Pack of 280 
KIMTECH  2855623 
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Component Company Cat No. 
Microcon YM-30 Merck 42409 
100μ x 150mm 3μ 200Å ProntoSIL C18AQ 
Column 
nanoLCMS Solutions PN 31001 
Sequencing Grade Modified Trypsin Promega V5111 
cOmplete Protease Inhibitor Cocktail ROCHE 4693116001 
Tris-(hydroxymethyl)-Aminomethane, 
Buffer Substance, Reagent Grade, ACS 
Scharlau TR04231000 
Ammonium Sulfate Sigma-Aldrich A4418-1KG 
DL-Dithiothreitol Sigma-Aldrich D0632-25G 
Iodoacetamide ≥99% (NMR), crystalline Sigma-Aldrich I6125-25G 
Trifluoroacetic Acid for HPLC, ≥99.0% Sigma-Aldrich 
302031-
10X1ML 
Acclaim PepMap 100 C18 LC Columns Thermo Scientific 164942 
Qubit Assay Tubes Thermo Scientific Q32856 
Qubit Protein Assay Kit Thermo Scientific Q33211 
Pierce Detergent Removal Spin Column, 
0.5 mL 
Thermo Scientific  87777 
Ammonium Hydrogen Carbonate VWR International BDH9206-1KG 
 
➢ Reagent preparation 
1. Stock protease inhibitors solution (25×), 2 mL 
• Dissolve one tablet in 2 mL LC/MS grade water, aliquot and store in - 20℃ freezer. 
2. Urea lysis buffer, 20 mL 
Reagents Final conc. (M) MW (g·mol−1) or Times Required amount 
Urea 7 60.06 8408.4 mg 
Thiourea 2 76.12 3044.8 mg 
Protease inhibitors 1× 25× in MS grade water 800 μL 
• Add 6 mL LC/MS grade water and dissolve the reagents in 50 mL tube. Make the 
volume to 19.5 mL. Then use around 4 μL NaOH and pH test stripes to adjust the 
buffer pH to 8.0. Lastly, make the final volume up to 20 mL. Aliquot and store in - 
20℃ freezer.  
3. 2% SDS heating buffer, 20 mL 
Reagents Final conc. (mM) MW (g·mol−1)  Required amount 
SDS 2% 288.38 400 mg 
Tris 100 121.14 242.28 mg 
DTT (Add before use) 50 154.25 154.25 mg 
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• Add 10 mL LC/MS grade water and dissolve the reagents in 50 mL tube. Make the 
volume to 19.5 mL. Then use around 170 μL concentrated HCl and pH test stripes 
to adjust the buffer pH to 7.6. Lastly, make the final volume up to 20 mL. 
4. UA-solution, 20 mL 
Reagents Final conc. (M) MW (g·mol−1)  Required amount 
Urea 8 60.06 9609.6 mg 
Tris 0.1 121.14 242.28 mg 
• Add 8 mL LC/MS grade water and dissolve the reagents in 50 mL tube. Make the 
volume to 19.5 mL. Then use around 74 μL concentrated HCl and pH test stripes 
to adjust the buffer pH to 8.5. Lastly, make the final volume up to 20 mL. 
5. 50 mM iodoacetamide (IAM; 184.96 g·mol−1) in UA-solution, 1.5 mL 
• Dissolve 13.87 mg IAM in the UA-solution to make the final volume at 1.5 mL (this 
solution should be fresh-made and used within one day. After adding UA-solution, 
the vial should be wrapped in tin foil immediately). 
6. Stock trypsin solution (1 μg/μL) 
• Add 20 μL of trypsin resuspension buffer to the 20 μg/vial sequencing grade 
modified trypsin; this results in the stock trypsin solution at 1 μg/μL. 
7. Working trypsin solution, 1.4 mL 
Reagents Required amount 
0.05 M AMBIC 1218 μL 
Stock trypsin solution 42 μL 
Acetonitrile 140 μL 
• Add 42 μL stock trypsin solution into 0.05 M AMBIC; the tip should be dipped into 
the liquid to make sure the trypsin is added. Then add acetonitrile and vortex well. 
This equates to 3 μg trypsin to each sample. 
 
➢ Procedure 
1. Tissue Homogenisation 
• Remove the tissues from the - 80℃ freezer. 
Note: Follow the tissue preparation randomisation order provided in Table 1. Complete each batch 
from the beginning to the homogenate aliquot and then continue to the next batch. 
• Use a scalpel to dice the tissues into cubes/chunks inside the ice box. 
• Weigh approximately 50 mg from each sample. (Two-three chunks, which means 
17-25 mg/chunk.) 
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Table 1. Details of tissues for homogenisation 
Extraction 
date 
13/04/18 14/04/18 15/04/18 























Weight (mg) 53 49 53 50-53 50 50-55 49 54 52 52 50-51 49-50 
 
• Transfer each tissue sample into a clean glass tissue grinder. 
• Add 300 μL cold urea lysis buffer. 
• Use a glass Pasteur pipette to push all the tissue pieces to the bottom before 
grinding. 
• Insert the glass grinder in the beaker; keep cool on ice. 
• Grind for 30 sec by fixing the Teflon pestle to the bottom, without up and down 
movement (this step should be accompanied with slow spinning of the tubes), 
then wait 10-20 sec. 
• Repeat this step three times, in total the grinding time is around 2 min. 
• Use an additional 200 μL cold urea lysis buffer to rinse around the Teflon pestle 
(2x 100 μL each) and accumulate all the liquid into the glass grinder. 
• After each tissue grinding, remove and clean the Teflon pestle by hot tap water, 
ethanol, dH2O, and then Kimwipe tissue paper. Use a new glass tissue grinder tube 
for each tissue sample and repeat as described above until all are finished. 
• Place the glass grinder tube/ tissue into an ultrasonic water bath for 15 min. 
• Transfer all the liquid into a low-binding 1.5 mL EP tube. 
• Use another 200 μL urea lysis buffer to wash the glass grinder tube and combine 
in the EP tube. 
• Centrifuge at 20,000 g for 30 min at 4℃. 
• Transfer the supernatant into a 0.45 μm filter, avoid the pellet as much as possible. 
• Spin at 10,000 g, 40 min and 4℃. If there is still some liquid left in the ultrafilter 
unit, then change to a new one and centrifuge for another 40 min until all the 
liquid passes through. 
• Aliquot into 10 vials for each sample. Keep the final tube (with the left-over 
homogenate after aliquoting). Also store an aliquot of urea lysis buffer. Store in - 
80℃ freezer. 
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2. Qubit Protein Assay 
• Solutions for thermal denaturation: 
▪ To each GC sample, mix 10 μL with 90 μL 2% SDS heating buffer (DTT+). 
▪ To each FP sample, mix 10 μL with 90 μL 2% SDS heating buffer (DTT+). 
▪ To each DPP sample, mix 10 μL with 90 μL 2% SDS heating buffer (DTT+). 
▪ To each MAP samples, mix 10 μL with 90 μL 2% SDS heating buffer (DTT+). 
▪ To a Blank solution of 10 μL urea lysis buffer (use the one set aside from the 
tissue homogenisation and stored in - 80℃ freezer), add 90 μL 2% SDS heating 
buffer (DTT+). 
• Heat all solutions including the blank one to 95℃ for 5 min. 
• Spin at 20,000 g for 20 min at room temperature (RT). 
• Mix 10 μL thermally denatured and blank solution with 90 μL LC/MS grade water 
in duplicate. Regard these as the 1:1 samples. 
• Take 10 μL from each 1:1 sample (in the order shown in Table 2) and measure the 
protein content (Table 3) as per the instructions. 





Standard Biological replicate ‘1-3’ - 1 Blank-1 Biological replicate ‘1-3’ -2 Blank-2 
Box1 
FP  S1 S2 S3 17 FP-1 19 FP-1 20 FP-1 B-1 17 FP-2 19 FP-2 20 FP-2 B-2 















































Table 3. Qubit protein assay result 
Batch name 















FP  4.76 3.68 3.60 1.00 5.04 3.58 3.69 1.10 
MAP  3.55 3.70 3.43 1.20 3.64 3.95 3.71 1.30 
DPP  3.53 4.77 3.49 1.10 3.59 4.90 3.59 1.20 
GC  4.81 5.12 4.97 1.10 4.99 5.44 5.03 1.00 
Notes: 
▪ Use reverse pipette to add working and sample solutions. 
▪ In each batch, keep the incubation time intervals between the first (S1) and last (B-2) tubes 
within 10 min. 
▪ The total incubation time in each batch should be 30 min, starting after the mixing of the first 
tube (S1). 
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▪ Stagger addition of Qubit dye to samples by 30 sec, then read at 30 sec intervals after 30 min 
incubation. 
▪ The Qubit working solution should be made up at the same time before use for each batch. 
(See Figure 1) 
▪ Spin briefly to eliminate bubbles before reading, and the adaptors used should be washed in 
case of contaminations. 
▪ The measurement for Qubit must have a stable temperature (around 22℃). 
▪ The premise for normalisation is that the fluorescence dye has the same reaction with all 
proteins regardless of the tissue types. For normalisation analysis, use the ratio between the 
values of 1:1 dilution samples minus blank sample from each sample. Normalise the loading 
volume of each sample based on a 25 μL sample with the lowest conc. among all tissues. 
 
 
Figure 1. Timeline of Qubit protein assay  
 
3. SDS-PAGE Using the Same Protein Homogenates as the Qubit Assay 
• Mix 3.5 μL homogenate from each sample with 7 μL loading buffer. 
• Heat them in boiling water for 4 min. 
• After a quick spin, load 9 μL samples into each lane of a 4-20% Criterion TGX 
Precast Midi Protein Gel as the order shown in Table 4. 
Table 4. Sample loading order 
Lane No. 1 2 3 4 5 6 7 8 9 10 11 12 
Sample 
name 







18DPP 19DPP 20DPP 528GC 722GC 358GC 
 
• The running condition are: 200V, 40 min. 
• After running, fix the gel in 50% ethanol, 10% acetic acid (100 mL) for 30 min. 
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• Then stain in 100 mL of 10% w/v ammonium sulphate, 10% phosphine acid, 0.12% 
Coomassie G250, and 20% methanol. The staining time is around 3-4 hours. 
• Use distilled water + kimiwipe tissues for destaining and keep changing the tissues 
until the image is ready for scanning. 
4. Filter-aided Sample Preparation (FASP) 
• Take the homogenates for FASP out of the - 80℃ freezer and recover to RT. 
• To conduct protein normalisation, based on the reference sample (358 MAP), take 
volumes of homogenate equivalent to 25 μL 358 MAP homogenate as shown in 
Table 5. 
Table 5. Sample preparation after normalisation 
Sample No. 1 2 3 4 5 6 7 8 9 10 11 12 



















Qubit average (μg/mL) 4.900 3.630 3.645 3.595 3.825 3.570 3.560 4.835 3.540 4.900 5.280 5.000 
- “Blank” 3.850 2.580 2.595 2.345 2.575 2.320 2.410 3.685 2.390 3.850 4.230 3.950 
Normalisation 0.603 0.899 0.894 0.989 0.901 1.000 0.963 0.630 0.971 0.603 0.548 0.587 
Equivalent homogenate 
volume (μL) 
15.1 22.5 22.4 24.7 22.5 25.0 24.1 15.7 24.3 15.1 13.7 14.7 
2% SDS heating buffer 
(DTT+) volume (μL) 
135.6 202.3 201.2 222.6 202.7 225.0 216.6 141.7 218.4 135.6 123.4 132.2 
In total (μL) 150.6 224.8 223.5 247.3 225.2 250.0 240.7 157.4 242.7 150.6 137.1 146.8 
 
• Mix the homogenate from each sample with 2% SDS heating buffer (DTT+) to make 
a 10 times dilution. 
• Place all the diluted samples in the thermomixer at 95℃ for 5 min. Cool the 
samples to RT. 
• Clarify the lysate by centrifugation at 20,000 g for 20 min, RT. 
• Transfer all the supernatant to 30 kDa ultrafiltration units. 
• Centrifuge at 14,000 g for 10 min at 25℃, so the majority of the supernatant flows 
through the membrane. No more than 40 μL should be left above the filter. 
• Re-spin samples with more liquid above the ultrafiltration membrane. 
• Add 200 μL of UA-solution to each ultrafiltration unit. Mix in the thermomixer: 
25℃, 2 min, 400 rpm. Then centrifuge at 14,000 g for 25 min at 25℃, continue 
until less than 10 μL of sample remains above the filter. 
• Add a further 200 μL of UA-solution to the ultrafiltration units. Mix in the 
thermomixer at 25℃, 2 min, 400 rpm and repeat the centrifugation. 
• Discard the flow-through from the collection tube. 
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• Add 100 μL 50 mM IAM in UA-solution to the concentrated sample, and incubate 
for 20 min at 25℃ and 300 rpm in the dark (covered in the thermoblock), and then 
centrifuge at 14,000 g for 15 min. 
• Add 150 μL of UA-solution to the ultrafiltration units. Mix at 25℃, 2 min, 400 rpm 
and centrifuge at 14,000 g for 15 min. Perform this step three times (if some still 
present on the filter, the last centrifugation should have a further 5-10 min). 
• Add 150 μL of Digestion Buffer (0.05 M AMBIC) into the filtration units. Mix at 25℃, 
2 min, 400 rpm and centrifuge at 14,000 g for 15 min. Perform this step three times 
(If some still present on the filter, the last centrifugation should have a further 5-
10 min). 
• Aspirate all liquid from the collection tubes. 
• Trypsin digestion: Add 100 μL working trypsin solution to each sample. Mix at 25℃, 
3 min, 400 rpm. Then place the tubes in a rack within a sealed container with a 
water layer (100 mL double dH2O) on the bottom. Incubate at 37℃ overnight. 
• Transfer the ultrafiltration units to new collection tubes. 
• Centrifuge the ultrafiltration units at 14,000 g until the solution entirely passed 
through the filter membrane (about 5 min). 
• Add 100 μL of 50 mM AMBIC (2 min, 400 rpm, 25℃ mixing) and centrifuge the 
ultrafiltration units at 14,000 g, until the solution entirely passed through the filter 
membrane (about 5 min). Repeat this step (centrifuge for 10 min) and combine all 
the eluates. 
Note: There should be a check here. Make sure all the liquid above the membrane has passed 
through the membrane. If not, add another 5 min centrifugation to all the tubes, until no obvious 
liquid is left. 
• Add 5 μL pure formic acid, then vortex the mixture. 
• Dry all the samples using a SpeedVac (40℃), for 1.5h. 
• Resuspend the pellet in 75 μL 50 mM AMBIC solution. 
• Use the detergent removal spin column as per the instructions to eliminate all the 
detergent in the peptide solutions. 
• Add 5 μL pure formic acid, then vortex the mixture. 
• SpeedVac and resuspend in 50 μL 0.1% formic acid/2% acetonitrile. 
• Keep them in the freezer prior to use. 
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• Centrifuge at 14,000 g, 15 min. 
• Then dilute 10 times for each sample using 0.1% trifluoroacetic acid respectively. 
• Spin briefly prior to uploading for LC-MS/MS.  
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Appendix 3.3 Stain-free Western blot protocol. 
➢ List of main reagents 
Component Company Cat No. 
Anti-CALR Abcam ab15607 
Anti-CSRP1 Abcam ab175319 
Anti-PRELP Abcam ab229719 
Goat Anti-Mouse IgG H&L (HRP) Abcam ab97040 
4x Laemmli Sample Loading Buffer Bio-Rad 1610747 
SDS-PAGE Running Buffer (10×) Bio-Rad 1610772 
Western Blot Transfer Buffer (10×) Bio-Rad 1610771 
Tween-20 Bio-Rad 1706531 
Clarity Western ECL Substrate Bio-Rad 1705060 
WesternC Marker Bio-Rad 1610385 
All Blue Marker Bio-Rad 1610373 
Any kD Mini-PROTEAN TGX Stain-Free 
Precast Gel 
Bio-Rad 4568126 
Immun-Blot Low Fluorescence PVDF/Filter 
Paper Sets 
Bio-Rad 1620261 
StrepTactin-HRP Conjugate Antibody (part 
of WesternC) 
Bio-Rad 1610385 
PBS Gibco SALB000 
Ethanol Lab Supply CHE2292.1 
Methanol Merck 1060182500 
DTT Roche 10708984001 
Anti-NPM1 (B23) Santa Cruz sc-53175 
HUV-EC-C Whole Cell Lysate Santa Cruz sc-364180 






➢ Experimental design 
Table 1. Sample loading order on 15-well gel 1 








































Table 2. Sample loading order on 15-well gel 2 


































5 12 6 12 
 
Table 3. Antibody incubation plan 
Gel No. Antibody (upper half) Antibody (lower half) 
1 Anti-CALR Anti-CSRP1 
2 Anti-PRELP Anti-NPM1 
 
1. Gel 1, cut the gel slightly below the 37 kDa (sixth marker from the top) of the ‘All Blue’ 
marker bands (Figure 1). 
 
 








2. Gel 2, cut the gel below the 50 kDa (fifth marker from the top) of the ‘All Blue’ marker 
bands, in the middle of 50 kDa and 37 kDa but closer to 50 kDa band (Figure 2). 
 
 
Figure 2. Cutting position in Gel 2 
 
➢ Reagent preparation 
1. 4× Loading buffer with 200 mM DTT, 500 μL 
• Add 15.425 mg DTT (MW = 154.25) into 500 μL 4× Loading buffer. Dispense into 
100 μL aliquots, and store them wrapped in tin foil in the freezer. Warm to room 
temperature (RT) before use. 
2. 1× Running buffer, 600 mL 
• Take 60 mL 1× running buffer and add dH2O to the final volume at 600 mL. 
3. 1× Transfer buffer with 20% ethanol, 1.3 L 
• Take 130 mL 10× transfer buffer and add dH2O to 1040 mL. Add 260 mL absolute 
ethanol to a final volume of 1.3 L and chill to 4℃ before use. 
4. Wash buffer (PBST), 500 mL 
• PBS with 0.1% (v/v) Tween-20. Add 0.5 mL Tween-20 into 500 mL PBS. 
5. Blocking buffer (5% skim milk in PBST) 
• Day1: Weigh 2.5 g skim milk powder and dissolve it in 50 mL PBST. 
• Day2: Weigh 5 g skim milk powder and dissolve it in 100 mL PBST. 
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6. Primary antibody (10 mL each antibody) 
















GEL1-U Anti-CALR Rabbit P 60 
Higher expression in GC 





GEL1-L Anti-CSRP1 Rabbit P 21 
Higher expression in 






GEL2-U Anti-PRELP Rabbit P Approx. 55 
Higher expression in 








Mouse M 40 
Higher expression in GC 





* Have chosen dilutions of 1:500 for all of them. This is because this dilution is within the dilution range 
recommended by the manufacturer and works in the pilot experiment. 
 
7. Secondary antibody (10 mL each) 
• Goat Anti-Mouse IgG H&L (HRP), 1:5000 (0.1 μg/mL). Add 2 μL into 10 mL blocking 
buffer. In addition, add 1 μL of StrepTactin-HRP conjugate antibody (for the Bio-
Rad WesternC marker). 
• Anti-Rabbit IgG (whole molecule)-Peroxidase antibody produced in goat (10.0 - 
20.0 mg/mL); dilution of 1:20,000 (0.5 - 1 μg/mL), i.e. add 1.5 μL into 30 mL 
blocking buffer. In addition, add 3 μL of StrepTactin-HRP conjugate antibody. 
8. ECL substrate (8 mL each time) 
• Mix substrate kit components in a 1:1 ratio, i.e. 4 mL of each component. 
 
➢ Procedure (Modified from Bio-Rad protocol) 
DAY ONE 
1. Protein Sample Preparation for Western Blot Analysis 
• Mix 10.5 μL of each tissue lysate with 3.5 μL of 4× Laemmli loading buffer. 
• A HUV-EC-C Whole Cell Lysate was used as a positive control. 12 μL (30 μg) was 
loaded. 
• Each sample including the positive control was boiled in loading buffer at 95℃ for 
5 min and centrifuged at 16,000 g for 1 min prior to loading. 
2. Electrophoresis with Stain-Free Gels 
• Warm to RT of an ‘Any kD Mini-PROTEAN TGX Stain-Free Precast Gel’, remove the 
comb, and remove the tape from the bottom of the cassette. 
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Note: Gel percentage selection is dependent on the size of the protein of interest. A 4-20% gradient 
gel separates the proteins of all sizes very well. It also facilitates better protein transfer of all sizes. 
• Place the cassette in a Mini-PROTEAN Tetra Cell. In the upper buffer chamber add 
60 mL 1× running buffer (25 mM Tris, 190 mM glycine, 0.1% SDS, pH 8.3). Rinse 
the wells with 1× running buffer. 
• Fill each half of the lower buffer tank with 400 mL 1× running buffer up to the 
marked line. 
• Load the protein samples, 5 μL of WesternC standard, and 6 μL of All blue standard. 
• Place the lid on the tank, aligning the color-coded banana plugs with 
corresponding jacks on the lid. 
• Set the voltage to 200 V and run the gel for around 30 min or until the dye front 
reaches the bottom of the gel. 
• After running, use the Bio-Rad gel opening lever to trim the gel to ensure that it 
fits the gel transfer cassette assemble with the PVDF membrane. Use water to 
wash away the debris. 
3. Visualise Protein Separation Using the Gel Doc XR+ Imaging System 
• After electrophoresis, turn off the power supply and disconnect the electrical leads. 
• Remove the gel cassette from the cell. Pull the two plates of the cassette apart to 
expose the gel. 
• Carefully lift the gel from the cassette and place on the sample stage of the Gel 
Doc XR+ Imaging System. 
• Capture the stain-free gel image (image A) using the following settings: 
▪ Application: Stain-Free Gel 
▪ Gel activation time: 2.5 min (Not the 45 sec option in the current software 
version) 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure 
• Remove the gel from the sample stage and keep it wet in 1× running buffer. 
4. Protein Transfer with the Mini Trans-Blot Electrophoretic Transfer Cell 
• Store the blue cooling unit in the freezer until ready to use. After use, rinse the 
outside with water and return the cooling unit to the freezer for storage. 
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• Prepare the 1× transfer buffer with 20% ethanol. (Using buffer chilled to 4℃ will 
improve heat dissipation). 
Note: Use only high quality, analytical reagent grade methanol/ethanol. Contaminated 
methanol/ethanol can result in increased transfer buffer conductivity, as well as poor transfer of 
macromolecules. Do not reuse transfer buffers or dilute transfer buffers below recommended 
levels. Reuse of transfer buffers is not advised, since these buffers have most likely lost their ability 
to maintain a stable solution pH. Dilution of transfer buffers below their recommended levels is 
also not advised, since this will decrease buffering capacity. 
• Use pre-cut Immun-Blot Low Fluorescence PVDF/Filter Paper Sets. Trim the PVDF 
membrane to ensure it fits into the block box and matches the SDS-PAGE gel. 
Always wear gloves when handling membranes to prevent contamination. Before 
use, soak the PVDF membrane in 100% methanol for 1 min. Drain the methanol 
then equilibrate the gel and soak the membrane, filter paper, and fibre pads in 1× 
transfer buffer with 20% ethanol for 15 min. 
Note: All electrophoresis gels should be pre-equilibrated in 1× transfer buffer prior to 
electrophoretic transfer. Pre-equilibration will facilitate the removal of contaminating 
electrophoresis buffer salts and neutralisation salts (salts resulting from the denaturation of 
nucleic acids prior to transfer). If the salts are not removed, they will increase the conductivity of 
the transfer buffer and the amount of heat generated during the transfer. Also, low percentage 
gels will shrink in methanol/ethanol buffers. Equilibration allows the gel to adjust to its final size 
prior to electrophoretic transfer. 
• Prepare the gel sandwich (after pre-equilibration in transfer buffer, all membranes 
should be assembled using a small amount of new transfer buffer. It is essential to 
avoid introducing air bubbles). 
▪ Place the cassette, with the grey side down, on a clean surface. 
▪ Place one prewetted fibre pad on the grey side of the cassette. 
▪ Place a sheet of filter paper on the fibre pad. 
▪ Place the equilibrated gel on the filter paper.* 
▪ Place the prewetted membrane on the gel.* 
▪ Complete the sandwich by placing a piece of filter paper on the membrane.* 
▪ Add the last fibre pad. 
* Removing any air bubbles which may have formed is very important for good 
results. Use a glass tube or roller to gently roll out air bubbles at each step. 
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• Close the cassette firmly, being careful not to move the gel and filter paper 
sandwich. Lock the cassette with the white latch. 
• Place the cassette in the module. Repeat for the other cassette. 
• Add the frozen blue cooling unit. Place in tank and fill to the “blotting” mark on 
the tank. 
• Add a standard stir bar to help maintain even buffer temperature and ion 
distribution in the tank. Set the speed as fast as possible (gear 6) to keep ion 
distribution even. 
• Put on the lid, plug the cables into the power supply, and run the blot. Set at 200 
mA for 45 min. 
• Upon completion of the run, disassemble the blotting sandwich and remove the 
membrane for development. Clean the cell, fibre pads, and cassettes with 
laboratory detergent and rinse well with deionised water. 
5. Verify Transfer Using the Gel Doc XR+ Imaging System 
• Put the post-transfer gel on the sample stage of the Gel Doc XR+ Imaging System. 
• Capture the stain-free image of the post-transfer gel (image B) with the following 
settings: 
▪ Application: Stain-Free Gel 
▪ Gel activation time: none 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure time: same as the exposure time points for the pre-transfer 
gel image (image A) 
Note: This stain-free image of the post-transfer gel is used to verify the transfer efficiency. After 
this, use Coomassie R250 to stain the gel for 10 min. Destain the gel twice, for 1 hour each, by using 
the destain buffer. Then use dH2O to wash overnight before imaging. This can be used to double 
check the transfer efficiency. This image is named as image B-2. 
• Image the blot (image C) with the following settings: 
▪ Application: Stain-Free Blot 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure and try some other longer 
exposure time points as well 
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Note: Keep the blot wet all the time in the transfer buffer; do not let it dry. This stain-free blot 
image is used to check the transfer quality. 
• Remove the blotting membrane from the sample stage and place it in a container 
with PBS with 0.1% (v/v) Tween 20 (PBST). 
6. Antibody Incubation - CALR and CSRP1 
• Cut the membrane with transferred proteins slightly below the 37 kDa (sixth 
marker from the top) of All Blue marker bands, as previously shown in Figure 1, 
while in PBST. Then do two times of PBST wash. 
• Block in 10 mL 5% skim milk/PBST separately at RT while rotating for 1 h. 
• Incubate in 10 mL anti-CALR (upper membrane) and anti-CSRP1 (lower membrane) 
primary antibody, at 4℃ overnight. 
 
DAY TWO 
• Rinse the blot thoroughly five times for 5 min each with PBST. 
• Incubate in 10 mL GantiR horseradish peroxidase (HRP)-conjugated secondary 
antibody solution for each half membrane, separately for 1 h at RT. 
• Rinse the blot thoroughly five times for 5 min each with PBST. 
7. Imaging and Analysis 
• After antibody incubation, place the two half membranes back together on the 
sample stage of the Gel Doc XR+ Imaging System and capture a stain-free image 
of the blot (image D) with the following settings: 
▪ Application: Stain-Free Blot 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure and try some other longer 
exposure time points as well 
Note: Keep the blot wet in PBST all the time; do not let it dry. This stain-free blot image is used for 
total protein loading control and normalisation (ensure none of the bands are saturated when 
imaging). 
• After imaging, keep the membrane in PBST while preparing the Clarity Western 
ECL Substrate mixture. 
• Mix the Clarity Substrate Kit components in a 1:1 ratio. Prepare 8 mL of solution 
for the whole membrane. 
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• Incubate the membrane in the substrate solution for 5 min. 
• Place the blotting membrane on the sample stage of the LiCOR Odyssey Imaging 
System and take photos of each half separately (image E) following the protocol, 
different exposure time points should be used (30s (minimum of the system), 60s, 
120s), each time take image under channel 700 nm for 30s as well. File (.zip) can 
be exported and analysed by the Image Studio lite. 
8. Antibody Incubation - PRELP and NPM1 
9. Repeat Steps 1 and 2 for gel 2 
Note: Make the running time slightly longer than gel 1, by increasing to 35 min. This is because the 
distance between PRELP and NPM1 is relatively small. A longer running time will make the distance 
larger and the membrane easier to cut. 
10. Visualise Separation Using the Gel Doc XR+ Imaging System 
• After electrophoresis, turn off the power supply and disconnect the electrical leads. 
• Carefully lift the gel from the cassette and place it on the sample stage of the Gel 
Doc XR+ Imaging System. 
• Capture the stain-free gel image (image F) using the following settings: 
▪ Application: Stain-Free Gel 
▪ Gel activation time: 2.5 min (Not the 45 sec option in the current software 
version) 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure 
• Remove the gel from the sample stage keeping it wet in 1× running buffer. 
11. Repeat Step 4 for gel transfer 
12. Verify Transfer Using the Gel Doc XR+ Imaging System 
• Put the post-transfer gel on the sample stage of the Gel Doc XR+ Imaging System. 
• Capture the stain-free image of the post-transfer gel (image G) with the following 
settings: 
▪ Application: Stain-Free Gel 
▪ Gel activation time: none 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure time: same as the exposure time points for the pre-transfer 
gel image (image F) 
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Note: Coomassie R250 stain the gel for 10 min. Destain the gel 2× 1 hour each using destain buffer. 
Use dH2O to wash overnight before imaging. This image can be used to double check the transfer 
efficiency. This image is named image G-2. 
• Image the blot (image H) with the following settings: 
▪ Application: Stain-Free Blot 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure and try some other longer 
exposure time points as well 
Note: Keep the blot wet in the transfer buffer; do not let it dry. This stain-free blot image is used 
to check the transfer quality. 
• Remove the blotting membrane from the sample stage and place it in a container 
with PBS containing 0.1% (v/v) Tween 20 (PBST). 
13. Antibody Incubation 
• Cut the gel below the 50 kDa (fifth marker from the top) of All Blue marker bands. 
See Figure 2. 
• Block each membrane in 10 mL 5% skim milk/PBST at RT, rotating for 1 h. 
• Incubate in 10 mL anti-PRELP (upper membrane) and anti-NPM1 (lower 
membrane), separately at 4℃ overnight (See Table 4). 
 
DAY THREE 
• Rinse the blot thoroughly five times for 5 min each with PBST. 
• Incubate in 10 mL GantiR and GantiM horseradish peroxidase (HRP)-conjugated 
secondary antibody solution (keep membranes separate), for 1 h at RT. 
• Rinse the blot thoroughly five times for 5 min each with PBST. 
14. Imaging and Analysis 
• After antibody incubation, place the two half blots together back on the sample 
stage of the Gel Doc XR+ Imaging System and capture a stain-free image of the 
blot (image I) with the following settings: 
▪ Application: Stain-Free Blot 
▪ Imaging size (W × L): mini; 9.5 × 7.1 cm 
▪ Image exposure: optimal automatic exposure and try some other longer 
exposure time points as well 
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Note: Keep the blot wet in the PBST all the time; do not let it dry. This stain-free blot image is used 
for total protein loading control and normalisation (ensure none of the bands are saturated when 
imaging). 
• After imaging, keep the membrane in PBST while preparing the Clarity Western 
ECL Substrate mixture. 
• Mix the Clarity Substrate Kit components in a 1:1 ratio. Prepare 8 mL of solution 
for the whole membrane. 
• Incubate the membrane in the substrate solution for 5 min. 
• Place the membrane on the sample stage of the LiCOR Odyssey Imaging System 
and take photos of each half separately (image J) following the protocol. Different 
exposure time points should be used (30s (minimum of the system), 60s, 120s), 
each time also take an image under channel 700 nm for 30s as well. File (.zip) can 
be exported and analysed by the Image Studio lite. 
15. Validate Total Protein Normalisation 
• Export the chemiluminescent blot image of the protein of interest (select an 
exposure time showing all the bands) and the stain-free blot image (one with a 
lower exposure time, i.e. for intense bands) captured in a 16-bit tiff format. 
• Use Image Studio Lite. Directly import the image for normalisation into Image 
Studio Lite. Convert to grey scale black on white in the chemi channel. 
• Pick all lanes by “Add rectangle” and “Draw rectangle”; rotate and change the size 
of rectangle if required to make sure all intensities are included but no extra areas. 
• Subtract background using “Average”-“Top/Bottom”-“Border Width-3 or others”. 
This is because in the 15 well gels the gaps between lanes are very narrow. If using 
only “Right/Left”, it will introduce errors and variances in background subtraction. 
• Calculate the normalisation factors using the following formula. 
 
Note: Select the first nonstandard lane as the reference lane against which all other lanes are 
compared. 
• Detect the bands of interest in the chemiluminescent images. 
• Adjust the target protein band intensity values based on the normalisation factors, 
i.e. “normalised volume = normalisation factor × volume (Intensity)”. This will 
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allow for accurate comparison of target proteins among the samples (the band 
volume in Image Studio Lite is called signal after background adjustment. This 
means the values of signal will be used for calculation). 
Note: The normalisation factors come from the stain-free gels (image D) and the volume (Intensity) 
from the protein of interest (image E). 
• Use PRISM and Photoshop to undertake the statistical analysis and graphing for 
each protein of interest. 
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Appendix 3.4 Analytical data for the 12 samples. SDS-PAGE gel and Qubit 
protein quantification. 












1 FP1 9.43E+07 2.7E+08 1.75E+08 4.900 3.850 0.603 
2 FP2 7.07E+07 2.46E+08 1.75E+08 3.630 2.580 0.899 
3 FP3 7.92E+07 2.55E+08 1.75E+08 3.645 2.595 0.894 
4 MAP1 8.41E+07 2.59E+08 1.75E+08 3.595 2.345 0.989 
5 MAP2 8.44E+07 2.6E+08 1.75E+08 3.825 2.575 0.901 
6 MAP3 7.81E+07 2.54E+08 1.75E+08 3.570 2.320 1.000 
7 DPP1 7.97E+07 2.55E+08 1.75E+08 3.560 2.410 0.963 
8 DPP2 1.03E+08 2.79E+08 1.75E+08 4.835 3.685 0.630 
9 DPP3 7.57E+07 2.51E+08 1.75E+08 3.540 2.390 0.971 
10 GC1 9.15E+07 2.67E+08 1.75E+08 4.900 3.850 0.603 
11 GC2 1.01E+08 2.76E+08 1.75E+08 5.280 4.230 0.548 
12 GC3 9.21E+07 2.68E+08 1.75E+08 5.000 3.950 0.587 
* MAP3 was chosen as the reference sample in Qubit protein quantification for normalisation across 
samples.  
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Appendix 3.7 Supplemental data for stain-free Western blot. 
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Appendix 4.1 Optimised condition for antibodies.  
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Appendix 4.2 Antler powder protein extraction and PTN detection. 
➢ List of main reagents 
Component Company Cat No. 
cOmplete, Mini, EDTA-free Protease 
Inhibitor Cocktail 
Roche 11836170001 
PBS Life Technologies SALB000 
BSA Standard Sigma-Aldrich P0834-1mL 
DC Protein Assay II Bio-Rad 5000112 
Bovine PTN ELISA Kit Mybiosource MBS455121 
 
➢ Experimental design 
Table 1. Colour coding 
Colour Meaning 
Blue Standard curves, blank 
Orange Technical replicate 1 
Yellow Technical replicate 2 
Green Technical replicate 3 
Black Sample control  
White Spare wells 
 
Table 2. ELISA experimental design. “1” and “2” mean buffer extraction and sonication 
respectively. Based on the antler powder processing methods, three velvet samples were 
processed in the method of traditional (a), freeze dried (b), and cryogenic/freeze dried (c). 
 1 2 3 4 5 6 7 8 
A 2000 pg/mL 2000 pg/mL 
Sample a1 
(1 in 5) 
Sample a1 
(1 in 5) 
Sample c1 
(1 in 10) 
Sample c1 
(1 in 10) 
Sample b2 
(1 in 10) 
 
B 1000 pg/mL 1000 pg/mL 
Sample b1 
(1 in 10) 
Sample b1 
(1 in 10) 
Sample a2 
(1 in 5) 
Sample a2 
(1 in 5) 
Sample b2 
(1 in 10) 
 
C 500 pg/mL 500 pg/mL 
Sample c1 
(1 in 10) 
Sample c1 
(1 in 10) 
Sample b2 
(1 in 10) 
Sample b2 
(1 in 10) 
Sample c2 
(1 in 10) 
 
D 250 pg/mL 250 pg/mL 
Sample a2 
(1 in 5) 
Sample a2 
(1 in 5) 
Sample c2 
(1 in 10) 
Sample c2 
(1 in 10) 
Sample c2 
(1 in 10) 
 
E 125 pg/mL 125 pg/mL 
Sample b2 
(1 in 10) 
Sample b2 
(1 in 10) 
Sample a1 
(1 in 5) 
Sample a1 
(1 in 5) 
PBS   
F 62.5 pg/mL 62.5 pg/mL 
Sample c2 
(1 in 10) 
Sample c2 
(1 in 10) 
Sample b1 
(1 in 10) 
Sample b1 
(1 in 10) 
PBS   
G 31.2 pg/mL 31.2 pg/mL 
Sample a1 
(1 in 5) 
Sample a1 
(1 in 5) 
Sample c1 
(1 in 10) 
Sample c1 
(1 in 10) 
  
H 0 pg/mL* 0 pg/mL* 
Sample b1 
(1 in 10) 
Sample b1 
(1 in 10) 
Sample a2 
(1 in 5) 
Sample a2 
(1 in 5) 
  
* Set as the blanks in the layout setting during plate reading. 
 
➢ Reagent preparation 
1. 1× protease inhibitor solution, 20 mL 
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• Dissolve two tablets of cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail into 
20 mL cold PBS. 
2. All reagents for ELISA, bring all kit B components and samples to room temperature 
(RT) before use. 
• Sample – Dilute the samples by 0.01 M PBS (pH=7.0-7.2) as suggested in Table 3. 
Table 3. Sample dilutions 
 Dilutions 
Taken from original 
supernatant (μL) 
PBS (μL) 
Sample a1 1 in 5 50 200 
Sample b1 1 in 10 25 225 
Sample c1 1 in 10 25 225 
Sample a2 1 in 5 50 200 
Sample b2 1 in 10 25 225 
Sample c2 1 in 10 25 225 
 
• Standard - Reconstitute the new vial of Standard with 1.0 mL of Diluent Buffer, keep 
for 10 minutes at RT, shake gently. The concentration of the standard in the stock 
solution is 2000 pg/mL. Prepare 7 tubes containing 0.5 mL Diluent Buffer and use 
the diluted standard to produce a double dilution series with 7 points including 
2000 pg/mL, 1000 pg/mL, 500 pg/mL, 250 pg/mL, 125 pg/mL, 62.5 pg/mL, 31.2 
pg/mL, and the last tube with Diluent Buffer is the blank at 0 pg/mL. 
• Detection Reagent A and Detection Reagent B - Briefly spin or centrifuge the stock 
Detection A and Detection B solutions before use. Dilute to the working 
concentrations with Diluent Buffer (1:100). 
• Wash Solution - Dilute 5 mL of Wash Solution concentrate (30×) with 145 mL of 
distilled water to prepare 150 mL of Wash Solution (1×). 
• TMB substrate - Aspirate the required amount of the solution under sterile 
conditions. Do not return the residual solution back into the vial. 
 
➢ Procedure 
1. Protein extraction 
• Weigh six 0.1 g antler powder from each sample and dissolve in 1 mL PBS 




Table 4. Colour coding 
Colour Meaning 
Orange Technical replicate 1 
Yellow Technical replicate 2 
Green Technical replicate 3 
 
Table 5. Antler powder weight 
Sample Method 1 (g) Method 2 (g) 
a 0.102 0.102 
a 0.103 0.100 
a 0.101 0.101 
b 0.100 0.102 
b 0.103 0.103 
b 0.102 0.102 
c 0.102 0.103 
c 0.103 0.102 
c 0.103 0.102 
 
• Two protein extraction methods. 
▪ Place each sample in a 2 mL EP tube inside an ice box and rotate for 2 hours 
(100 rpm/min). 
▪ Sonicate each sample in 15 mL falcon tube on ice for 3 × 15 sec (pulse length) 
with an amplitude of 50% and with 3 min lapse between each pulse using 
Branson Sonifier 450. 
• Spin the solutions from method 1 at 15,000 g for 30 min at 4℃ and spin the 
solutions from method 2 at 5,250 g (maximum for 15 mL falcon tube) for 1 hour at 
4℃. 
• Transfer the supernatant into new 1.5 mL EP tube. 
• Spin all solutions again at 15,000 g for 10 min at 4℃. 
• Aliquot the solution and store in - 80℃ freezer. 
2. DC protein assay 










Volume of a 2 mg/ml 
BSA standard (μL) 
PBS with 1× proteinase 
inhibitors (μL) 
1 0 (blank) 0 50 
2 0.2 5 45 
3 0.4 10 40 
4 0.6 15 35 
5 0.8 20 30 
6 1.0 25 25 
7 1.5 37.5 12.5 
 
• Pipet 10 μL of standards and samples (1 in 5) into a clean, dry EP tube. 
• Add 50 μL of reagent A into each tube. 
• Add 400 μL of reagent B into each tube, and mix well. 
• After 15 min, place 200 μL of each sample, in duplicate, into the microwell plate. 
• Read absorbance at 750 nm. 
3. PTN ELISA detection (Modified based on the manufacturer’s protocol) 
• Prepare 7 tubes for the standards, 2 wells for blank. Add 100 μL each of dilutions 
of standard, blank, and samples into the appropriate wells as planned (Table 2). 
Cover with the plate sealer. Incubate for 2 hours at 37℃. 
• Remove the liquid from each well; do not wash. 
• Add 100 μL of Detection Reagent A working solution to each well. Incubate for 1 
hour at 37℃ after covering it with the plate sealer. 
• Aspirate the solution and wash with 300 μL of 1× Wash Solution to each well, and 
let it sit for 1.5 minutes. Remove the remaining liquid from all wells completely by 
tapping the plate onto absorbent paper. Wash thoroughly 3 times. After the last 
wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the 
plate and blot it against absorbent paper. 
• Add 100 μL of Detection Reagent B working solution to each well. Incubate for 1 
hour at 37℃ after covering it with the plate sealer. 
• Repeat the aspiration/wash process a total of 5 times. 
• Add 90 μL of Substrate Solution to each well. Cover with a new plate sealer. 
Incubate for 15 minutes at 37℃ (Do not exceed 30 minutes). Protect from light. 
The liquid will turn blue with the addition of the Substrate Solution. 
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• Add 50 μL of Stop Solution to each well. The liquid will turn yellow with the addition 
of the Stop Solution. Mix the liquid by tapping the side of the plate. If the colour 
change does not appear uniform, gently tap the plate to ensure thorough mixing. 
• Remove any drops of water and fingerprints on the bottom of the plate and confirm 
there are no bubbles on the surface of the liquid. Run on a Synergy 2 Multi-mode 
Microplate Reader and take measurements at 450 nm immediately. 
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Appendix 4.3 Relevant methodologies of tissue culture. 
➢ List of main reagents 
Component Company Cat No. 
DMEM, High Glucose, GlutaMAX 
Supplement, Pyruvate Life Technologies 10569010 
Fetal Bovine Serum Life Technologies 10091148 
Antibiotic-Antimycotic (100×) Life Technologies 15240062 
Gentamicin Life Technologies 15710064 
Trypsin-EDTA (0.25%) Life Technologies 25200056 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich D4540 
 
➢ Reagent preparation 
1. Cell culture media, 500 mL 
Medium Serum Supplement 
DMEM (442.5 mL) 10% FBS (50 mL) 
Antibiotic-antimycotic (5 mL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 
50 µg/mL Gentamycin (2.5 mL) 
2. Freezing solution, amount as needed. 
• Prepare freezing solution by mixing 90% FBS with 10% DMSO. 
 
➢ Procedure 
1. Primary tissue culture (antler growth centre as an example) 
• Clean the antler tissue with water and tissue papers. 
• Use the electric clippers to remove velvet hair. 
• Use 70% alcohol cotton balls, povidone-iodine Prep Pads then 70% alcohol cotton 
balls to sterilise the antler tip. 
• Use microtome blades wiped by 70% alcohol to cut the antler growth centre. 
• In the hood, use a sterilised microtome blade to cut a 5 mm slice to uncover a clean 
surface of the growth centre. 
• Cut three serial slices (5 mm in thickness). Remove only the subdermal area 
containing reserve mesenchyme and part precartilage layers (Length = 1 cm; Width 
= 5 mm). 
• Each of the samples was washed in separate autoclaved PBS (×3) before culturing. 
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• Place in a petri dish with 0.5 mL media and cut into fine pieces. 
• Each sample was divided into 4 wells (5 mL media per well) of a 6-well plate. 
• 6-well plate incubated at 37℃ with 5% CO2. 
2. Primary cell passaging 
• Choose and passage the two best wells within each 6-well plate. 
• After removing the media, use filter tips to pick the tissue pieces out of the well. 
• Add 6 mL autoclaved PBS into the wells as a wash set. 
• Add 600 μL of trypsin and incubate for 2 - 3 min, and check cells are rounded and 
beginning to detach. Tap flask to detach cells. 
• Add 2.5 mL media to each of the wells to inactivate the trypsin and transfer the 
media from the two selected wells into 50 mL falcon tubes. 
• Spin the tubes at 150 g for 5 min, remove the supernatant and resuspend the cell 
pellets in 0.5 mL media. 
• Transfer all the cell suspension solution to a T-25 flask with 5.5 mL media. 
• Incubate at 37℃ with 5% CO2. 
3. Cell passaging (from T25 to T25 flask) 
• Decant the cell culture media. 
• Wash with warm PBS. 
• Add 600 μL trypsin. 
• Leave at room temperature for 2 - 3 min or until cells become round and floating 
in the media. Tap the flask firmly. 
• Add 5.5 mL cell culture media into the T25 flask and aliquot cell suspension solution 
into new T25 flasks. 
• Incubate at 37℃ with 5% CO2. 
4. Cell freezing 
• Grow cells to nearly confluent and ‘happy’. 
• Decant the media before warm PBS wash. 
• Trypsinise around 3 min and inactivate with media as per usual. 
• Transfer cell suspension solution from plates into 50 mL falcon tubes. Spin at 150 g 
for 5 min. 
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• Remove supernatant using pipette to transfer the media out and leave around 500 
μL. 
• Flick pellet using pipette to disperse the cells before adding freezing solution. 
• Add freezing solution and mix gently, i.e. 0.5 mL for every T-25 flask equivalent cells. 
• Aliquot into labelled cryo tubes (0.5 mL for each tube). 
• Freeze gently by placing cryotubes in green polystyrene holder (12 tubes together, 
if not full, use the balance tubes to make it full) and into -80℃ freezer overnight. 
Then transfer into liquid nitrogen for long time preservation. 
5. Cell growing from frozen 
• Take the cryotubes from Dewar. 
• Immediately place into a 37℃-water bath while loosening cap slightly to ensure the 
tubes do not explode. 
• After around 30 sec, when completely thawed, transfer them into the hood. 
• Withdraw 0.5 mL warm media and pipette into the cryotube. 
• Pipette up and down gently and then transfer into T25 flasks with 9 mL of media. 
• Incubate at 37℃ with 5% CO2. 
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Appendix 4.4 Quantitation of osteogenesis. 
➢ List of main reagents 
Component Company Cat No. 
L-Ascorbic Acid 2-phosphate Sigma-Aldrich 49752 
Dexamethasone Sigma-Aldrich D2915 
β-glycerophosphate Sigma-Aldrich G9422 
Trypan Blue Solution (0.4%) Life Technologies 15250061 
Osteogenesis Quantitation Kit Merck ECM815 
 
➢ Experimental design 
Table 1. Colour coding  
Colour Meaning 
Orange The 1st time point (T1 = 7 days) 
Yellow The 2nd time point (T2 = 14 days) 
Green The 3rd time point (T3 = 21 days) 
White Spare wells 
 
Table 2. Experimental design for mineralisation quantitation within the 24-well plates. “-
1” to “-3” are biological replicates of each sampling region. Growth centre cells, GCCs; 
Dormant pedicle periosteum cells, DPPCs. 
 
 Normal media Osteogenic media 
 1 2 3 4 5 6 
A GCCs-1   GCCs-1   
B GCCs-2   GCCs-2   
C GCCs-3   GCCs-3   
D       
 1 2 3 4 5 6 
A GCCs-1   GCCs-1   
B GCCs-2   GCCs-2   
C GCCs-3   GCCs-3   
D       
 1 2 3 4 5 6 
A GCCs-1   GCCs-1   
B GCCs-2   GCCs-2   
C GCCs-3   GCCs-3   
D       
 1 2 3 4 5 6 
A DPPCs-1   DPPCs-1   
B DPPCs-2   DPPCs-2   
C DPPCs-3   DPPCs-3   
D       
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 1 2 3 4 5 6 
A DPPCs-1   DPPCs-1   
B DPPCs-2   DPPCs-2   
C DPPCs-3   DPPCs-3   
D       
 1 2 3 4 5 6 
A DPPCs-1   DPPCs-1   
B DPPCs-2   DPPCs-2   
C DPPCs-3   DPPCs-3   
D       
 
➢ Reagent preparation 
1. Cell culture media, 500 mL each 






Antibiotic-antimycotic (5 mL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 






Antibiotic-antimycotic (5 mL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 
50 µg/mL Gentamycin (2.5 mL) 
100 µM L-Ascorbic acid 2-phosphate (500 µL) 
10 nM Dexamethasone (50 µL) 
5 mM β-glycerophosphate (β-GP) (2.5 mL) 
Note: Make up new osteogenic media only for use during the following week. 
 
2. L-Ascorbic acid 2-phosphate working solution, final conc. at 100 µM 
Step 1 
(Stock at 1 M) 
Weigh 1.61 g of L-Ascorbic acid and add 5 mL of sterile molecule water; 
Filter sterilise (0.22 µm) in the hood. 
Step 2 
(Working stock at 100 mM) 
100 µL of 1 M Ascorbic acid + 900 µL of sterile water. 
Step 3 
(Working solution at 100 µM) 
Add 500 µL of 100 mM Ascorbic acid in 500 mL media. 
 
3. Dexamethasone working solution, final conc. at 10 nM 
Step 1 
(Stock at 10 mM) 
39.25 mg Dexamethasone in 10 mL sterile water; 
Filter sterilise the stock (0.22 µm) in the hood. 
Step 2 
(Working stock at 100 µM) 
50 µL of stock (10 mM) + 4950 µL of sterile water. 
Step 3 
(Working solution at 10 nM) 




4. β-glycerophosphate working solution, final conc. at 5 mM 
Step 1 
(Stock at 1 M) 
Make a stock solution at 1 M by adding 2.1604 g of β-glycerophosphate in 
10 mL of distilled water; 
Filter sterilise the stock solution (0.22 µm) in the hood. 
Step 2 
(Working solution at 5 mM) 
Add 2.5 mL in 500 mL of DMEM. 
 
➢ Procedure 
1. Cell counting and culturing 
• Recovery cells from Dewar and culture them in T-75 flasks as required in Table 2; 
all methodologies can be found in appendix 4.3. 
• Clean haemocytometer using Milli-Q water and 70% ethanol. Breathe onto the 
haemocytometer and the coverslip deeply to make them damp. 
• Moisten the shoulders of the haemocytometer and affix the coverslip using gentle 
pressure and small circular motions. This step should be done in advance to leave 
enough time for drying the coverslip. 
• Mix the cell suspension to be counted well using pipette. 
• Take out about 15 µL of cell suspension and place it in an Eppendorf tube. Add 15 
µL trypan blue solution (0.4%) and mix gently. 
• Use a pipette to take out cell suspension containing trypan blue solution. Carefully 
fill the haemocytometer by gently resting the end of the pipette tip at the edge of 
the chambers. Re-load the pipette and fill the second chamber. 
• Count the cells by focusing on the grid lines of the haemocytometer using the 10× 
objective of the microscope. Focus on nine sets of 16 corner square as indicated by 
the circle and flow direction in the diagram shown in Figure 1. 
 
 
Figure 1. Cell counting method on the haemocytometer 
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• Count the number of cells in the area of the nine sets of 16 squares using a hand 
tally counter. In each 16 squares, count the cells on the right and bottom lines 
instead of the left and top lines, and do this to all the others. 
• Move the haemocytometer to another set of 16 corner squares and repeat the 
counts. 
• The haemocytometer is designed so that the number of cells in one set of 16 corner 
squares is equivalent to the number of cells × 104/mL. 
Therefore, to obtain the cell count: 
▪ Add the counts of upper and lower chamber together and divide them by 18 
or the number counted. 
▪ Multiple by 2 to adjust for the 1:2 dilution in trypan blue to get “x”. 
• The total cell count is equivalent to “x cells/mL × 104”. 
• Calculate required cells based on the cell density and seed them into 24-well plates. 




Figure 2. Cell culturing method for mineralisation quantitation 
 
2. Alizarin Red S staining (Modified from Merck Millipore protocol) 
• Carefully aspirate the media from each well. Being careful not to aspirate the cells. 
• Wash cells once with 1 mL PBS. 
• Fix cells in 1 mL ice-cold 70% ethanol for 1 hour. 
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• Carefully remove the fixative and rinse cells three times (5 minutes each) with 1 mL 
distilled water. Use care to wash gently as possible, to avoid disrupting the 
monolayer. 
• Remove water and add 0.6 mL/well Alizarin Red S Stain Solution. 
• Incubate at room temperature for 30 minutes while rotating. 
• Remove excess dye and wash four times with 1 mL deionised H2O. 
• Carefully aspirate all the water from each well. The plate is now ready for visual 
inspection and image acquisition. Differentiated cells containing mineral deposits 
will be stained bright red by the Alizarin Red S Stain Solution. 
• Add 400 μL 10% acetic acid to each well of the 24-well plate and incubate for 30 
minutes with shaking. 
• The monolayer will now be loosely attached. With the aid of a 1 mL tip, gently 
scrape the cells from the plate and transfer the cells and acetic acid to a 1.5 mL EP 
tube. 
• Vortex vigorously for 30 seconds. 
• Heat to 85℃ for 10 minutes. 
Note: To avoid evaporation, microcentrifuge tubes may be sealed with parafilm. 
• Transfer tubes to ice for 5 minutes. Take care not to open the tubes until fully 
cooled. 
• Centrifuge the slurry at 20,000 g for 15 minutes. 
• While centrifuging, make up Alizarin Red S standards. Begin by diluting the 10× ARS 
Dilution buffer 1:10 in distilled H2O to obtain a 1× working ARS Dilution buffer. Next, 
dilute the 40 mM Alizarin Red S solution 1:20 in 1× ARS dilution buffer (e.g. 50 μL 
Alizarin Red S + 950 μL 1× ARS dilution buffer). This gives a 2 mM working stock. 
Standards can be constructed in a ‘high range’ or ‘low range’ set. Construct the 
‘high range’ set by diluting the 2 mM working stock in 2-fold serial dilutions in 1.5 
mL EP tubes. To generate a ‘low range’ set, begin by first diluting the 2 mM working 
stock 1:66 (15 μL 2 mM Alizarin Red solution + 985 μL 1× ARS dilution buffer) to 
achieve a 30 μM working stock. Construct the ‘low range’ set by further diluting 
this 30 μM working stock in 2-fold serial dilutions in 1.5 mL EP tubes. The blank will 
consist of just the 1× ARS dilution buffer. Details are shown in Tables 3 and 4. 
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Table 3. High range set of standards 
No. Conc. (μM) ARS solution (μL) 1× Dilution buffer (μL) 
1 2000 50 from original ARS solution 950 
2 1000 500 from No. 1 500 
3 500 500 from No. 2 500 
4 250 500 from No. 3 500 
5 125 500 from No. 4 500 
6 62.5 500 from No. 5 500 
7 31.3 500 from No. 6 500 
8 0 0 500 
 
Table 4. Low range set of standards 
No. Conc. (μM) ARS solution (μL) 1× Dilution buffer (μL) 
0 2000 10 from original ARS solution 190 
1 30 15 from No. 0 985 
2 15 500 from No. 1 500 
3 7.5 500 from No. 2 500 
4 3.75 500 from No. 3 500 
5 1.88 500 from No. 4 500 
6 0.94 500 from No. 5 500 
7 0.47 500 from No. 6 500 
8 0 0 500 
 
• When centrifugation is complete, remove 400 μL of the supernatant and transfer 
to a new 1.5 mL EP tube. 
• Neutralise the pH with 30 μL 10% Ammonium hydroxide. Take a small aliquot and 
test pH to ensure it falls within the range of 4.1 - 4.5. 
• Add standard/sample (150 μL) to an opaque-walled, transparent bottom 96-well 
plate. 
• Read at OD405 using a Synergy 2 Multi-mode Microplate Reader. 
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Appendix 4.5 Alkaline phosphatase assay. 
➢ List of main reagents 
Component Company Cat No. 
Alkaline Phosphatase Assay Kit (Fluorometric) Abcam Ab83371 
BMP-2 PEPROTECH 120-02-10UG 
Bovine Serum Albumin Sigma-Aldrich A7906-50g 
 
➢ Experimental design 
Table 1. Colour coding of cell culturing for ALP assay 
Name Colour Meaning 
SC Red Sample control without PTN and BMP-2 
C1 Green 100 ng/mL BMP-2 without PTN 
C2 Blue 100 ng/mL BMP-2 with 1 pg/mL PTN 
C3 Orange 100 ng/mL BMP-2 with 100 pg/mL PTN 
C4 Purple 100 ng/mL BMP-2 with 10 ng/mL PTN 
C5 Dark grey 100 ng/mL BMP-2 with 100 ng/mL PTN 
 White Spare wells 
 
 Table 2. GCC-1 for ALP assay. “-1-X” to “-3-X” are three biological replicates of 
each sample region; “-X-1” to ”-X-2” are two technical repeats under each 
biological replicate. Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 
A GCC-1-1 GCC-1-2    GCC-1   
B    GCC-1-1 GCC-1-2 GCC-2   
C GCC-1-1 GCC-1-2       
D    GCC-1-1 GCC-1-2    
E GCC-1-1 GCC-1-2       
F    Sample control    
 
 Table 3. GCC-2 for ALP assay. “-1-X” to “-3-X” are three biological replicates of 
each sample region; “-X-1” to ”-X-2” are two technical repeats under each 
biological replicate. Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 
A GCC-2-1 GCC-2-2    GCC-1   
B    GCC-2-1 GCC-2-2 GCC-2   
C GCC-2-1 GCC-2-2       
D    GCC-2-1 GCC-2-2    
E GCC-2-1 GCC-2-2       
F    Sample control    
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 Table 4. GCC-3 for ALP assay. “-1-X” to “-3-X” are three biological replicates of 
each sample region; “-X-1” to ”-X-2” are two technical repeats under each 
biological replicate. Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 
A GCC-3-1 GCC-3-2    GCC-1   
B    GCC-3-1 GCC-3-2 GCC-2   
C GCC-3-1 GCC-3-2       
D    GCC-3-1 GCC-3-2    
E GCC-3-1 GCC-3-2       
F    Sample control    
 
Table 5. Dilutions of GCC for ALP assay 








2x 60 60 120 
8x 15 105 120 
 
Table 6. Colour coding for ALP assay 
Colour Meaning 
Red Sample control without PTN and BMP-2 
Green 100 ng/mL BMP-2 without PTN 
Blue 100 ng/mL BMP-2 with 1 pg/mL PTN 
Orange 100 ng/mL BMP-2 with 100 pg/mL PTN 
Purple 100 ng/mL BMP-2 with 10 ng/mL PTN 
Dark grey 100 ng/mL BMP-2 with 100 ng/mL PTN 
White Spare wells 
 Dark red Background wells - 110 μL ALP Assay Buffer 
Yellow Standards for ALP assay 
 
 Table 7. GCC plate for ALP assay. “-1” to “-3” are three biological replicates of each sample region. 
Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S1 S1 
B GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S2 S2 
C GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S3 S3 
D GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S4 S4 
E GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S5 S5 
F GCC-1 8× GCC-2 8× GCC-3 8×  GCC-1 2× GCC-2 2× GCC-3 2×    S6 S6 
G             






➢ Reagent preparation 
1. Normal media, 500 mL 






Antibiotic-antimycotic (5 mL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 
50 µg/mL Gentamycin (2.5 mL) 
2. Osteogenic media, make fresh as required 
• Weigh 0.1 g BSA and dissolve it into 1 mL sterile PBS to make a 10% BSA/PBS in the 
hood. 
• Add 15 μL 10% BSA/PBS into 1485 μL sterile PBS to make 0.1% BSA/PBS. Filter the 
0.1% BSA/PBS with 0.22 µm filter in the hood. 
• Take one vial of 10 μg BMP-2. Centrifuge vial prior to opening. Reconstitute in 1000 
μL 0.1% BSA/PBS to make a 10 µg/mL BMP-2 working solution. Do not vortex. Put 
on ice for 10 minutes to dissolve. 
• At each time point, make 10.6 mL osteogenic media by mixing 106 µL BMP-2 with 
10.494 mL normal media. This gives a final BMP-2 concentration at 100 ng/mL. 
3. Osteogenic media with different concentrations of PTN (Table 8 and 9) 
Table 8. Serial dilutions of PTN solutions 
No. Conc. (ng/mL) PTN solution (μL) Sterile PBS (μL) 
1 10,000 
3.2 from stock PTN (100 µg/mL) 
solution 
28.8 
2 1,000 5 from No. 1 45 
3 100 5 from No. 2 45 
4 10 5 from No. 3 45 
5 1 5 from No. 4 45 
6 0.1 5 from No. 5 45 
 


















0 0 0 21 21 0 2.058 
C1 100 0 0 21 0 2.079 0 
C2 100 1 
21 of serial 
dilution No. 6 
0 0 2.079 0 
C3 100 100 
21 of serial 
dilution No. 4 
0 0 2.079 0 
C4 100 10,000 
21 of serial 
dilution No. 2 
0 0 2.079 0 
C5 100 100,000 
21 of serial 
dilution No. 1 
0 0 2.079 0 
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Note: This is for one time point. Will do three times for each of the three time points, and make 
the fresh media each time just before use. 
 
4. MUP Substrate (MUP Standard), 1.2 mL 
• Dissolve MUP substrate in 1.2 mL Assay Buffer to generate 5 mM MUP substrate 
solution (also used as MUP standard). Aliquot substrate into 120 μL × 10 vials. Store 
at -20℃. Use within 2 months. 
5. ALP Enzyme Solution, 1 mL 
• Reconstitute ALP Enzyme with 1 mL Assay Buffer. The reconstituted enzyme is 
stable for up to 2 months at 4℃. Take 130 μL enzyme out each time so as to have 
enough to perform the desired number of assays. Keep on ice whilst in use. 
 
➢ Procedure 
1. Cell counting and culturing 
• Recovery cells from Dewar. 
• Culture them in T25 flasks and passage once into T75 flasks in normal media. Count 
cells as instructed in Appendix 4.4 before seeding. 
• Cell density calculation for 48 well plates: 
The seeding density is 3 × 104 cells/cm2. Require 12 wells of 48 well plates, each 
well has 1 cm2 surface area. Each well = 3 × 104 cells. Take the cell density after 
culturing in the flasks as ‘ρ’ and the volume of cell suspension from the flasks with 
the same number of cells as all the wells needed as ‘v’, in the equations below. 
Then allocate 200 µL to each of the 12 wells. 
▪ 13 wells × 200 µL = 2.6 mL; 
▪ 3 × 104 cells × 13 wells = 3.9 × 105 cells; 
▪ v ∗ ρ = 3.9 × 105 cells; 
▪ Balance normal media = 2.6 mL - v. 
• Seed cells into 48 well plate in 200 μL/well normal media as shown in Tables 2-4. 




Figure 1. Cell culturing method for ALP assay 
 
2. Alkaline phosphatase assay (modified from Abcam protocol) 
• Standard preparation 
▪ Prepare a 50 μM MUP standard by diluting 2 μL of the 5 mM MUP substrate 
(standard) with 198 μL Assay Buffer. 
▪ Prepare standard curve dilution as shown in Table 10. 







standard in well (μL) 
End [MUP] in well 
1 0 300 120 0 nmol/well 
2 5 295 120 0.1 nmol/well 
3 10 290 120 0.2 nmol/well 
4 15 285 120 0.3 nmol/well 
5 20 280 120 0.4 nmol/well 
6 25 275 120 0.5 nmol/well 
 
• Sample preparation 
▪ Use 200 μL PBS to wash each well. 
▪ Then add 100 μL of Trypsin to each well. 
▪ Leave at room temperature for 2 - 3 min or until cells round and float in the 
media. 
▪ Tap the plate firmly to dislodge any remaining adherent cells. 
▪ Confirm under microscope that cells are off the flask surface. 
▪ Add 0.5 mL normal media to deactivate trypsin and retrieve cells. 
▪ Wash two times with 200 μL cold PBS, and centrifuge at 180 g, 4 min at 4℃. 
▪ Resuspend cells in 100 μL of Assay Buffer. 
▪ Homogenise cells quickly by pipetting up and down a few times. 
 259 
▪ Centrifuge 3 minutes at 4℃ at 13,000 g to remove any insoluble material. 
▪ Collect supernatant and transfer to a clean tube. 
▪ Keep on ice. 
• Assay procedure and detection 
▪ Set up reaction wells as shown in Tables 5-7: 
a. Standard wells = 120 μL standard dilutions. 
b. Sample wells = 1 - 110 μL samples (adjust volume to 110 μL/well with Assay 
Buffer). 
c. Background wells = 110 μL ALP Assay Buffer. 
▪ Prepare 20 μL MUP Reaction Mix (2 μL MUP substrate and 18 μL Assay Buffer) 
for each reaction. 
▪ Add 20 μL MUP Reaction Mix to both sample and background control wells and 
mix well. 
▪ To the standard curve wells, add 10 μL of ALP enzyme. 
▪ Incubate for 30 minutes at 25℃ protected from light. 
▪ Add 20 μL Stop Solution to sample, standard and background wells. In total, 
the volume of each well is 150 μL. 
▪ Gently shake the plate. 
▪ Measure output on a Synergy 2 Multi-mode Microplate Reader. Fluorometric 
assay: measure Ex/Em = 360/440 nm. 
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Appendix 4.6 Cell proliferation and F-actin staining. 
➢ List of main reagents 
Component Company Cat No. 
PrestoBlue Cell Viability Reagent Invitrogen A13261 
Triton X-100 Sigma-Aldrich T8787 
Alexa Fluor 647 Phalloidin Invitrogen A22287 
DAPI Invitrogen D3571 
 
➢ Experimental design 
Table 1. Colour coding table 
Colour Meaning 
Green 1% FBS without PTN (C1) 
Blue 1% FBS with 1 pg/mL PTN (C2) 
Yellow 1% FBS with 10 pg/mL PTN (C3) 
Orange 1% FBS with 100 pg/mL PTN (C4) 
Grey 1% FBS with 1 ng/mL PTN (C5) 
Purple 1% FBS with 10 ng/mL PTN (C6) 
Black 1% FBS with 50 ng/mL PTN (C7) 
Dark grey 1% FBS with 100 ng/mL PTN (C8) 
Dark red 10% FBS with 50 ng/mL PTN (10%T) 
Gold Media (1% and 10% FBS) without cells used as background subtraction (MCs) 
White Spare wells 
 
 Table 2. GCC-1 for cell proliferation. “-1-X” to “-3-X” are three biological replicates of each sample 
region; “-X-1” to ”-X-3” are three technical repeats under each biological replicate. Growth centre 
cell, GCC. 
 1 2 3 4 5 6 7 8 9 10 11 (1%) 12 (10%) 
A GC-1-1 GC-1-2 GC-1-3        Media controls (1% and 10 %) 
B     GC-1-1 GC-1-2 GC-1-3     GC-1 
C GC-1-1 GC-1-2 GC-1-3          
D     GC-1-1 GC-1-2 GC-1-3      
E GC-1-1 GC-1-2 GC-1-3          
F     GC-1-1 GC-1-2 GC-1-3      
G GC-1-1 GC-1-2 GC-1-3          








 Table 3. GCC-2 for cell proliferation. “-1-X” to “-3-X” are three biological replicates of each 
sample region; “-X-1” to ”-X-3” are three technical repeats under each biological replicate. 
Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 9 10 11 (1%) 12 (10%) 
A GC-2-1 GC-2-2 GC-2-3        Media controls (1% and 10 %) 
B     GC-2-1 GC-2-2 GC-2-3     GC-2 
C GC-2-1 GC-2-2 GC-2-3          
D     GC-2-1 GC-2-2 GC-2-3      
E GC-2-1 GC-2-2 GC-2-3          
F     GC-2-1 GC-2-2 GC-2-3      
G GC-2-1 GC-2-2 GC-2-3          
H     GC-2-1 GC-2-2 GC-2-3      
 
 Table 4. GCC-3 for cell proliferation. “-1-X” to “-3-X” are three biological replicates of each 
sample region; “-X-1” to ”-X-3” are three technical repeats under each biological replicate. 
Growth centre cell, GCC. 
 1 2 3 4 5 6 7 8 9 10 11 (1%) 12 (10%) 
A GC-3-1 GC-3-2 GC-3-3        Media controls (1% and 10 %) 
B     GC-3-1 GC-3-2 GC-3-3     GC-3 
C GC-3-1 GC-3-2 GC-3-3          
D     GC-3-1 GC-3-2 GC-3-3      
E GC-3-1 GC-3-2 GC-3-3          
F     GC-3-1 GC-3-2 GC-3-3      
G GC-3-1 GC-3-2 GC-3-3          
H     GC-3-1 GC-3-2 GC-3-3      
 
➢ Reagent preparation 
1. Normal media, 500 mL 
Medium Serum Supplement 
DMEM (442.5 mL) 10% FBS (50 mL) 
Antibiotic-antimycotic (5 mL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 
50 µg/mL Gentamycin (2.5 mL) 
2. Normal reduced media, 70 mL 
Medium Serum Supplement 
DMEM (68.25 ml) 1% FBS (700 μL) 
Antibiotic-antimycotic (700 μL) 
a. 100 unit/mL Penicillin 
b. 100 µg/mL Streptomycin 
c. 250 ng/mL Amphotericin B 
50 µg/mL Gentamycin (350 μL) 





Table 5. Serial dilutions of PTN 
No. Conc. (ng/mL) PTN solution (μL) Sterile PBS (μL) 
1 5333 4 from stock PTN (100 µg/ml) solution 71 
2 2666.5 28 from No. 1 28 
3 533.3 5 from No. 1 45 
4 53.33 5 from No. 3 45 
5 5.333 5 from No. 4 45 
6 0.5333 5 from No. 5 45 
7 0.05333 5 from No. 6 45 
 
Table 6. Normal reduced media with different concentrations of PTN 
Final PTN conc. 
(pg/mL) 
Normal reduced media (2 mL for each PTN conc. under each time point) 
Working PTN volume (µL) PBS volume (µL) 
0 0 37.5 
1 37.5 of serial dilution No. 7 0 
10 37.5 of serial dilution No. 6 0 
100 37.5 of serial dilution No. 5 0 
1,000 37.5 of serial dilution No. 4 0 
10,000 37.5 of serial dilution No. 3 0 
50,000 37.5 of serial dilution No. 2 0 
100,000 37.5 of serial dilution No. 1 0 
 
Table 7. Normal media with 50,000 pg/mL of PTN 
Final PTN conc. 
(pg/mL) 
Normal media (0.7 mL) 
Working PTN volume (µL) PBS volume (µL) 
50,000 13.125 of serial dilution No. 2 0 
Note: This is for one time point. Will do four times for each of the four time points, and make the 
fresh media each time immediately before use. 
 
4. 1% BSA/PBS, 10 mL 
• Weigh 0.1 g BSA and dissolve it into 10 mL sterile PBS. 
5. Alexa Fluor 647 Phalloidin working solution, 100 µL/well 
• Dilute 2.5 μL of the 40× methanol stock solution of Alexa Fluor 647 Phalloidin in 
97.5 μL of 1% BSA/PBS for each well to be stained. When staining more than one 
well, adjust volumes accordingly. 
6. DAPI working solution, final conc. at 750 nM 
• To make a 5 mg/mL DAPI stock solution (10.9 mM for the dilactate), dissolve the 
contents of one vial (10 mg) in 2 mL of deionized water (dH2O). 
• Dilute the DAPI stock solution (10.9 mM) to 750 nM in PBS. 
 
➢ Procedure 
1. Cell culturing and proliferation detection 
• Recovery cells from Dewar. 
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• Culture them in T25 flasks and passage into T75 flasks in normal media. Count cells 
as present in Appendix 4.4 before seeding. 
• Cell density calculation for 48 well plates: 
Each well requires GCCs in 100 µL media. Seeding density is 6000 cells/cm2. For 96 
well plates, each well has 0.32 cm2 surface area. 
• Seed cells into 96 well plate in 100 μL/well normal media with 10% FBS as shown 
in Tables 2-4. 
• After 24 hours, add media as planned in Figure 1. 
 
Figure 1. Cell culturing method for proliferation and F-actin staining 
 
• Four hours prior to each time point add 11 µL (10×) PrestoBlue. 
• After 4 hours incubation, take out the media and read the plate at an 
excitation/emission wavelength of 560/590 nm using a Synergy 2 Multi-mode 
Microplate Reader. 
• After reading, incubate the cells with defined PTN conc. media for another 20 hours. 
Then add 11 µL (10×) PrestoBlue for another 4 hours incubation, read the plate 
with transferred media again. 
• Repeat the procedures for four times (T1 to T4) in total. 
• After T4, undertake F-actin staining to the first well of each biological replicate test 
and control condition. 
2. F-actin staining (modified from Invitrogen protocols; For 48/96 well plate) 
• Wash cells twice with prewarmed PBS. 
• Fix the cells with 100-200 µL 10% Neutral buffered formalin for 15 minutes at RT. 
• Wash two times with 100-200 µL PBS for 3 minutes each on the shaker. 
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• Incubate each well with 100-200 µL 0.1% Triton X-100 in PBS for 15 minutes. 
• Wash two times with 100-200 µL PBS for 3 minutes each on the shaker. 
• Pre-incubate each well with 100-200 µL 1% BSA/PBS for 30 minutes on the shaker 
prior to adding the phallotoxin staining solution.  
• Place 100 µL/well of the Alexa Fluor 647 Phalloidin working solution in the plate 
covered by tin foil for 45 minutes on the shaker at RT. 
• Wash three times with 100-200 µL PBS for 3 minutes each on the shaker. 
• Add 100-200 µL of DAPI working solution to each well, assuring that the cells are 
completely covered. 
• Incubate for 10 minutes in the dark. 
• Rinse the sample three times in the dark with 100-200 µL PBS for 3 minutes each 
on the shaker. Drain excess buffer from the wells and dry. 
• Image the wells using an EVOS M5000 under DAPI and CY5 channels for DAPI and 
Alexa Fluor 647 Phalloidin respectively. 
➢ Result 
 
Figure 2. F-actin staining images with different channel under 10% FBS + 5× 104 pg/mL 
PTN. Red indicates F-actin staining and blue indicates DAPI staining. Scale bar = 400 μm. 
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Appendix 4.8 Relative protein levels of detected proteins as determined by 




















































































Appendix 4.9 Antler powder protein quantification and PTN ELISA detection 
data. 
ELISA results (pg/mL) 
Processing and extraction methods Replicate 1 Replicate 2 Replicate 3 
Traditional and buffer extraction 0.00 0.00 0.00 
Freeze dried and buffer extraction 1518.21 1770.51 1762.76 
Cryogenic/freeze dried and buffer extraction 6806.50 8395.68 4540.27 
Traditional and sonication 0.00 97.98 192.81 
Freeze dried and sonication 3473.96 4031.73 3195.92 
Cryogenic/freeze dried and sonication 1578.78 6643.20 4464.12 
 
DC protein quantification (mg/mL) 
Processing and extraction methods Replicate 1 Replicate 2 Replicate 3 
Traditional and buffer extraction 1.32 1.29 1.34 
Freeze dried and buffer extraction 0.65 0.63 0.65 
Cryogenic/freeze dried and buffer extraction 2.61 2.69 2.49 
Traditional and sonication 1.60 1.58 1.47 
Freeze dried and sonication 0.78 0.74 0.74 
Cryogenic/freeze dried and sonication 3.49 2.94 3.03 
 
Normalisation of ELISA results by protein quantification (pg/mg) 
Processing and extraction methods Replicate 1 Replicate 2 Replicate 3 
Traditional and buffer extraction 0.00 0.00 0.00 
Freeze dried and buffer extraction 2332.45 2798.22 2708.16 
Cryogenic/freeze dried and buffer extraction 2603.32 3124.24 1825.40 
Traditional and sonication 0.00 62.08 131.24 
Freeze dried and sonication 4464.21 5434.94 4308.23 
Cryogenic/freeze dried and sonication 452.73 2258.20 1471.98 
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Appendix 4.10 Quantitative Alizarin Red S staining data.  
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0 29 1.00E+00 75 1.00E+00 53 1.00E+00 
1 31 1.07E+00 72 9.60E-01 29 5.47E-01 
100 22 7.59E-01 100 1.33E+00 13 2.45E-01 
10000 20 6.90E-01 89 1.19E+00 65 1.23E+00 
100000 32 1.10E+00 109 1.45E+00 12 2.26E-01 
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Appendix 4.12 Cell proliferation statistical analysis. 
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One-way ANOVA with post-hoc Tukey HSD test 
 Tukey's multiple comparisons test (Adjusted p value) 
PTN conc. (pg/mL) 
comparison 
24 h 48 h 72 h 96 h 
1 vs. 10 4.82E-01 3.58E-01 4.84E-01 9.86E-01 
1 vs. 102 9.97E-01 9.99E-01 1.00E+00 9.99E-01 
1 vs. 103 4.82E-02 5.73E-02 1.34E-01 1.07E-01 
1 vs. 104 9.79E-01 9.95E-01 1.00E+00 >0.9999 
1 vs. 5×104 1.00E+00 >0.9999 8.07E-01 9.99E-01 
1 vs. 105 3.35E-01 3.77E-01 >0.9999 9.99E-01 
10 vs. 102 8.00E-01 1.72E-01 6.79E-01 8.92E-01 
10 vs. 103 7.50E-01 9.03E-01 9.67E-01 3.44E-01 
10 vs. 104 1.52E-01 1.42E-01 7.03E-01 9.92E-01 
10 vs. 5×104 6.64E-01 2.90E-01 9.97E-01 >0.9999 
10 vs. 105 1.22E-02 9.30E-03 5.94E-01 8.90E-01 
102 vs. 103 1.28E-01 2.34E-02 2.28E-01 5.14E-02 
102 vs. 104 8.03E-01 >0.9999 >0.9999 9.98E-01 
102 vs. 5×104 >0.9999 1.00E+00 9.37E-01 9.68E-01 
102 vs. 105 1.43E-01 6.54E-01 >0.9999 >0.9999 
103 vs. 104 1.10E-02 1.89E-02 2.43E-01 1.22E-01 
103 vs. 5×104 8.38E-02 4.38E-02 7.56E-01 2.28E-01 
103 vs. 105 9.00E-04 1.20E-03 1.82E-01 5.11E-02 
104 vs. 5×104 9.08E-01 9.99E-01 9.48E-01 1.00E+00 
104 vs. 105 7.81E-01 7.21E-01 >0.9999 9.98E-01 
5×104 vs. 105 2.12E-01 4.55E-01 8.90E-01 9.68E-01 
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One sample t test 
Time 
point 
Cells with different PTN conc. (pg/mL) compared to the theoretical mean of 1 (cells without PTN) 
1 10 102 103 104 5×104 105 
24 h 8.80E-03 1.22E-01 5.30E-02 8.23E-01 6.20E-02 1.24E-02 9.80E-03 
48 h 4.44E-02 3.45E-01 1.03E-01 4.74E-01 2.24E-02 2.27E-02 1.55E-02 
72 h 4.65E-02 4.56E-01 1.15E-01 4.22E-01 2.06E-02 4.47E-01 9.60E-02 
96 h 2.93E-02 3.14E-02 2.45E-02 5.40E-01 1.05E-01 2.06E-01 6.97E-02 
 
